Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.7984929082988093,2.188540482242896,0.0,0.0,0.0,13/27,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;RPS13;RPS16;FAU;GEMIN5;RPS12;RPS15;RPS15A
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.6874189291767016,2.1635968536237282,0.0,0.00208284599477885,0.003,21/49,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.6852829624672679,2.1572982379291124,0.0,0.001388563996519233,0.003,21/49,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.6941808850469174,2.155959497484419,0.0,0.001041422997389425,0.003,21/47,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.6831668747623257,2.150144110619156,0.0,0.001388563996519233,0.004,21/51,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,KEGG_2021_Human__Ribosome,0.6857092848995927,2.147832611997584,0.0,0.0011571366637660276,0.004,22/51,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,0.6804445296981124,2.147100806136776,0.0,0.0009918314260851666,0.004,21/50,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.6838339083767389,2.1393932920521364,0.0,0.0008678524978245207,0.004,21/48,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,KEGG_2021_Human__Coronavirus disease,0.6456994113650877,2.1364547344227542,0.0,0.000771424442510685,0.004,24/68,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;NRP1;RPS16;MAPK3;FAU;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.6855907205680121,2.132551871019397,0.0,0.0009719947975634632,0.004,21/48,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.6723985687485659,2.1176722451038494,0.0,0.0013885639965192332,0.007,21/51,8.64%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;SRP9;RPS16;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6800158066267737,2.116576679633312,0.0,0.0012728503301426303,0.007,21/50,8.64%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;SRP9;RPS16;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.6430626989998698,2.1142753566852512,0.0,0.001174938766285505,0.007,23/63,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;C1D;FAU;RPL23;MPHOSPH6;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.6371922537881918,2.09710612308878,0.0,0.0013885639965192332,0.007,23/64,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;C1D;FAU;RPL23;MPHOSPH6;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.6605567179781191,2.0930984942172848,0.0,0.001295993063417951,0.007,21/52,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.6323025880139732,2.0890376058340756,0.0,0.001214993496954329,0.007,23/65,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;C1D;FAU;RPL23;MPHOSPH6;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.6474446603904673,2.0770963868268066,0.0,0.0014702442316085998,0.009,24/59,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;ATP6V0E1;RPS16;MIOS;FAU;CASTOR2;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6560592104696089,2.0712945760849535,0.0,0.0014657064407703018,0.01,20/52,8.64%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.6389238586661843,2.0709025236457794,0.0,0.0013885639965192332,0.01,21/62,8.64%,TENT2;RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.6550090775769883,2.0686342428673368,0.0,0.0013191357966932716,0.01,21/51,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.6079659580807941,2.0680585088062102,0.0,0.0012563198063745443,0.01,28/80,8.64%,RPS21;RPS7;RPS27A;RPL32;POLR2B;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;CREBL2;RPS16;MCM9;RPA1;BRIP1;MRPL42;RPL23;DNA2;RPL10;RPS12;RPS15;RPS15A;TOPBP1;RPL7A
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6503494225248143,2.0608254317133965,0.0,0.0012623309059265756,0.011,21/51,9.28%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A;RWDD1
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.6473071074542345,2.058477583632593,0.0,0.0012074469534949853,0.011,21/54,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,0.653066747437847,2.057333649250484,0.0,0.0011571366637660276,0.011,23/53,9.32%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;HNMT;RPS12;RPS15;RPS15A;RPL7A;GSR
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.631604706731801,2.0122353910934176,0.0,0.0027771279930384665,0.022,22/55,8.64%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;SRP9;RPS16;RPL23;RPL10;EDEM1;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.6316072377125805,1.9951674397583292,0.0,0.0033111910686227865,0.027,21/55,8.64%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;MRPL42;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.5979750860281453,1.9903647292184796,0.0,0.003394267547047014,0.03,24/66,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;POLR2B;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;NUP210;FAU;RPL23;NUP107;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.7457450002822297,1.9903333325084231,0.002232142857142857,0.0032730437060810498,0.03,11/23,12.42%,PDZD2;RPS27A;MAPKAPK5;BRIP1;DNA2;PRKAB2;TOPBP1;HIPK2;HIPK1;MRE11;RBBP8
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.6288467082526519,1.9795034212096918,0.0,0.0036281833457438026,0.041,21/54,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.6288467082526519,1.9795034212096918,0.0,0.0036281833457438026,0.041,21/54,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.6288467082526519,1.9795034212096918,0.0,0.0036281833457438026,0.041,21/54,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.7476774400529796,1.9740790711256426,0.0,0.0036449804908629865,0.041,12/20,18.46%,RPS27A;BRIP1;RAD51C;DNA2;TOPBP1;MRE11;ERCC4;RBBP8;H2BC5;RNF8;POLE2;ERCC1
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.5883462294953207,1.973396147257069,0.0,0.0035766042334586306,0.041,25/70,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;POLR2B;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;NUP210;FAU;RPL23;NUP107;RPS12;RPS15;RPS15A;RAN;RPL7A
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.5866866826272021,1.9508330963573643,0.0,0.005921817043979082,0.068,22/66,9.28%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;MRPL42;RPL23;RPL10;RPS12;RPS15;RPS15A;RPL7A;RWDD1
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.5928562737377548,1.9481438329802838,0.0,0.006070008327641219,0.071,20/70,8.16%,GPC5;RPS21;RPS7;GPC6;RPS27A;RPS14;RPS24;RPS23;YWHAH;RPS13;NRP1;RPS16;NUP210;SEC24A;FAU;GEMIN5;NUP107;RPS12;RPS15;RPS15A
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.5379403711213403,1.9204131576956478,0.0,0.008485668867617537,0.108,34/108,12.58%,RPS21;RPS7;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PHKA2;CALU;ST8SIA4;CDH2;RPS16;PLOD2;FSTL1;MRPL42;RPL23;LGMN;RPL10;RPS12;RPS15;RPS15A;RPL7A;SPCS3;UBA3;HSP90B1;FDX1;CHRDL1;UBL5
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.6005653367188938,1.906665292400531,0.0,0.009569832948983904,0.128,17/56,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;YWHAH;RPS13;RPS16;NUP210;SEC24A;FAU;GEMIN5;NUP107;RPS12;RPS15;RPS15A
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.6574696347835922,1.8543401477060124,0.0022988505747126436,0.01717077917646954,0.259,12/32,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;RPS13;RPS16;FAU;RPS12;RPS15;RPS15A
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.6574696347835922,1.8543401477060124,0.0022988505747126436,0.01717077917646954,0.259,12/32,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;RPS13;RPS16;FAU;RPS12;RPS15;RPS15A
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.6574696347835922,1.8543401477060124,0.0022988505747126436,0.01717077917646954,0.259,12/32,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;RPS13;RPS16;FAU;RPS12;RPS15;RPS15A
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.6574696347835922,1.8543401477060124,0.0022988505747126436,0.01717077917646954,0.259,12/32,8.16%,RPS21;RPS7;RPS27A;RPS14;RPS24;RPS23;RPS13;RPS16;FAU;RPS12;RPS15;RPS15A
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.7520878831564759,1.8490406525710918,0.0021929824561403508,0.01791908776460534,0.28,7/15,12.42%,RPS27A;BRIP1;RAD51C;DNA2;TOPBP1;MRE11;RBBP8
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.5037119925975746,1.829482953780362,0.0,0.02302432859344682,0.352,33/124,9.00%,CUX1;CUX2;HDAC9;RPS27A;RPS14;NFIB;ZFPM2;GLIS3;PER3;EDNRB;ID2;ZNF451;CRY1;RARB;IRF2BPL;USP2;ZHX2;MEIS2;FOXP2;JDP2;ZNF684;ZNF566;RPL23;SDCBP;CGGBP1;RPL10;SIRT1;CTBP2;HDAC3;PPID;ZNF439;PER1;SMAD3
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.6147440306926393,1.8286511791712736,0.0021645021645021645,0.022753514579326523,0.355,12/34,12.42%,PDZD2;RPS27A;USP2;MAPKAPK5;BRIP1;DNA2;PRKAB2;TOPBP1;HIPK2;HIPK1;MRE11;RBBP8
prerank,KEGG_2021_Human__Viral carcinogenesis,0.6308110018098364,1.8271725571992172,0.0,0.022525593721312003,0.358,14/35,14.88%,HDAC9;KAT2B;YWHAH;GTF2B;MAPK3;POLB;GTF2H3;RHOA;GSN;HDAC3;TRAF5;KRAS;STAT3;H2BC5
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.7254331067543032,1.8215585553030802,0.00211864406779661,0.023756518810013838,0.378,2/17,1.30%,CHGA;RPL30
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.5144589251900961,1.819142521877239,0.0,0.02416692232239857,0.385,40/101,16.12%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;CHGA;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PSMB1;RPS16;FAU;MRI1;ALDH7A1;RPL23;HNMT;KYAT3;RPS12;RPS15;RPS15A;SOAT1;RPL7A;GSR;CHDH;FTCD;DHTKD1;PSTK;APIP;TXNRD1;PSMB2;RPS4X;CARNMT1;DLST;RPL10A
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.7323646763342085,1.8102622045495842,0.0044444444444444444,0.02681664218277769,0.423,8/16,17.84%,RPS27A;BRIP1;DNA2;TOPBP1;MRE11;RBBP8;H2BC5;RNF8
prerank,KEGG_2021_Human__Olfactory transduction,-0.6927018703335158,-1.808141829269451,0.0019267822736030828,1.0,0.634,7/26,9.72%,PRKG1;PDE1A;GNAL;CAMK2D;PDE1C;PRKG2;GNG7
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.7361775809566901,1.8060238883506086,0.004319654427645789,0.027799617971129953,0.442,8/15,17.84%,YWHAH;BRIP1;DNA2;TOPBP1;MRE11;RBBP8;H2BC5;RNF8
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.7292381210202558,1.7918627961610465,0.0,0.03207582831959429,0.494,7/16,10.48%,RPS27A;CRY1;PPARGC1A;SIRT1;HDAC3;PER1;LIN9
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.690040410041961,1.791501084169657,0.002277904328018223,0.03094895523011137,0.494,6/19,8.62%,HDAC9;TTC39B;CYP7B1;DISP3;SIRT1;SOAT1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.690040410041961,1.791501084169657,0.002277904328018223,0.03094895523011137,0.494,6/19,8.62%,HDAC9;TTC39B;CYP7B1;DISP3;SIRT1;SOAT1
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,0.4727540027533203,1.790325302974461,0.0,0.030862799771691637,0.5,54/153,16.24%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;POLR2B;RPS14;SF3B3;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PSMB1;RBMX;RPS16;PHAX;C1D;NUP210;CPSF2;FAU;GEMIN5;GTF2H3;SRSF10;RPL23;TRMT13;MPHOSPH6;PAIP1;NUP107;RPS12;RPS15;RPS15A;RAN;RPL7A;SRSF3;LIN9;FAM98B;WDR75;GCFC2;HNRNPR;RTCB;PSMB2;CNOT7;HNRNPH2;ANP32A;RPS4X;NUP155;POLR2I;RPL10A;DNAJC8;TRMT61B
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.5235773729988341,1.7897593416420678,0.0,0.03041983718300468,0.502,20/88,8.16%,GPC5;RPS21;RPS7;GPC6;RPS27A;RPS14;RPS24;RPS23;YWHAH;RPS13;NRP1;RPS16;NUP210;SEC24A;FAU;GEMIN5;NUP107;RPS12;RPS15;RPS15A
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.7682889449572103,-1.7894521322464063,0.0074487895716946,0.8668568793139838,0.703,6/15,0.88%,PTPRD;ROBO2;GRID2;CLSTN2;IL1RAPL2;SLIT1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.7454294832196611,-1.7832379291538105,0.012962962962962963,0.6195533390136563,0.728,10/15,17.24%,CAMK2D;ITPR2;ASIC2;ADCY8;PRKCH;HRH1;HTR2C;PRKCQ;PRKCG;CALM3
prerank,Reactome_2022__Translation R-HSA-72766,0.5178133359251358,1.7806498077223831,0.0,0.03302257649903922,0.535,23/82,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;RPS16;MRPL48;FAU;MRPL42;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.4698656617560952,1.7801164842716082,0.0,0.03253207077559347,0.537,57/174,15.12%,FKBP5;RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;NR3C2;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PSMB1;ATP6V0E1;PPARGC1A;HSPH1;RPS16;MIOS;MAPKAPK5;DNAJB6;H2AZ2;NUP210;MAPK3;HIKESHI;FAU;CASTOR2;MINK1;BRIP1;ANAPC1;RPL23;SIRT1;EDEM1;NUP107;RPS12;HDAC3;RPS15;RPS15A;RPL7A;GSR;EXTL1;LIN9;HSP90B1;MRE11;H3-3B;H2AZ1;STAT3;TXNRD1;PSMB2;GML;SIN3A;H2BC5;RPS4X;NUP155
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.4684199693405955,1.7797012797773695,0.0,0.03210749732302367,0.54,57/176,15.12%,FKBP5;RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;NR3C2;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PSMB1;ATP6V0E1;PPARGC1A;HSPH1;RPS16;MIOS;MAPKAPK5;DNAJB6;H2AZ2;NUP210;MAPK3;HIKESHI;FAU;CASTOR2;MINK1;BRIP1;ANAPC1;RPL23;SIRT1;EDEM1;NUP107;RPS12;HDAC3;RPS15;RPS15A;RPL7A;GSR;EXTL1;LIN9;HSP90B1;MRE11;H3-3B;H2AZ1;STAT3;TXNRD1;PSMB2;GML;SIN3A;H2BC5;RPS4X;NUP155
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.5450515882057141,1.7792990795211983,0.002364066193853428,0.03176938661001762,0.542,22/58,10.78%,RPS7;RPL32;RPS14;RPLP1;RPS24;RPL26;RPL30;RPL8;RPL5;RPS16;C1D;DHX29;RPL23;RPL10;MPHOSPH6;RPS15;RAN;RPL7A;RRP12;HEATR3;HELQ;WDR75
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.5656975336619611,1.7784163339504664,0.0,0.03160748215805644,0.546,19/50,10.78%,RPS7;RPL32;RPS14;RPLP1;RPS24;RPL26;RPL30;RPL8;RPL5;RPS16;C1D;RPL23;RPL10;MPHOSPH6;RPS15;RPL7A;RRP12;HELQ;WDR75
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.5433411849425545,1.7668704404975915,0.0023148148148148147,0.03596380750984814,0.592,20/57,10.78%,RPS7;RPL32;RPS14;RPLP1;RPS24;RPL26;RPL30;RPL8;RPL5;RPS16;C1D;RPL23;NSA2;RPL10;MPHOSPH6;RPS15;RPL7A;RRP12;HELQ;WDR75
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.688043163616356,1.7661082821400031,0.002150537634408602,0.035692923713805856,0.594,9/19,14.22%,YWHAH;ID2;TIAM1;CNTN4;DISP3;BRINP3;RHOA;NREP;SIN3A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.7135423983517375,1.7609572724901323,0.0043859649122807015,0.037200077390620104,0.61,8/16,11.46%,ZFPM2;ID2;CREBL2;CCDC85B;FOXO1;SIRT1;SMAD3;PTPRQ
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.7092772416669009,-1.750805381790777,0.00945179584120983,0.6557990103731034,0.818,8/17,9.80%,PTPRD;IL1RAPL2;SYT2;LIN7C;SYT12;SYT10;BEGAIN;HOMER1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.5302544531607291,1.746282176359463,0.0,0.0439932339214665,0.676,21/61,10.78%,RPS7;RPL32;RPS14;RPLP1;RPS24;RPL26;RPL30;RPL8;RPL5;RPS16;C1D;RPL23;INTS9;RPL10;MPHOSPH6;RPS15;RPL7A;SMAD3;RRP12;HELQ;WDR75
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.5928864332849418,1.745994086866346,0.004484304932735426,0.0435011064534541,0.677,14/33,12.42%,RPL5;USP2;MAPKAPK5;RPA1;BRIP1;RPL23;DNA2;RPS15;PRKAB2;TOPBP1;HIPK2;HIPK1;MRE11;RBBP8
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.5022209132841474,1.74532129593408,0.0,0.043045483892096226,0.679,26/93,8.64%,RPS21;RPS7;RPS27A;RPL32;POLR2B;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;CREBL2;RPS16;NUP210;CPSF2;MRPL42;RPL23;RPL10;NUP107;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.579873525058224,-1.734917454082534,0.005415162454873646,0.6205439039452189,0.858,12/51,5.32%,PTPRD;ROBO2;GRID2;LRRC4C;SDK1;CNTN6;TENM4;PTPRM;CDH13;CDHR3;DSCAML1;CDH4
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.5108038813470476,1.729601933672838,0.0,0.051439984416507954,0.752,25/77,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;DCC;RPL5;RPS13;PSMB1;NRP1;RPS16;FAU;RHOA;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.6626508515082243,1.7277264526347689,0.018218623481781375,0.051936438436973105,0.758,12/19,19.88%,YWHAH;TOMM7;PPP3CC;HDAC3;RAN;SMAD3;FIS1;UBL5;TFDP1;BID;SAR1B;CD81
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.45879878657839746,1.7256535118282932,0.0,0.052622491456324465,0.764,45/160,14.22%,CUX1;RORB;CUX2;HDAC9;RPS27A;RPS14;ZFPM2;GLIS3;PER3;EDNRB;ID2;CCDC85B;CRY1;RARB;IRF2BPL;FOXO1;USP2;ZHX2;MEIS2;FOXP2;JDP2;ZNF684;ZNF566;NRG1;RPL23;SDCBP;CGGBP1;RPL10;SIRT1;CTBP2;HDAC3;PPID;ZNF439;PER1;SMAD3;NAB1;TCEAL7;CTCF;PRMT2;GCFC2;STAT3;ZNF391;ZNF589;CNOT7;SIN3A
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.727231314422667,-1.7227665151909095,0.009596928982725527,0.5793679207673126,0.886,4/17,8.14%,ROBO2;GREB1L;TGFBR1;PCSK5
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5738721907587909,-1.722641532714411,0.0036363636363636364,0.4969870093323313,0.886,11/46,10.70%,KIAA1217;SOX6;BMPR1B;COL19A1;XYLT1;PAPSS2;FGFR2;TGFBR1;PCSK5;EIF2AK3;ETS2
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.5851950045225017,-1.7130690010860241,0.009191176470588236,0.47420481993637,0.901,16/44,16.64%,PDE1A;GNAL;CAMK2D;ADORA1;PDE1C;ITPR2;RGS12;GRM8;GNG2;ADCY8;RGS20;GNG7;OPRM1;GRM4;PRKCG;RGSL1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.6587526158907283,1.7119248678236063,0.008247422680412371,0.06011073416815868,0.811,9/20,12.42%,MCM9;POLB;RPA1;BRIP1;DNA2;TOPBP1;MRE11;WDHD1;RBBP8
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.7074227248792021,-1.7054108279345348,0.009560229445506692,0.4516826002329454,0.92,9/18,12.24%,PDE1A;GNAL;CAMK2D;PDE1C;ITPR2;GNG2;ADCY8;GNG7;OPRM1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.5093176040597833,1.7032455815227356,0.0,0.06484593863744818,0.836,22/70,8.64%,RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PSMB1;RPS16;FAU;RPL23;RPS12;RPS15;RPS15A;RPL7A
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.6148252862203335,-1.669389476879283,0.015570934256055362,0.5588812369554512,0.96,11/31,11.72%,GRID2;CLSTN2;LRRC4C;MCTP1;GRIK4;CHRNA7;GRM8;NPTX2;BEGAIN;HOMER1;LRP8
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.6677355323209598,1.6659044182618354,0.01079913606911447,0.09324891740005216,0.915,10/17,14.88%,PMEPA1;H2AZ2;SYCE1;STAG3;RAD51C;MRE11;H3-3B;RBBP8;H2AZ1;H2BC5
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.4956827522078983,-1.6657502331112968,0.00510204081632653,0.5253268732096501,0.966,16/95,5.24%,RBFOX1;ROBO2;IL1RAPL2;ADGRV1;SOX6;SDK1;CNTN6;ADORA1;GDA;ACVR1C;MET;SNTG2;ERBB4;ASIC2;TEAD1;DSCAML1
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.6595247739436627,1.6534324568871333,0.010660980810234541,0.10362158824024777,0.933,8/19,17.06%,HDAC9;H2AZ2;MAPK3;HDAC3;H3-3B;H2AZ1;H2BC5;PLCB4
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5382827325958743,-1.6519201731024091,0.013745704467353952,0.5389010920290479,0.973,19/59,15.92%,GRID2;PDE7B;GRIK4;CHRNA7;ASIC2;SLC1A2;LIN7C;SYT10;NPTX2;GABRG3;SLC17A6;SHISA6;STXBP3;HOMER1;HRH1;HTR2C;SYT5;GRIK3;GRM4
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.7035658299423416,-1.6496171004025724,0.012367491166077738,0.5072142706387237,0.975,6/17,12.58%,ROBO2;GHR;SLIT3;SERPINB9;AR;ATP1A1
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,-0.6524904316892414,-1.64881082917107,0.017857142857142856,0.47412039678879364,0.975,9/21,11.72%,PRKG1;PDE1A;ITPR2;TRPC6;GNG2;PRKG2;GNG7;TRPC7;LRP8
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.649362929616148,1.6408317885117536,0.017543859649122806,0.11412854765911505,0.95,7/17,9.52%,RPS7;RPS24;RPL26;RPL5;RPS16;RPS15;HEATR3
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.6798206093437401,1.635808673614954,0.016494845360824743,0.11770894527250202,0.956,7/15,20.90%,CYP7B1;ALDH1A1;ACSS2;FDX1;MAOB;CYP3A4;CYB5B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.6089201956268697,1.6343154325486096,0.017391304347826087,0.11778725527807148,0.957,11/23,11.78%,RPS27A;PMEPA1;ZNF451;LDLRAD4;SMURF1;SDCBP;SIRT1;SMAD3;HIPK2;STRAP;NREP
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.5672307793106708,1.631753702766995,0.014705882352941176,0.11888665691250855,0.957,17/30,19.66%,RPS27A;BRIP1;RAD51C;DNA2;TOPBP1;DCLRE1C;MRE11;ERCC4;RBBP8;TDP2;H2BC5;EYA4;RNF8;POLE2;ERCC1;LRIG3;XRCC4
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.6553223407251918,1.6306716620451627,0.014373716632443531,0.11855090536516152,0.961,9/17,14.48%,TIAM1;EPHA7;EPHA10;RHOA;EPHA3;SDCBP;EPHA6;AP2S1;VAV3
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.6601276563654417,1.629573094762126,0.015250544662309368,0.11818815862681012,0.961,11/16,16.90%,RGPD8;RANBP17;HIKESHI;RPL23;NUP107;RAN;HEATR3;IPO8;STAT3;NUP155;APPL1
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.6467806859612276,1.6243858067498482,0.019230769230769232,0.12208817113699486,0.966,10/18,14.88%,PMEPA1;H2AZ2;SYCE1;STAG3;RAD51C;MRE11;H3-3B;RBBP8;H2AZ1;H2BC5
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.6473734942520432,1.6214138481106524,0.015151515151515152,0.1238425514395591,0.966,8/18,9.14%,RPS27A;PMEPA1;ZNF451;LDLRAD4;SMURF1;SIRT1;SMAD3;STRAP
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.4193953549810823,1.609631008645103,0.0,0.13556498869721106,0.971,41/203,9.02%,GPC5;RPS21;RPS7;GPC6;RPL36AL;RPS27A;RPL32;POLR2B;VIPR2;RPS14;RPLP1;CHGA;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;YWHAH;RPS13;PSMB1;NRP1;RAB5A;GTF2B;RPS16;NUP210;MAPK3;SEC24A;FAU;GEMIN5;GTF2H3;RPL23;NUP107;RPS12;HDAC3;RPS15;RPS15A;MYO1E;RAN;RPL7A;WASF2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.6255504967867583,1.604070982538556,0.02040816326530612,0.14080377598850516,0.974,11/17,23.92%,RPL26;HIPK2;ARID3A;CRADD;GML;CNOT7;PLAGL1;TFDP1;RGCC;PLK2;ACER2
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.6745341727104812,1.6021187486024668,0.010845986984815618,0.14126547453745064,0.974,6/15,11.40%,HDAC9;RPS27A;KAT2B;TLE4;HDAC3;MAML3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.608798239689057,-1.6004634814185583,0.01904761904761905,0.6488650558521656,0.994,7/25,5.32%,ROBO2;SDK1;CNTN6;PTPRM;CDH13;DSCAML1;CDH4
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.6392149189053834,1.5943881708452488,0.02528735632183908,0.14819614558089197,0.98,9/15,19.98%,RPL26;ARID3A;CRADD;GML;CNOT7;PLAGL1;TFDP1;FBXO31;RGCC
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.5375744581757325,1.5938849594567246,0.015486725663716814,0.14692640687875272,0.98,11/38,8.02%,RORB;HDAC9;POLR2B;KAT2B;NR3C2;RARB;PPARGC1A;GTF2B;MAPK3;GTF2H3;HDAC3
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.5863431763010056,1.5801196897286027,0.02736842105263158,0.16267188680152644,0.985,13/23,19.54%,RPS27A;BRIP1;RAD51C;DNA2;TOPBP1;MRE11;ERCC4;RBBP8;H2BC5;RNF8;POLE2;ERCC1;LRIG3
prerank,Reactome_2022__Disease R-HSA-1643685,0.38608681285797847,1.579900617448865,0.0,0.1611372656190595,0.985,90/357,15.84%,CUX1;THSD4;HDAC9;GPC5;RPS21;RPS7;GPC6;RPL36AL;RPS27A;RPL32;POLR2B;KAT2B;VIPR2;RPS14;RPLP1;CYP7B1;CHGA;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;YWHAH;RPS13;PSMB1;NRP1;RAB5A;GTF2B;TPST2;FOXO1;RPS16;H2AZ2;NUP210;MAPK3;SEC24A;SLC24A4;FAU;GEMIN5;GTF2H3;BRIP1;RAD51C;NRG1;GBE1;B3GLCT;ANAPC1;RPL23;DNA2;CTBP2;FZD6;NUP107;RPS12;HDAC3;RPS15;RPS15A;MYO1E;TOPBP1;RAN;RPL7A;SMAD3;WASF2;KITLG;AP1S2;KSR1;ADAMTS2;HEXB;KLKB1;GALNT3;MRE11;MAML3;H3-3B;STAM;FDX1;TPM4;RBBP8;H2AZ1;STAT3;ADRB1;AP2S1;TXNRD1;PSMB2;SIN3A;VAV3;H2BC5;RPS4X;NUP155;GRSF1;TFDP1;POLR2I;ADAMTS17
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.5585216367770974,1.5772109057631052,0.01805869074492099,0.16291958254614866,0.986,10/30,14.88%,RPS27A;YWHAH;PSMB1;BRIP1;DNA2;TOPBP1;MRE11;RBBP8;PSMB2;H2BC5
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.524111683085367,1.5752797956036357,0.01279317697228145,0.16364772763472177,0.988,16/39,16.36%,HDAC9;RPS27A;KAT2B;TLE4;PSMB1;H2AZ2;HDAC3;SMAD3;MAML3;H3-3B;H2AZ1;POGLUT1;PSMB2;H2BC5;TFDP1;NOTCH2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.5522763521157685,1.573398508929765,0.014861995753715499,0.1642979777659257,0.988,18/31,19.66%,MCM9;POLB;RPA1;BRIP1;RAD51C;DNA2;APLF;HELQ;DCLRE1C;MRE11;ERCC4;RBBP8;TDP2;MMS22L;RNF8;ERCC1;FBH1;XRCC4
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.41627558855004704,1.5730240217288405,0.002570694087403599,0.16313338117348483,0.989,40/160,8.92%,SEMA6D;RPS21;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;DCC;RPL5;RPS13;CACNA1G;UNC5D;TIAM1;PSMB1;NRP1;ST8SIA4;CACNB4;EPHA7;RPS16;MAPK3;SPTB;EPHA10;FAU;RHOA;EPHA3;RPL23;GFRA1;SDCBP;RPS12;RPS15;RPS15A;RPL7A;EPHA6;DPYSL3
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4588197158519817,1.5676090037895294,0.009216589861751152,0.16938971448842777,0.994,21/79,14.22%,RORB;HDAC9;ZFPM2;ID2;CCDC85B;CRY1;FOXO1;ZHX2;FOXP2;NRG1;SIRT1;CTBP2;HDAC3;PER1;NAB1;TCEAL7;CTCF;PRMT2;GCFC2;CNOT7;SIN3A
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.47756080692549957,-1.5605202801881053,0.010830324909747292,0.8075496181415964,0.999,21/78,9.88%,PTPRD;GNAL;CAMK2D;IL1RAPL2;GRIK4;ERBB4;KCNH8;SYT2;NEFL;SLC1A2;LIN7C;KCNN3;GNG2;SYT12;ADCY8;SYT10;GABRG3;BEGAIN;GNG7;HOMER1;KCNK1
prerank,KEGG_2021_Human__mTOR signaling pathway,0.5901332752965661,1.5590943677530003,0.027139874739039668,0.17990115692537892,0.995,10/21,16.60%,MIOS;MAPK3;CASTOR2;RHOA;WNT2B;FZD6;DEPTOR;KRAS;WNT3;LPIN2
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.6520178584718411,1.558891148697035,0.03624733475479744,0.17838615768049212,0.995,9/16,13.56%,MCM9;MCMDC2;RPA1;RAD51C;HELQ;MRE11;ERCC4;RBBP8;MMS22L
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.4461382560949398,1.5585715009011207,0.007407407407407408,0.17690305315655028,0.996,25/81,15.86%,PDZD2;RPS27A;POLR2B;YWHAH;USP2;MAPKAPK5;GTF2H3;BRIP1;DNA2;PRKAB2;TOPBP1;HIPK2;GSR;ARID3A;CRADD;HIPK1;MRE11;RBBP8;FANCI;TXNRD1;CNOT7;PLAGL1;TFDP1;POLR2I;BID
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.5078168447075594,1.5585692874146277,0.017897091722595078,0.17506031301950287,0.996,13/45,14.88%,RPS27A;YWHAH;PSMB1;BRIP1;ANAPC1;DNA2;NUP107;TOPBP1;NDEL1;MRE11;RBBP8;PSMB2;H2BC5
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.5595562504353015,-1.5573034847945604,0.03189493433395872,0.7774080714230864,0.999,5/29,5.34%,PTPRD;MET;ERBB4;FGFR2;ROR2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.5400866398254889,1.5534795690404632,0.02,0.18037016862002409,0.996,10/33,8.02%,RORB;HDAC9;POLR2B;KAT2B;NR3C2;RARB;PPARGC1A;GTF2B;GTF2H3;HDAC3
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.5511205079746465,1.5450362266007114,0.030737704918032786,0.19007740829903585,0.997,12/31,15.14%,HDAC9;KAT2B;ZNF451;NUP210;PLOD2;PARK7;SENP1;SIRT1;NUP107;SUMO3;NUP155;ATPSCKMT
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.3904022050586121,1.54290269608571,0.0,0.191523650226971,0.997,77/244,16.16%,SEMA6D;RPS21;UTRN;RPS7;RPL36AL;RPS27A;RPL32;POLR2B;KAT2B;RPS14;RPLP1;ZFPM2;RPS24;RPS23;RPL26;RPL30;RPL8;DCC;RPL5;RPS13;CACNA1G;UNC5D;TIAM1;PSMB1;NRP1;ST8SIA4;KRT10;CACNB4;RARB;PPARGC1A;CDH2;EPHA7;FOXO1;RPS16;H2AZ2;MAPK3;SPTB;EPHA10;RBBP5;FAU;RHOA;EPHA3;RPL23;GFRA1;SDCBP;MEIS1;POU3F2;RPS12;HDAC3;RPS15;RPS15A;RPL7A;EPHA6;DPYSL3;SMAD3;NAB1;LIN9;MED10;CTCF;SCN1B;MAML3;H3-3B;H2AZ1;STAT3;SEMA4A;AP2S1;PSMB2;COL4A2;MYL12B;VAV3;H2BC5;RPS4X;TRPC3;TFDP1;POLR2I;RPL10A;KRT17
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.4242876888734214,1.5406189094786082,0.0070921985815602835,0.1928854247564867,0.997,51/114,23.76%,RPS27A;POLR2B;YWHAH;PMEPA1;NEK7;PSMB1;FBXL18;H2AZ2;NUP210;MAPK3;SYCE1;STAG3;BRIP1;RAD51C;MZT2B;ANAPC1;DNA2;NUP107;TOPBP1;RAN;TMPO;CEP135;NDEL1;LIN9;MRE11;H3-3B;LIN54;RBBP8;H2AZ1;PSMB2;H2BC5;NUP155;VRK2;TFDP1;POLR2I;CCP110;LPIN2;RNF8;POLE2;TUBB4B;TUBG2;KMT5A;DCTN1;FBXL7;RBBP4;NUP85;NDC1;PSMA1;TUBGCP5;CENPE;UBE2D1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.6209332924435975,1.530945268163813,0.051224944320712694,0.20590616807790646,0.997,6/16,12.92%,ADCY10;ZBBX;DNAAF5;DNAI1;CABYR;TTC29
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.40175816431848543,1.5258103817300102,0.0,0.2125728118200767,0.997,42/170,8.92%,SEMA6D;RPS21;UTRN;RPS7;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;RPS24;RPS23;RPL26;RPL30;RPL8;DCC;RPL5;RPS13;CACNA1G;UNC5D;TIAM1;PSMB1;NRP1;ST8SIA4;CACNB4;EPHA7;RPS16;MAPK3;SPTB;EPHA10;FAU;RHOA;EPHA3;RPL23;GFRA1;SDCBP;POU3F2;RPS12;RPS15;RPS15A;RPL7A;EPHA6;DPYSL3
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.6238564838833153,1.5253415109939834,0.042643923240938165,0.20927261616771595,0.997,5/16,7.90%,PDZD2;RPS27A;NUP210;MAPK3;NUP107
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.6238564838833153,1.5253415109939834,0.042643923240938165,0.20927261616771595,0.997,5/16,7.90%,PDZD2;RPS27A;NUP210;MAPK3;NUP107
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.5025796649934363,1.5211086277034935,0.022172949002217297,0.21407689500622235,0.997,15/42,16.90%,RPS27A;DCC;YWHAH;PSMB1;ARHGAP10;BCAP31;MAPK3;PPP3CC;GSN;STAT3;APIP;PSMB2;TFDP1;BID;APPL1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5531659760359273,1.5204368480228234,0.015021459227467811,0.21323627108811394,0.997,8/26,19.98%,HDAC9;ANXA1;PER1;GAPDH;TWSG1;IL15;CD276;RGCC
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.5935942821535646,-1.5197992440912693,0.05343511450381679,0.9443760894885365,0.999,14/24,15.96%,GRIK4;ITPR2;SLC1A2;GRM8;GNG2;ADCY8;SLC17A6;GNG7;HOMER1;GLUL;GRIN3A;GRIK3;GRM4;PRKCG
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5912640452326681,1.5176224655238872,0.0437636761487965,0.21548696413272772,0.997,8/19,17.08%,HDAC9;KAT2B;FOXO1;SIRT1;CPEB1;INSIG2;LPIN2;TBC1D4
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.5582075453758685,1.5162752912120419,0.029723991507430998,0.21534313312685774,0.998,11/24,15.78%,POLR2B;RARB;H2AZ2;RBBP5;MEIS1;HDAC3;CTCF;H3-3B;H2AZ1;H2BC5;POLR2I
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.562581283912647,-1.5154242094952493,0.0347985347985348,0.9206210943494502,0.999,7/30,7.40%,ROBO2;PID1;BMPR1B;ACVR1C;GHR;SLIT3;TGFBR1
prerank,KEGG_2021_Human__Long-term depression,-0.6515544637147512,-1.5149002476357287,0.04816955684007707,0.877426657390543,0.999,5/15,6.46%,GRID2;PRKG1;RYR1;ITPR2;PRKG2
prerank,KEGG_2021_Human__Salivary secretion,-0.6127256653434403,-1.5078370598133866,0.034482758620689655,0.8755564836642326,0.999,9/19,17.24%,PRKG1;RYR3;ITPR2;PRKG2;ADCY8;ATP1A1;NOS1;PRKCG;CALM3
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.5428068541699125,1.50404987214707,0.02536997885835095,0.23359722939608418,0.998,7/27,5.94%,GPC5;RPS27A;IFT52;PSMB1;ADCY10;IQCE;SMURF1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.6048688141855738,1.4986133501179808,0.06209850107066381,0.24107995641385738,0.999,2/16,0.64%,GPC5;GPC6
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.5715556160999657,1.4926579220687008,0.04742268041237113,0.24959125097794363,1.0,9/20,15.66%,RPS27A;MAPKAPK5;H2AZ2;MAPK3;MINK1;H3-3B;H2AZ1;H2BC5;TFDP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.5024287496223937,1.4914651418543485,0.029535864978902954,0.24909846266128957,1.0,15/37,15.48%,NEK7;PSMB1;BRINP3;USP2;MEIS2;BTG1;ANAPC1;SDCBP;LGMN;SIRT1;PTPN3;SMAD3;CKS2;PSMB2;RNF20
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.6124964947158562,1.4913374534200334,0.05152224824355972,0.2471889677343442,1.0,8/17,10.88%,ECHDC2;PPARGC1A;ABCD2;DECR1;ADIPOR2;ABCD3;HADHB;HADHA
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.417024974025278,1.485947177614027,0.009302325581395349,0.25478931297534485,1.0,23/94,14.22%,RORB;HDAC9;ZFPM2;ID2;CCDC85B;CRY1;FOXO1;ZHX2;FOXP2;TOB1;NRG1;SIRT1;CTBP2;HDAC3;PER1;NAB1;GAPDH;TCEAL7;CTCF;PRMT2;GCFC2;CNOT7;SIN3A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.6365780695666177,-1.485547592770446,0.05947955390334572,0.9576961861061387,1.0,5/15,8.14%,KIAA1217;XYLT1;FGFR2;TGFBR1;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4697180767659869,1.48355074193166,0.02109704641350211,0.256908488295128,1.0,13/46,9.00%,RORB;ZFPM2;ID2;CNTN4;CCDC85B;FOXO1;DISP3;MEIS2;LDLRAD4;MEIS1;SIRT1;COL5A1;SMAD3
prerank,KEGG_2021_Human__Axon guidance,-0.47604404906812314,-1.48350720198671,0.028169014084507043,0.9271570301133016,1.0,14/55,6.82%,ROBO2;LRRC4C;CAMK2D;SLIT1;PARD3;BMPR1B;PLXNA4;SEMA3A;MET;SLIT3;TRPC6;RGMA;SEMA3E;NCK1
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.5536740074717683,1.4829549262253736,0.05122950819672131,0.25565139029018324,1.0,11/23,17.18%,TIAM1;EPHA7;EPHA10;RHOA;EPHA3;SDCBP;EPHA6;AP2S1;MYL12B;VAV3;LIMK1
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.5830650217410038,1.4801338059182019,0.048458149779735685,0.2589612513166638,1.0,8/19,14.88%,RPS27A;PSMB1;H2AZ2;ANAPC1;H3-3B;H2AZ1;PSMB2;H2BC5
prerank,KEGG_2021_Human__Morphine addiction,-0.5863987185666617,-1.4780208242168782,0.06433823529411764,0.9181861530404059,1.0,11/22,15.96%,PDE1A;PDE7B;ADORA1;PDE1C;GNG2;ADCY8;GABRG3;GNG7;OPRM1;GRK5;PRKCG
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.628657650899024,-1.4740987401652228,0.06066176470588235,0.9020444472238073,1.0,9/17,17.56%,NASP;CDKN2D;PHF8;NPAT;CUL4B;CDK18;ACVR1;CCNH;CDK15
prerank,KEGG_2021_Human__Gastric acid secretion,-0.618766833958566,-1.469612537007115,0.0562015503875969,0.8921318708806887,1.0,7/15,17.24%,CAMK2D;ITPR2;ADCY8;MYLK;ATP1A1;PRKCG;CALM3
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.47007644708852536,-1.4670153102348433,0.035523978685612786,0.8736232382530662,1.0,23/64,19.74%,PDE1A;GNAL;CAMK2D;RYR3;RYR1;PDE1C;CHRNA7;FGF9;ITPR2;MET;ERBB4;FGFR2;ADCY8;MCU;MYLK;HRH1;HTR2C;NOS1;PRKCG;CALM3;PDGFD;CAMK1G;FGF5
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.5254047077976577,-1.4665995334057593,0.04251386321626617,0.8444968056559042,1.0,10/34,11.00%,DLC1;SPOCK3;MCTP1;PTPRK;MITF;DACH1;ROBO1;TMEFF2;DLG5;TPM1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.4808861319888486,1.4665196429686111,0.025974025974025976,0.28340826518787465,1.0,13/41,14.88%,PDZD2;YWHAH;H2AZ2;MAPK3;RHOA;NUP107;WASF2;NDEL1;KLKB1;H3-3B;H2AZ1;MYL12B;H2BC5
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.6405713814840384,-1.4645949257463913,0.06769825918762089,0.8252275341297824,1.0,4/15,12.28%,PID1;CD63;STARD4;SFRP4
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.5812524945356995,1.46323084093694,0.06277056277056277,0.28701267749902165,1.0,5/17,8.06%,SF3B3;SMU1;PPARGC1A;SRSF10;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.6198594500372273,1.4587492381968794,0.0514018691588785,0.2932531446982244,1.0,8/15,19.98%,SMCHD1;OTUD4;SIRT1;APLF;MRE11;EYA4;RNF8;RGCC
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.5094705244508722,1.4542125703274569,0.041666666666666664,0.300354425461966,1.0,12/30,15.66%,RPS27A;MAPKAPK5;H2AZ2;MAPK3;MINK1;ANAPC1;MRE11;H3-3B;H2AZ1;STAT3;H2BC5;TFDP1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5162264201406527,1.4483996122501492,0.06852248394004283,0.3093879927654288,1.0,10/27,17.08%,HDAC9;KAT2B;ATP6V0E1;FOXO1;ATP6AP1;CPEB1;INSIG2;LPIN2;APPL1;TBC1D4
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5510971347003393,-1.446071151034174,0.06204379562043796,0.8889644875593111,1.0,10/23,19.28%,CAMK2D;RYR3;RYR1;ITPR2;TPM1;ATP1A1;NOS1;TGFB2;CALM3;KCNG2
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.5300506633984061,1.445051628974343,0.0737527114967462,0.313589680449685,1.0,10/27,17.88%,RPS27A;PSMB1;H2AZ2;ANAPC1;DNA2;H3-3B;H2AZ1;PSMB2;H2BC5;POLE2
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.6140016383381919,-1.4450097829728834,0.08527131782945736,0.8654080691684799,1.0,2/17,0.72%,RBFOX1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5893383270193259,1.4430915573555454,0.08860759493670886,0.31485688621073615,1.0,7/15,20.58%,CADPS2;RAB5A;ATP6AP1;PPID;MYOM1;RGCC;SLC12A2
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.3624139746938932,1.4373613412224613,0.0029154518950437317,0.32477956452986256,1.0,77/243,16.82%,RORB;PDZD2;FKBP5;HDAC9;RPS27A;POLR2B;KAT2B;NR3C2;CHGA;PPM1D;YWHAH;PSMB1;RARB;PPARGC1A;GTF2B;FOXO1;PHAX;USP2;MAPKAPK5;H2AZ2;MAPK3;BTG1;CPSF2;RBBP5;ZNF684;GTF2H3;BRIP1;SMURF1;ZNF566;ANAPC1;DNA2;INTS9;ZNF678;SIRT1;RNF141;HDAC3;PRKAB2;CCNG2;TOPBP1;ZNF439;SMAD3;HIPK2;GSR;SRSF3;ARID3A;CRADD;MED10;HIPK1;MRE11;MAML3;H3-3B;RBBP8;ZNF43;H2AZ1;ZFP2;INTS2;FANCI;TXNRD1;PSMB2;ZNF354C;ZNF589;CNOT7;SIN3A;ZNF143;H2BC5;PLAGL1;ZNF711;TRPC3;ZFP14;TFDP1;POLR2I;BID;PCGF6;ZNF302;NOTCH2;ZNF577;ZNF521
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.5642212131766048,1.4357840462213367,0.0735930735930736,0.3254529519460793,1.0,8/19,13.76%,TOMM7;LAMP2;ACBD5;PRKAB2;ARL8B;RUBCNL;STAM;ATG16L1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.527240182710253,1.433666762453519,0.047961630695443645,0.32750429883257565,1.0,8/26,9.00%,RERG;DCC;PSRC1;CCDC85B;BTG1;SIRT1;PPT1;SMAD3
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.35661579502690816,1.428196677425886,0.0030581039755351682,0.3365640468125719,1.0,87/278,16.82%,RORB;PDZD2;FKBP5;HDAC9;RPS27A;POLR2B;KAT2B;NFIB;NR3C2;CHGA;PPM1D;YWHAH;PSMB1;RARB;PPARGC1A;GTF2B;FOXO1;PHAX;USP2;MAPKAPK5;H2AZ2;NUP210;MAPK3;BTG1;CPSF2;RBBP5;ZNF684;GTF2H3;BRIP1;SMURF1;ZNF566;ANAPC1;DNA2;TDRD9;INTS9;ZNF678;SIRT1;RNF141;TET3;NUP107;HDAC3;PRKAB2;MYO1E;CCNG2;TOPBP1;ZNF439;RAN;SMAD3;HIPK2;GSR;SRSF3;ARID3A;CRADD;MED10;HIPK1;MRE11;MAML3;H3-3B;RBBP8;IPO8;ZNF43;H2AZ1;ZFP2;INTS2;FANCI;TXNRD1;PSMB2;ZNF354C;ZNF589;CNOT7;SIN3A;ZNF143;H2BC5;PLAGL1;NUP155;ZNF711;TRPC3;ZFP14;TFDP1;POLR2I;BID;MOV10L1;PCGF6;ZNF302;NOTCH2;ZNF577;ZNF521
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5954661563232162,1.4251036375329469,0.07510729613733906,0.3412100009741331,1.0,3/15,4.48%,GPC5;GPC6;ALDH1A1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5112818019272082,1.4166909241590464,0.06236559139784946,0.3576620417188194,1.0,4/26,1.84%,HDAC9;KAT2B;ZFPM2;ID2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5842960001503789,-1.415094450989948,0.0928030303030303,0.9943147263673815,1.0,5/18,12.96%,ESR1;HOMER1;OPRM1;HRH1;HTR2C
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.4673276926266262,1.4150004138306305,0.037383177570093455,0.35875829790984703,1.0,14/40,15.10%,RPL26;RPL5;MAPKAPK5;GEMIN5;TOB1;RPL10;PAIP1;GAPDH;EIF1B;EIF3E;CNOT7;KLHL25;METAP1;RPS4X
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.5387848624117872,1.4143333821524733,0.07439824945295405,0.35749211255840624,1.0,13/22,21.58%,KAT2B;FOXO1;MAPK3;HDAC3;KRAS;SIN3A;NOTCH2;PLCB4;TBC1D4;PFKM;SLC16A2;ITGAV;HDAC2
prerank,Reactome_2022__Metabolism R-HSA-1430728,0.33959281065343827,1.4140523068019777,0.0,0.35545150244732193,1.0,119/429,18.32%,INPP4B;GPC5;RPS21;RPS7;GPC6;RPL36AL;RPS27A;RPL32;RPS14;RPLP1;CYP7B1;CHGA;RPS24;RPS23;RPL26;RPL30;GK;RPL8;RPL5;RPS13;CEPT1;NMRK1;FLVCR1;PSMB1;PHKA2;PPARGC1A;RAB5A;TPST2;ATP5MG;RPS16;C1D;TPK1;NUP210;ALDH1A1;CPNE3;SEC24A;ACSS2;NDUFB2;FAU;PLCH2;MRI1;BRIP1;DECR1;GBE1;ALDH7A1;RPL23;ADIPOR2;LGMN;HNMT;KYAT3;ACBD5;HADHB;NUP107;RPS12;HSD11B2;HDAC3;RPS15;PRKAB2;RPS15A;MTMR6;ATP5F1E;PPT1;CA5B;RAN;SOAT1;RPL7A;GSR;MTHFD2L;FECH;CHDH;FTCD;LIN9;DHTKD1;MED10;HADHA;PRKD1;INSIG2;NDUFC1;HEXB;SPNS2;FDX1;PSTK;UST;NME3;NDUFC2;MGST1;APIP;TXNRD1;PSMB2;ABCC3;CHKA;SIN3A;NEU3;ATP5PF;RPS4X;NUP155;SRD5A1;CARNMT1;SLC37A1;DLST;RPL10A;PRSS3;NDUFB11;GNPAT;LPIN2;MDH1;AK4;INPP1;PLCB4;AMPD3;SAR1B;RPS25;LDLR;MAOB;PFKM;ITPKB;GALC;MGST2;LYPLA1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.34249186251821484,1.4138926146861233,0.0,0.3532548256816467,1.0,93/367,16.22%,THSD4;RPS21;RPS7;RPL36AL;RPS27A;RPL32;KAT2B;RPS14;RPLP1;NR3C2;CHGA;RPS24;RPS23;RPL26;RPL30;RPL8;RPL5;RPS13;PMEPA1;ST8SIA3;CNTN4;PSMB1;CALU;ST8SIA4;PPARGC1A;RAB5A;CDH2;TPST2;RPS16;CASP8AP2;USP2;FBXL18;NUP210;FSTL1;SPTB;SEC24A;RBBP5;MRPL48;FAU;RHOA;B3GLCT;MRPL42;RPL23;PARK7;SENP1;GSN;EDEM1;NUP107;RPS12;HDAC3;RPS15;RPS15A;KBTBD6;FEM1C;RPL7A;SMAD3;HIPK2;KIFC3;ADAMTS2;USP30;SPCS3;UBA3;HSP90B1;KLKB1;GALNT3;H3-3B;STAM;CHRDL1;H2AZ1;TRAM1;STAT3;EIF3E;COG2;MRRF;PSMB2;UBE2Q2;ZRANB1;KLHL25;SIN3A;NEU3;ST6GAL2;CCT8;H2BC5;OTUD5;MRPS30;RPS4X;NUP155;ABRAXAS2;RNF20;FBXO31;ADAMTS17;RPL10A;CCP110
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.5561170694395643,1.4108853311998828,0.07905982905982906,0.3566552339207734,1.0,11/19,16.90%,RANBP17;HIKESHI;LAMP2;NUP107;RAN;HEATR3;IPO8;STAT3;NUP155;ZDHHC15;APPL1
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.5873075720813355,1.408153680787736,0.07021276595744681,0.3600158461857697,1.0,3/15,2.58%,GPC5;RPS27A;PSMB1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.5401399461152887,-1.4081403057006576,0.08856088560885608,1.0,1.0,14/23,20.98%,CAMK2D;RYR3;ADGRV1;RYR1;SYT2;SYT12;ADCY8;SYT10;SYT17;SYT5;CPNE9;GPLD1;CPNE7;CPNE4
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.47996202086633716,1.4074757676665053,0.0603448275862069,0.35878669279404624,1.0,6/35,2.32%,HDAC9;KAT2B;ZFPM2;SGCD;ID2;SGCG
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.46408828816699005,-1.4025553709705953,0.05719557195571956,1.0,1.0,10/53,6.96%,ROBO2;CA10;IL1RAPL2;SOX6;CNTN6;JHY;SNTG2;ASIC2;DSCAML1;PHF8
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,0.3786207784971093,1.3993440596352689,0.016203703703703703,0.37467078966949396,1.0,33/126,14.30%,INPP4B;CYP7B1;CHGA;GK;CEPT1;PPARGC1A;RAB5A;CPNE3;SEC24A;DECR1;LGMN;ACBD5;HADHB;HSD11B2;HDAC3;PRKAB2;MTMR6;PPT1;RAN;SOAT1;LIN9;MED10;HADHA;PRKD1;INSIG2;HEXB;SPNS2;FDX1;TXNRD1;ABCC3;CHKA;SIN3A;NEU3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5101597983678585,1.3990787367469677,0.07234042553191489,0.3724947791525839,1.0,11/24,19.74%,PLOD2;TMTC2;B3GLCT;GALNT13;TET3;GXYLT2;GALNT3;POGLUT1;GALNT7;GALNT8;GCNT4
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.5193587997138837,1.396322725292379,0.0641025641025641,0.3761421500285385,1.0,17/27,28.00%,PPARGC1A;ATP5MG;ACSS2;HDAC3;PRKAB2;ATP5F1E;LIN9;GABPA;ATP5PF;APOOL;TFB1M;ATP5PO;ATP5F1C;ATP5MC2;ATP5MC3;ATP5MF;DNAJC11
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.6092179299772118,-1.396001727614861,0.11007462686567164,1.0,1.0,10/15,23.52%,DPP10;PID1;STAC;PRKCH;AR;MRAP2;PLS1;WNK3;EGFR;STX3
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.5283767398478025,1.39558727034641,0.09050772626931568,0.37506984660589726,1.0,9/23,17.88%,RPS27A;PSMB1;H2AZ2;ANAPC1;H3-3B;H2AZ1;PSMB2;H2BC5;POLE2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.557679717666019,1.3937273047300456,0.09552845528455285,0.37658442302783224,1.0,10/17,16.90%,RANBP17;HIKESHI;GEMIN5;NUP107;RAN;HEATR3;IPO8;STAT3;NUP155;APPL1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.575911702497635,1.3889140975962193,0.09513742071881606,0.38470990893773077,1.0,7/15,16.90%,DCC;CASP8AP2;SMAD3;CRADD;HIPK1;BID;APPL1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.49447776892342615,1.3888541979758755,0.07802874743326489,0.3821829544308562,1.0,12/30,20.00%,RPS27A;PSMB1;POLB;MCMDC2;RPA1;DNA2;TOPBP1;WDHD1;PSMB2;PRIMPOL;POLE2;MCMBP
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5214331614869354,1.3875460969280815,0.07236842105263158,0.3826690848338521,1.0,9/24,9.14%,RPS27A;PMEPA1;ZNF451;LDLRAD4;SMURF1;SIRT1;SMAD3;HIPK2;STRAP
prerank,KEGG_2021_Human__Measles,-0.5539829378908407,-1.3860669421038103,0.1,1.0,1.0,9/20,21.62%,IL2RA;EIF2S1;RCHY1;EIF2AK3;HSPA1A;CYCS;RACK1;JUN;TBK1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.5050949087236638,-1.386058742931649,0.09323583180987204,1.0,1.0,16/32,20.98%,CAMK2D;RYR3;ADGRV1;RYR1;SYT2;SYT12;ADCY8;SYT10;SYT17;HOMER1;SYT5;CPNE9;CALM3;GPLD1;CPNE7;CPNE4
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.5268022624794315,1.3844776942285246,0.08091286307053942,0.38758054785035473,1.0,7/20,16.36%,RPS27A;KAT2B;PSMB1;SMAD3;MAML3;PSMB2;NOTCH2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.41664993690906443,1.3814658535071893,0.03631961259079903,0.39192454952094896,1.0,15/71,8.02%,RORB;HDAC9;POLR2B;KAT2B;NR3C2;GLIS3;RARB;PPARGC1A;GTF2B;RBMX;PHAX;CPSF2;GTF2H3;INTS9;HDAC3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5769391532878306,1.3808021932358974,0.10775862068965517,0.39086200064183274,1.0,12/15,29.42%,ATP5MG;ATP5F1E;ATP5PF;APOOL;ATP5PO;ATP5F1C;AFG3L2;ATP5MC2;ATP5MC3;ATP5MF;DNAJC11;LETM1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.3495445987116626,1.3807911432145952,0.002793296089385475,0.3882760426240089,1.0,70/226,16.82%,RORB;PDZD2;FKBP5;HDAC9;RPS27A;POLR2B;KAT2B;NR3C2;CHGA;PPM1D;YWHAH;PSMB1;RARB;PPARGC1A;FOXO1;USP2;MAPKAPK5;H2AZ2;MAPK3;BTG1;RBBP5;ZNF684;GTF2H3;BRIP1;SMURF1;ZNF566;ANAPC1;DNA2;ZNF678;SIRT1;RNF141;HDAC3;PRKAB2;CCNG2;TOPBP1;ZNF439;SMAD3;HIPK2;GSR;ARID3A;CRADD;MED10;HIPK1;MRE11;MAML3;H3-3B;RBBP8;ZNF43;H2AZ1;ZFP2;FANCI;TXNRD1;PSMB2;ZNF354C;ZNF589;CNOT7;SIN3A;H2BC5;PLAGL1;ZNF711;TRPC3;ZFP14;TFDP1;POLR2I;BID;PCGF6;ZNF302;NOTCH2;ZNF577;ZNF521
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.5605192588889356,1.3785144600629156,0.10408163265306122,0.3906771089673413,1.0,7/16,15.78%,POLR2B;H2AZ2;DNA2;H3-3B;H2AZ1;H2BC5;POLR2I
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.5614128148179183,1.3780930479162352,0.10782241014799154,0.3890921842431907,1.0,6/16,19.88%,MAPK3;PPP3CC;KRAS;VAV3;NFATC3;CD81
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.436251537538956,1.3778744803390166,0.05128205128205128,0.3869069141090729,1.0,25/53,20.18%,RPS27A;POLB;RPA1;GTF2H3;BRIP1;RAD51C;PARK7;DNA2;SIRT1;TOPBP1;APLF;DCLRE1C;MRE11;WDHD1;ERCC4;RBBP8;TDP2;FANCI;PRIMPOL;RNF8;POLE2;ERCC1;FBH1;XRCC4;VCPIP1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5470326999885791,1.3706756591648062,0.10217391304347827,0.4011044077788498,1.0,8/17,12.98%,CRY1;PPARGC1A;FOXO1;PARK7;ADIPOR2;SIRT1;BACE2;STAT3
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.44337104425994817,1.366982460503076,0.06222222222222222,0.4076427161210034,1.0,16/48,16.90%,RPS27A;DCC;YWHAH;PSMB1;ARHGAP10;BCAP31;MAPK3;PPP3CC;SDCBP;GSN;STAT3;APIP;PSMB2;TFDP1;BID;APPL1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.47102281197564116,-1.3665269419990873,0.08407871198568873,1.0,1.0,10/40,11.00%,DLC1;MCTP1;ACVR1C;PTPRK;MITF;DACH1;ROBO1;TMEFF2;DLG5;TPM1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.586800569438956,-1.3642980505123798,0.11819887429643527,1.0,1.0,3/15,10.36%,ELOVL5;GPX1;ELOVL2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.5486249474190992,1.3640200506661297,0.09130434782608696,0.4122064204634805,1.0,8/17,18.84%,RPS27A;RPA1;GTF2H3;DNA2;MRE11;ERCC4;ERCC1;FBH1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.5152824125822314,1.3633886977285656,0.09523809523809523,0.4109437345596151,1.0,14/23,16.90%,RANBP17;ABCD2;HIKESHI;ABCD3;LAMP2;ACBD5;NUP107;RAN;HEATR3;FIS1;IPO8;STAT3;NUP155;APPL1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.47852611887218494,-1.363181085234228,0.10278745644599303,1.0,1.0,18/38,24.66%,CAMK2D;RYR1;CALB1;CHRNA7;TRPC6;ADCY8;RMDN3;MCU;TRPC7;TRPC5;HTR2C;ATP2C2;CCDC47;MAIP1;MCUB;HERPUD1;SLC24A3;TMCO1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.4943392383631322,-1.3617385462159075,0.0912280701754386,1.0,1.0,3/33,1.52%,GRID2;BMPR1B;RYR1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.5186139584560504,-1.361208026559154,0.1050656660412758,1.0,1.0,5/26,5.36%,PTPRD;LRRC4C;SDK1;CHRNA7;SEMA3E
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.500449752299095,1.3593403939915858,0.0891304347826087,0.41763052175565724,1.0,7/24,7.52%,RPS27A;POLR2B;POLB;RPA1;GTF2H3;BRIP1;SIRT1
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.3849001704609882,1.357898538731147,0.03926096997690531,0.4189156963422929,1.0,40/91,23.76%,RPS27A;PMEPA1;NEK7;PSMB1;FBXL18;H2AZ2;NUP210;MAPK3;MZT2B;ANAPC1;DNA2;NUP107;RAN;TMPO;CEP135;NDEL1;LIN9;H3-3B;LIN54;H2AZ1;PSMB2;H2BC5;NUP155;VRK2;TFDP1;CCP110;LPIN2;POLE2;TUBB4B;TUBG2;KMT5A;DCTN1;FBXL7;RBBP4;NUP85;NDC1;PSMA1;TUBGCP5;CENPE;UBE2D1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.5339870271611425,-1.3562527509631428,0.113345521023766,1.0,1.0,4/22,5.10%,DLC1;PTPRK;CD63;LYPD5
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5293916080250579,1.3550036104156067,0.09615384615384616,0.4231888939832013,1.0,3/20,4.48%,GPC5;GPC6;ALDH1A1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.4121730761216246,1.3505944302712867,0.06067961165048544,0.4311925135441131,1.0,11/62,11.82%,THSD4;GPC5;GPC6;RPS27A;CYP7B1;GBE1;B3GLCT;ADAMTS2;HEXB;GALNT3;FDX1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.4404993898077957,1.3491539040099638,0.06711409395973154,0.43210214155037324,1.0,10/39,9.88%,RPS7;PER3;RPL5;CREBL2;PPARGC1A;USP2;RPL23;PARK7;LAMP2;GAPDH
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.48904164345901063,1.3469976609834498,0.10217391304347827,0.43483481547788405,1.0,12/27,21.50%,NR3C2;CYP7B1;ABCD2;ALDH1A1;PEX1;ABCD3;CAT;EFHC1;GNPAT;PFKM;ABCA1;ALDH8A1
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.4882633598950699,-1.3455433514876936,0.10766423357664233,1.0,1.0,6/34,9.38%,IL2RA;BMPR1B;ACVR1C;GHR;TGFBR1;IL17D
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.5613693244490346,-1.3433554820859321,0.12431444241316271,1.0,1.0,7/17,16.74%,RYR3;RYR1;USP16;HOMER1;TDO2;NUDT21;ALDH1A2
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.5249674004454046,1.3432721853308298,0.12658227848101267,0.44161446367826407,1.0,7/20,13.72%,RPS27A;PSMB1;RHOA;SMURF1;FZD6;AP2S1;PSMB2
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.509411338291058,1.337408264036658,0.12526096033402923,0.4536116836190117,1.0,11/21,15.78%,POLR2B;H2AZ2;NUP210;NUP107;RAN;H3-3B;IPO8;H2AZ1;H2BC5;NUP155;POLR2I
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5088458645308197,1.33466568346611,0.125,0.458276612087584,1.0,9/19,20.02%,RPS27A;WNT2B;FZD6;CCDC88C;NXN;ZRANB1;WNT3;VPS26A;VPS29
prerank,KEGG_2021_Human__Longevity regulating pathway,0.5286634829113926,1.333978015471519,0.13725490196078433,0.45732271576927414,1.0,7/18,11.56%,PPARGC1A;FOXO1;ADIPOR2;SIRT1;PRKAB2;CAT;KRAS
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.5382572596591241,1.3328398210023262,0.12418300653594772,0.45785195490018904,1.0,7/17,15.78%,POLR2B;GTF2B;PHAX;INTS9;INTS2;ZNF143;POLR2I
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.5553501432192619,-1.3327097560056973,0.14232209737827714,1.0,1.0,2/17,6.70%,GNAL;ADCY8
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.5486989147420887,1.3292506925301129,0.13808463251670378,0.4648052673110452,1.0,6/16,10.88%,ECHDC2;ABCD2;DECR1;ABCD3;HADHB;HADHA
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.5243498497963156,-1.3272001480841507,0.1364522417153996,1.0,1.0,4/21,8.98%,LRP1B;SLC35F3;KIF3A;SLC6A6
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.4917741137146843,-1.3269560176469193,0.1219047619047619,1.0,1.0,13/32,15.96%,GNAL;CAMK2D;GRIK4;ERBB4;NEFL;LIN7C;GNG2;ADCY8;GABRG3;GNG7;GRIN3A;GRIK3;PRKCG
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.5469594940911897,1.326852190947792,0.148068669527897,0.46852121167761085,1.0,4/15,10.52%,PPARGC1A;HDAC3;LIN9;MED10
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.45423828007681843,1.326637614425749,0.10262008733624454,0.4663287981722121,1.0,3/31,2.46%,EDNRA;EDNRB;ANXA1
prerank,KEGG_2021_Human__Cholinergic synapse,-0.5400852153525111,-1.3250777288683302,0.13518886679920478,1.0,1.0,6/18,9.72%,CAMK2D;CHRNA7;ITPR2;GNG2;ADCY8;GNG7
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.46794358629082294,-1.3250367732961765,0.1111111111111111,1.0,1.0,17/35,22.98%,CAMK2D;RYR3;ADGRV1;RYR1;SYT2;SYT12;ADCY8;SYT10;SYT17;SYT5;CPNE9;JUN;GPLD1;CPNE7;CPNE4;EGFR;SYT9
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.41352509565684664,1.324751350684796,0.06437768240343347,0.4686119279247276,1.0,23/53,19.66%,RPS27A;POLR2B;H2AZ2;GTF2H3;BRIP1;RAD51C;DNA2;TOPBP1;DCLRE1C;MRE11;ERCC4;RBBP8;H2AZ1;TDP2;FANCI;H2BC5;POLR2I;EYA4;RNF8;POLE2;ERCC1;LRIG3;XRCC4
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.46781057121394287,1.3224954837136265,0.11040339702760085,0.471506280329685,1.0,7/29,8.02%,RPS27A;PPM1D;PSMB1;PPARGC1A;MAPK3;SMURF1;HDAC3
prerank,KEGG_2021_Human__Cellular senescence,0.4506092480587062,1.3208043562266056,0.11013215859030837,0.4726816319018159,1.0,12/34,11.92%,FOXO1;MAPK3;PPP3CC;SIRT1;PPID;SMAD3;HIPK2;LIN9;HIPK1;MRE11;KRAS;LIN54
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.5016428824420331,1.3206150153761105,0.12608695652173912,0.47046782672870613,1.0,13/22,26.62%,RPS27A;PSMB1;FOXO1;MAPKAPK5;CDC42EP3;PSMB2;MAPK6;HSPB1;DNAJB1;PSMA1;PSME4;MAPK4;PSMA5
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.5030938148428306,-1.319167363174651,0.11934900542495479,1.0,1.0,8/27,10.48%,PARD3;SDK1;SKAP2;CDH13;PARVB;CDH4;NCK1;CDH6
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5373566690515307,-1.3185940571995853,0.15083798882681565,1.0,1.0,9/19,26.68%,PCSK6;HSPD1;ADAMTS3;PCSK5;CIAO2B;TSPAN14;ADAM19;ISCA1;APH1B
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.5399002591437307,1.3180387232526793,0.1368421052631579,0.47457150075323046,1.0,6/15,16.56%,PHKA2;ST8SIA4;PLOD2;UBA3;UBL5;SERP1
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.5394972511743681,1.3162120879525239,0.15702479338842976,0.47685338928192594,1.0,6/16,19.40%,MAPK3;PPP3CC;KRAS;VAV3;BID;IFNAR1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.5399066162054115,1.3123839425018642,0.12967032967032968,0.48416167010836714,1.0,7/16,15.78%,POLR2B;GTF2B;PHAX;INTS9;INTS2;ZNF143;POLR2I
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.43912276300903585,1.3121796868305842,0.1292517006802721,0.48201892890406417,1.0,17/36,26.74%,RPS27A;PSMB1;SIRT1;HIPK2;CPEB1;FAM162A;STOX1;PSMB2;AK4;OPRD1;EGLN3;RGCC;PSMA1;PSME4;MDM2;PSMA5;EPAS1
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.454254540248673,-1.3107642488901645,0.12750455373406194,1.0,1.0,15/42,15.96%,GNAL;CAMK2D;GRIK4;ERBB4;NEFL;SLC1A2;LIN7C;GNG2;ADCY8;GABRG3;GNG7;GLUL;GRIN3A;GRIK3;PRKCG
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4391216963563341,-1.3100029449915023,0.09444444444444444,1.0,1.0,6/43,8.48%,PTPRD;HNRNPU;PARP2;DDX21;NPTX2;HSPA13
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.5033159509194891,1.3095034466986322,0.13513513513513514,0.48574140653656317,1.0,8/20,19.98%,SIRT1;HIPK2;CPEB1;FAM162A;AK4;OPRD1;EGLN3;RGCC
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.41937971432241566,-1.3074234558837803,0.10175438596491228,1.0,1.0,12/68,9.72%,IL2RA;LAMA2;HSP90AA1;FGF9;MET;GHR;ERBB4;FGFR2;GYS1;GNG2;LAMA3;GNG7
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.4039826357095892,1.3072690048676774,0.08390022675736962,0.48901366835194837,1.0,26/59,18.60%,YWHAH;RANBP17;RAB5A;HIKESHI;SMURF1;TRAK2;LAMP2;NUP107;RAN;TBC1D2B;HEATR3;ARL4A;STAM;SURF4;TBC1D9B;IPO8;STAT3;NUP155;GIPC1;APPL1;TBC1D4;VPS26A;SAR1B;SNX31;DNAJC27;RAB5B
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.35484357810699035,1.3066291422334313,0.02857142857142857,0.48796133460001295,1.0,41/132,16.62%,PDZD2;PRAG1;YWHAH;RHOBTB1;TIAM1;GNA13;ARHGAP10;MCF2;OSBPL11;RBMX;ARHGAP24;BCAP31;H2AZ2;MAPK3;TMOD3;RHOA;RASGRF2;ATP6AP1;TRAK2;SENP1;ABCD3;ACBD5;NUP107;CDC42EP3;PGRMC2;WASF2;TMPO;NDEL1;KLKB1;H3-3B;STAM;TPM4;H2AZ1;ARMCX3;MYL12B;VAV3;H2BC5;RNF20;VRK2;CCP110;EMC3
prerank,KEGG_2021_Human__cAMP signaling pathway,0.42579464148883484,1.3039785002904942,0.09282700421940929,0.49202468206332606,1.0,8/41,7.92%,PDE3A;VIPR2;EDNRA;TIAM1;ADCY10;MAPK3;RHOA;PDE10A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.47086594008991023,-1.3023453404933933,0.11678832116788321,1.0,1.0,6/32,6.96%,ROBO2;CA10;SOX6;JHY;DSCAML1;PHF8
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.5230024334985911,1.3012638232886518,0.13692946058091288,0.4969313917816453,1.0,5/18,8.42%,CHGA;PPARGC1A;PARK7;LGMN;PPT1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3912970393911711,1.300872736215443,0.08705357142857142,0.49536265921477707,1.0,27/66,18.84%,CRY1;FOXO1;MCM9;MAPK3;POLB;RBBP5;RPA1;GTF2H3;RAD51C;PARK7;SIRT1;NRDE2;TOPBP1;APLF;MRE11;WDHD1;ERCC4;RBBP8;VAV3;RNF169;FBXO31;BID;RNF8;POLE2;SETD7;ERCC1;FBH1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.39193816128721587,1.3006049646000193,0.06698564593301436,0.4933830580929474,1.0,17/62,17.04%,HDAC9;KAT2B;PPM1D;RPS13;ID2;DIP2A;TOB1;PARK7;LGMN;SIRT1;GAPDH;TWSG1;STOX1;CNOT7;NOTCH2;CRKL;OPRD1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.4712137527637864,1.2984782316994163,0.11363636363636363,0.49625485540118014,1.0,6/27,7.52%,RPL26;RPL5;HSPH1;ABCB10;DNA2;SIRT1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.4811787326645384,-1.298463268736665,0.14671814671814673,1.0,1.0,4/29,6.82%,PTPRD;PTPRK;PTPRM;NCK1
prerank,KEGG_2021_Human__Insulin signaling pathway,0.5391814204933988,1.2973283720392614,0.14285714285714285,0.4963113848307434,1.0,6/15,11.56%,PHKA2;PPARGC1A;FOXO1;MAPK3;PRKAB2;KRAS
prerank,Reactome_2022__S Phase R-HSA-69242,0.45743878401320964,1.2958622413489145,0.13304721030042918,0.49743089381690064,1.0,10/30,17.88%,RPS27A;PMEPA1;PSMB1;ANAPC1;DNA2;LIN9;LIN54;PSMB2;TFDP1;POLE2
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.410998275530357,-1.2953811020939772,0.12033898305084746,1.0,1.0,17/69,15.92%,GRID2;PARD3;ADORA1;GRIK4;CHRNA7;RXFP1;GHR;GRM8;GABRG3;ADCYAP1R1;OPRM1;HRH1;HTR2C;GRIN3A;GLP2R;GRIK3;GRM4
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.40884116696106054,1.294428781146637,0.09929078014184398,0.4988324321252189,1.0,18/55,16.22%,RPS27A;KAT2B;USP9Y;PSMB1;USP38;USP2;OTUD4;POLB;RHOA;SENP1;SMAD3;USP30;STAM;PSMB2;ZRANB1;OTUD5;ABRAXAS2;CCP110
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.48295404252591917,1.2936769046570649,0.1288056206088993,0.49827522780358585,1.0,12/25,19.98%,CHGA;SYNPO2;NRG1;PARK7;SDCBP;SMAD3;STAM;CX3CL1;BID;LIMK1;ERCC1;RGCC
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.46739162442230875,1.2916628596399387,0.14222222222222222,0.5008790244407624,1.0,7/25,9.00%,RERG;PSRC1;CCDC85B;BTG1;SIRT1;PPT1;SMAD3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.44009179698503664,-1.289701603052927,0.12237762237762238,1.0,1.0,13/43,19.50%,PHACTR2;SYT2;CD63;SYT12;SYT10;F5;LHFPL2;SYT17;SYT5;ENDOD1;STEAP2;TGFB2;SNAP25
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5452755079578187,1.2877511090935803,0.15848214285714285,0.508373529017307,1.0,5/15,13.14%,KAT2B;PRAG1;MAML3;STAT3;POGLUT1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.43045629454922074,1.287700350987491,0.09808102345415778,0.5059193350841241,1.0,13/41,12.42%,RPS27A;POLB;RPA1;GTF2H3;RAD51C;PARK7;DNA2;TOPBP1;RAN;MRE11;WDHD1;ERCC4;RBBP8
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.47787054768790155,1.2873269522246489,0.129979035639413,0.5042992448595649,1.0,7/24,8.02%,RPS27A;TIAM1;GNA13;MCF2;RHOA;RASGRF2;HDAC3
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.3518327198502018,1.2872874574279805,0.03864734299516908,0.501855511706082,1.0,40/129,16.62%,PDZD2;PRAG1;YWHAH;RHOBTB1;TIAM1;GNA13;ARHGAP10;MCF2;OSBPL11;RBMX;ARHGAP24;BCAP31;H2AZ2;MAPK3;TMOD3;RHOA;RASGRF2;ATP6AP1;SENP1;ABCD3;ACBD5;NUP107;CDC42EP3;PGRMC2;WASF2;TMPO;NDEL1;KLKB1;H3-3B;STAM;TPM4;H2AZ1;ARMCX3;MYL12B;VAV3;H2BC5;RNF20;VRK2;CCP110;EMC3
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.4698766140107765,1.28634815438911,0.14192139737991266,0.5016470817833183,1.0,15/27,22.08%,NEK7;H2AZ2;NUP210;MAPK3;NUP107;TMPO;H3-3B;H2AZ1;H2BC5;NUP155;VRK2;LPIN2;KMT5A;NUP85;NDC1
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.5278823318948402,1.2855288624830072,0.18487394957983194,0.5010390006526556,1.0,7/15,15.86%,YWHAH;MAPK3;PPP3CC;STAT3;APIP;TFDP1;BID
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.5311451227287289,1.2852772577179195,0.17607223476297967,0.49909758840545854,1.0,2/16,0.78%,CUX1;POLR2B
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.513442274205672,1.2839582170946604,0.15384615384615385,0.49991792728955003,1.0,7/17,17.38%,MARCHF1;SEC24A;LGMN;KLC2;AP1S2;AP2S1;SAR1B
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.49428361759399364,1.282817020233217,0.16155419222903886,0.5007161771448354,1.0,4/20,6.90%,RPS27A;PSMB1;ANAPC1;DNA2
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.5424720033274864,-1.282137333040063,0.1648148148148148,1.0,1.0,5/16,10.48%,PARD3;SDK1;CDH13;CDH4;CDH6
prerank,Reactome_2022__M Phase R-HSA-68886,0.38258769505970414,1.280922855098279,0.09049773755656108,0.5030055806694448,1.0,32/72,23.76%,RPS27A;PMEPA1;NEK7;PSMB1;H2AZ2;NUP210;MAPK3;MZT2B;ANAPC1;NUP107;RAN;TMPO;CEP135;NDEL1;H3-3B;H2AZ1;PSMB2;H2BC5;NUP155;VRK2;CCP110;LPIN2;TUBB4B;TUBG2;KMT5A;DCTN1;NUP85;NDC1;PSMA1;TUBGCP5;CENPE;UBE2D1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.5153995506296312,1.2808144589749526,0.1688888888888889,0.5008247875960483,1.0,6/16,9.52%,RPL26;RPL5;NSA2;RPL10;RPL7A;HEATR3
prerank,KEGG_2021_Human__Gap junction,-0.5037835170114613,-1.2792606802094069,0.15769944341372913,1.0,1.0,9/20,18.22%,PRKG1;ITPR2;TUBB2A;PRKG2;ADCY8;HTR2C;MAP3K2;PRKCG;PDGFD
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.467946646800013,1.278652487648566,0.1540130151843818,0.5036998796831689,1.0,12/25,19.68%,CUX2;RETREG3;EPHA3;DPYSL3;PRKD1;SCN1B;PTN;CX3CL1;ZDHHC15;BMP5;CAPRIN1;RIT2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4801552415672936,1.2777962880839662,0.14847161572052403,0.5035382292671731,1.0,7/21,17.08%,HDAC9;KAT2B;FOXO1;CPEB1;INSIG2;LPIN2;TBC1D4
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.5237595897780359,-1.2777759245454472,0.16573556797020483,1.0,1.0,3/18,2.52%,PTPRD;ROBO2;PLXNA4
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.41035126123934956,1.2762893950946521,0.11208791208791209,0.5050579796900493,1.0,13/45,11.36%,KAT2B;NEK7;SPTB;CROCCP2;MKRN1;TRAK2;SDCBP;LAMP2;CCDC28A;NFE2L1;FECH;FTCD;CAT
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4868357669005429,1.2758096001811914,0.1561771561771562,0.5039476217076088,1.0,7/22,10.88%,ECHDC2;ABCD2;DECR1;ABCD3;ACBD5;HADHB;HADHA
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.40362090571667225,1.2736428943256703,0.10239651416122005,0.5071075963520022,1.0,4/45,2.46%,EDNRA;CHGA;EDNRB;ANXA1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5428823357377494,-1.2731134341801114,0.18853974121996303,1.0,1.0,5/15,9.72%,HSP90AA1;KCNH8;GNG2;ESR1;GNG7
prerank,KEGG_2021_Human__Alcoholism,0.46276308965127166,1.2720561695716237,0.13559322033898305,0.5087885405322925,1.0,9/27,17.78%,HDAC9;H2AZ2;MAPK3;HDAC3;KRAS;H3-3B;H2AZ1;H2BC5;MAOB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3050635967656284,1.2692908947748438,0.014970059880239521,0.5137088840902565,1.0,87/381,16.08%,CUX1;RORB;CUX2;HDAC9;RPS27A;KAT2B;RPS14;NFIB;NR3C2;ZFPM2;RFX2;GLIS3;PPM1D;PER3;EDNRB;ZBTB7C;ID2;HSF2;ZNF451;CRY1;RARB;PPARGC1A;IRF2BPL;RBMX;FOXO1;USP2;HBP1;MAPK3;ZHX2;MEIS2;FOXP2;JDP2;ZNF684;SP4;GTF2H3;BRIP1;ZNF566;RPL23;PARK7;SDCBP;SENP1;CGGBP1;RPL10;MEIS1;POU3F2;TOX4;SIRT1;CTBP2;ZNF507;TET3;HDAC3;PPID;ZNF439;PER1;SMAD3;HIPK2;NFE2L1;PGBD1;ARID3A;LIN9;MED10;CTCF;PRKD1;GABPA;MAML3;KDM3A;RBBP8;ZNF43;H2AZ1;ZFP2;MYNN;STAT3;HIVEP2;ZNF391;ZNF354C;ZNF589;CX3CL1;SIN3A;ASXL3;ZNF143;PLAGL1;MTF1;TSHZ1;ZFP14;TFDP1;PCGF6;ZNF302
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.43578214256215236,1.2690853609326225,0.13865546218487396,0.511785015859946,1.0,17/35,24.80%,RPS27A;ID2;PSMB1;ANAPC1;CEP135;PSMB2;KCNH5;CCP110;APPL1;CDC14B;TUBB4B;RGCC;DCTN1;PSMA1;CENPE;UBE2D1;PSME4
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.46504360437952136,1.2662168734735777,0.14375,0.5168353650740971,1.0,6/27,5.80%,CCK;DCC;SLITRK2;CNTN4;DIP2A;MINK1
prerank,KEGG_2021_Human__FoxO signaling pathway,0.45922695695211985,1.2657620381265764,0.1561712846347607,0.5155371328586266,1.0,9/26,12.98%,FOXO1;MAPK3;SIRT1;PRKAB2;CCNG2;SMAD3;CAT;KRAS;STAT3
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.41959417921588854,-1.2623294765743849,0.11985688729874776,1.0,1.0,18/48,19.30%,RUNX1;CHRNA7;FGFR2;CD63;RGS12;NCK1;RGS20;KCTD8;ESR1;GNG7;HOMER1;WWTR1;GRK5;USP20;ACVR1;SEMA5A;TRIM5;DHRS3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.4022525164347091,1.2618578906359454,0.12322274881516587,0.523723313560402,1.0,17/52,16.22%,RPS27A;KAT2B;USP9Y;PSMB1;USP38;USP2;OTUD4;POLB;RHOA;SMAD3;USP30;STAM;PSMB2;ZRANB1;OTUD5;ABRAXAS2;CCP110
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.4394880889810091,1.2597574284353208,0.15265486725663716,0.5272260699681017,1.0,12/33,17.38%,CYP7B1;CHGA;SEC24A;LGMN;HSD11B2;RAN;LIN9;INSIG2;FDX1;ABCC3;SRD5A1;SAR1B
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.48224742744517135,1.259343559303387,0.16560509554140126,0.5259880418814855,1.0,4/20,5.94%,RPS27A;PSMB1;PPARGC1A;SMURF1
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.44693478548765386,1.2592563148077938,0.18736383442265794,0.5237586252426295,1.0,13/29,15.90%,POLR2B;H2AZ2;NUP210;TDRD9;NUP107;RAN;H3-3B;IPO8;H2AZ1;H2BC5;NUP155;POLR2I;MOV10L1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.40076826889585504,1.2590405888190048,0.12951167728237792,0.5219272920557201,1.0,23/52,24.80%,RPS27A;PSMB1;FBXL18;SMURF1;ANAPC1;SIRT1;EDEM1;KBTBD6;FEM1C;HSP90B1;PSMB2;FBXO31;AREL1;DNAJC18;FBXO38;NFE2L2;FBXL7;MAEA;PSMA1;UBE2D1;NSFL1C;FBXO2;PSME4
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.5230017001218408,1.2567410455349728,0.19264069264069264,0.5255651031229126,1.0,3/15,4.18%,RPS27A;PSMB1;FBXL18
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.47283299069662277,-1.255769306614166,0.17234848484848486,1.0,1.0,3/29,3.70%,PTPRD;PTPRK;PTPRM
prerank,KEGG_2021_Human__Apoptosis,-0.45632669201217413,-1.2538790016238817,0.17383512544802868,1.0,1.0,9/27,18.56%,EIF2S1;ITPR2;PARP2;PARP1;EIF2AK3;CYCS;HRK;CFLAR;JUN
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.4739907722978291,1.2532194230567728,0.16630196936542668,0.5326632938245698,1.0,7/22,16.60%,CEPT1;CPNE3;HADHB;HADHA;CHKA;GNPAT;LPIN2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.5131252988683723,1.2508323463325832,0.17880794701986755,0.5367178545818614,1.0,7/17,15.78%,POLR2B;GTF2B;PHAX;INTS9;INTS2;ZNF143;POLR2I
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5223992337496103,1.2497519488270628,0.19791666666666666,0.5372109061827645,1.0,5/16,5.80%,CCK;DCC;SLITRK2;CNTN4;MINK1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.47478854692848693,-1.2494599624069516,0.1787709497206704,1.0,1.0,3/26,4.58%,LRP1B;HSP90AA1;FNBP1L
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.5238131794545531,-1.2492652434996527,0.19736842105263158,1.0,1.0,6/17,9.72%,TBCB;CCT3;CCT2;TUBB2A;GNG2;GNG7
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.4098239409912047,1.2486024548527594,0.13555555555555557,0.5379184336245522,1.0,5/42,2.64%,PCSK1N;HDAC9;ID2;TOR1AIP2;NRP1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.4911976435746757,1.2481000934530788,0.15765765765765766,0.5368200864032113,1.0,6/20,10.86%,PCSK1N;TLE4;DCC;SIRT1;TOPBP1;ARL4A
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.40571609589590213,-1.247977039472287,0.1504424778761062,1.0,1.0,18/60,17.00%,DGKG;PHACTR2;ITPR2;CAP1;CD63;TRPC6;GNG2;F5;STXBP3;LHFPL2;GNG7;PRKCH;TRPC7;DGKK;ENDOD1;PRKCQ;PRKCG;TGFB2
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.431168949916254,1.247455047538196,0.15517241379310345,0.5359485089779459,1.0,10/36,16.60%,INPP4B;CEPT1;RAB5A;CPNE3;HADHB;MTMR6;HADHA;CHKA;GNPAT;LPIN2
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.5126875339155689,1.2463022651544322,0.1913978494623656,0.5367447843078544,1.0,3/15,5.94%,RPS27A;PSMB1;SMURF1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5066853823683987,-1.2444828064344928,0.20786516853932585,1.0,1.0,7/18,22.72%,FGF9;FGFR2;GPX1;TGFB2;TGFBR3;EGFR;MCC
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.492700403840748,1.2415866777998352,0.19426048565121412,0.5466702725234459,1.0,5/18,14.22%,ID2;DISP3;HDAC3;RUBCNL;SIN3A
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.49199105702776985,-1.24028181084354,0.17531305903398928,1.0,1.0,6/23,10.48%,PARD3;SDK1;CDH13;PARVB;CDH4;CDH6
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.4320897867221355,1.2392003638722717,0.17633928571428573,0.550538098020826,1.0,8/33,13.72%,MARCHF1;ST8SIA4;TDRD7;BTG1;SRI;ARL4A;STAT3;PSMB2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4952135923240638,1.2381726019940715,0.20833333333333334,0.5508153225315306,1.0,7/18,13.72%,TIAM1;PSMB1;RHOA;SMURF1;FZD6;AP2S1;PSMB2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.4151673727544368,-1.2343728523207935,0.1635434412265758,1.0,1.0,12/50,13.12%,PDE7B;GRIK4;CHRNA7;ASIC2;SLC1A2;SYT10;NPTX2;GABRG3;HOMER1;HRH1;HTR2C;SYT5
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.48965658335803924,-1.2328753826512617,0.1950286806883365,1.0,1.0,6/19,9.62%,GRID2;EIF2S1;CHRNA7;EGR1;DHCR24;CHMP4B
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.45221686823889434,1.231691984443378,0.16400911161731208,0.5658186059877542,1.0,8/25,11.56%,RERG;TIAM1;MAPKAPK5;PARK7;KSR1;CCDC88C;PRKD1;KRAS
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.49392916231773876,1.2313318420554122,0.2017167381974249,0.5643607060635562,1.0,9/17,23.86%,NUP107;RAN;NDEL1;RMDN1;EFHC1;TUBG2;NUP85;CENPE;PLK2
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.501713881566779,1.2302537514977596,0.19230769230769232,0.5648690360039345,1.0,3/16,6.34%,RPS27A;PSMB1;MKRN1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.47163114103467874,1.2286620412920368,0.1761006289308176,0.5668872367686171,1.0,4/19,5.76%,RPS27A;POLR2B;RPA1;GTF2H3
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.4099755868930399,1.228600140679845,0.17494089834515367,0.5646449484043253,1.0,7/40,11.32%,THSD4;GPC5;GPC6;B3GLCT;ADAMTS2;HEXB;GALNT3
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.49654562887833165,-1.228401102375607,0.1977401129943503,1.0,1.0,7/20,16.62%,DPP10;ANK1;LIN7C;RAB3C;RAB11A;MRAP2;TSPAN14
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.40399618314681746,1.227344777216312,0.13926940639269406,0.5655075226678906,1.0,13/41,16.44%,RPS27A;TLE4;PSMB1;H2AZ2;RBBP5;FZD6;CCDC88C;H3-3B;PYGO1;H2AZ1;PSMB2;H2BC5;WNT3
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5167385669882665,-1.2267900711704842,0.20767888307155322,1.0,1.0,6/16,21.90%,TRPC6;HOMER1;MYLK;NOS1;WNK3;PLPP4
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5131048129005481,1.2257615685177121,0.19866071428571427,0.5672963435821917,1.0,5/15,11.80%,RPL5;CRY1;SH3RF2;PARK7;NXN
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.4204187485882541,1.2250542804866873,0.17713004484304934,0.5644424762053434,1.0,17/35,24.80%,RPS27A;PSMB1;FBXL18;MZT2B;CEP135;LIN9;LIN54;PSMB2;CCP110;TUBB4B;TUBG2;DCTN1;FBXL7;RBBP4;PSMA1;TUBGCP5;PSME4
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.4204187485882541,1.2250542804866873,0.17713004484304934,0.5644424762053434,1.0,17/35,24.80%,RPS27A;PSMB1;FBXL18;MZT2B;CEP135;LIN9;LIN54;PSMB2;CCP110;TUBB4B;TUBG2;DCTN1;FBXL7;RBBP4;PSMA1;TUBGCP5;PSME4
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.4975947562292494,-1.2237593540747336,0.21956087824351297,1.0,1.0,6/19,9.72%,GNAL;CAMK2D;ITPR2;GNG2;SCN1A;GNG7
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.5054997687143201,-1.2235350353282812,0.24282982791587,1.0,1.0,10/17,20.20%,RGS12;RGS20;KCTD8;GNG7;CAMKMT;GRK5;USP20;MRAP2;CNGB1;PPEF1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.41708935907653427,1.2232735550662008,0.16263736263736264,0.5665691163948855,1.0,15/36,19.68%,RERG;TIAM1;GNA13;MAPKAPK5;RHOA;PARK7;CDC42EP3;KSR1;PRKD1;KRAS;CRKL;GNA12;LIMK1;ARHGDIG;RIT2
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.46846685767279356,1.2221680809663824,0.19402985074626866,0.5672138678501096,1.0,5/20,13.72%,RPS27A;PSMB1;UBA3;EDA;PSMB2
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.45980052182563247,1.2193642537322986,0.21199143468950749,0.5726611492144883,1.0,4/23,3.12%,SGCD;SGCG;CACNB4;CDH2
prerank,KEGG_2021_Human__Purine metabolism,-0.4468776175217313,-1.2189891209003332,0.181651376146789,1.0,1.0,7/33,6.70%,PDE1A;PDE7B;AK5;PDE1C;GDA;PAPSS2;ADCY8
prerank,KEGG_2021_Human__Tryptophan metabolism,0.5063946158545896,1.2180717431773775,0.21286031042128603,0.5737477293501462,1.0,8/15,21.50%,ALDH7A1;KYAT3;DHTKD1;HADHA;CAT;DLST;MAOB;ALDH8A1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.4423046175988978,-1.2174803000144616,0.18653846153846154,1.0,1.0,6/33,6.52%,PTPRD;ROBO2;PLXNA4;ZNF804A;ROR2;GRIP1
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.5112619956697451,-1.2166605101720882,0.23193916349809887,1.0,1.0,8/16,21.46%,CAMK2D;ITPR2;EGR1;ADCY8;MAP3K2;CALM3;JUN;EGFR
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.4395771705455319,1.2164501899710614,0.1841541755888651,0.5758122427384074,1.0,8/26,16.56%,RPS27A;TOMM7;ABCD2;ABCD3;ACBD5;FIS1;GNPAT;SERP1
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.4698886467625483,1.2149000691691354,0.20454545454545456,0.5774426236224611,1.0,6/20,14.16%,RPS27A;TLE4;PSMB1;CTBP2;PSMB2;ZRANB1
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.4539274722011304,1.214667664068162,0.19027484143763213,0.5756394482619404,1.0,9/24,15.12%,HSPH1;DNAJB6;NUP210;MAPK3;HIKESHI;SIRT1;NUP107;GML;NUP155
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.4311374940532986,1.2144007492804154,0.21318681318681318,0.5739870152958585,1.0,7/29,13.72%,RPS27A;PMEPA1;PSMB1;ANAPC1;NUP107;NDEL1;PSMB2
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.4932054933793224,1.214087665567864,0.2229299363057325,0.5723818841586842,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.47850484894508405,1.2139515471073299,0.2127659574468085,0.5704412036064903,1.0,5/18,15.68%,RPS27A;PSMB1;ANAPC1;PSMB2;FBXO31
prerank,KEGG_2021_Human__Circadian entrainment,-0.4695240379951746,-1.2136582006491892,0.19925512104283055,1.0,1.0,12/24,17.24%,PRKG1;CAMK2D;RYR3;RYR1;GNG2;PRKG2;ADCY8;GNG7;ADCYAP1R1;NOS1;PRKCG;CALM3
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.4219050086839455,1.2134184930691305,0.1956989247311828,0.5695575967013002,1.0,10/30,14.88%,KAT2B;H2AZ2;GTF2H3;SIRT1;TET3;MYO1E;H3-3B;H2AZ1;SIN3A;H2BC5
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.5334584836141412,-1.2128071658803823,0.21102661596958175,1.0,1.0,6/15,16.44%,KIF3A;KIF26B;KIF27;KIF21B;ARFGAP3;COPB1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.47202995900757794,-1.2109041574320922,0.22242647058823528,1.0,1.0,4/22,6.70%,GNAL;RXFP1;GNG2;ADCY8
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.47031813429807434,1.2090670916309623,0.22666666666666666,0.5762262872755514,1.0,6/19,15.66%,RPS27A;PSMB1;LIN9;LIN54;PSMB2;TFDP1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.47031813429807434,1.2090670916309623,0.22666666666666666,0.5762262872755514,1.0,6/19,15.66%,RPS27A;PSMB1;LIN9;LIN54;PSMB2;TFDP1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.34679191311746443,1.2084901717181618,0.15584415584415584,0.5756344602781504,1.0,23/91,12.42%,RPL5;TIAM1;GNA13;ARHGAP10;MCF2;ARHGAP24;USP2;MAPKAPK5;MAPK3;CASTOR2;RPA1;MINK1;BRIP1;RHOA;RASGRF2;DNA2;PRKAB2;TOPBP1;HIPK2;TRAF5;HIPK1;MRE11;RBBP8
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.4783977209802436,1.2081226524367104,0.22291666666666668,0.5743199872746158,1.0,7/19,13.72%,TIAM1;PSMB1;RHOA;SMURF1;FZD6;AP2S1;PSMB2
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.5057418911177817,-1.2079210711739592,0.2314647377938517,1.0,1.0,5/16,14.52%,RYR3;RYR1;CHRNA7;TRPC5;GRIN3A
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.414056751564232,1.2071315441627828,0.19480519480519481,0.5747612150493425,1.0,8/34,8.02%,RPS27A;TIAM1;GNA13;MCF2;USP2;RHOA;RASGRF2;HDAC3
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.417536539543841,1.2066834111286953,0.1936842105263158,0.5736409341840794,1.0,9/34,9.08%,NR3C2;PMEPA1;PPARGC1A;CASP8AP2;NUP210;PARK7;SENP1;NUP107;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.34520353327391723,1.2061317597174872,0.12240184757505773,0.572872496822782,1.0,24/90,16.36%,RPS27A;ANXA1;ARHGAP10;PPARGC1A;FOXO1;DNAJB6;FSTL1;MAPK3;SH3RF2;PARK7;LGMN;RPL10;SIRT1;HDAC3;PPT1;HSP90B1;CAT;MRE11;UFM1;APIP;CX3CL1;BID;VSTM2L;NOTCH2
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.48477040868369636,1.205297362217081,0.23809523809523808,0.5728151930328521,1.0,6/18,14.22%,PPARGC1A;HDAC3;LIN9;MED10;TXNRD1;SIN3A
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.46762115158023,1.2044928659301806,0.2267818574514039,0.5727421262685655,1.0,5/19,6.04%,RPS27A;TIAM1;GNA13;MCF2;RASGRF2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4029268763511667,-1.2016475104973823,0.19378427787934185,1.0,1.0,14/48,16.90%,HNRNPU;EIF2S1;CCT3;CCT2;PSMA4;CBX3;HSPD1;DDX21;SNRPA1;HNRNPA2B1;SRSF7;USP1;GOT2;RACK1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.44819292900961655,1.2007325780952693,0.2100656455142232,0.580699616156741,1.0,8/23,19.98%,HDAC9;ANXA1;ABCD2;TWSG1;CX3CL1;OTUD5;MACIR;RGCC
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.4244180897639981,-1.1991935433852698,0.2146690518783542,1.0,1.0,6/36,7.40%,PTPRD;TENM4;RUNX1;MET;MTPN;TGFBR1
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.46041663349096545,1.1964857025147733,0.2296137339055794,0.5901718660263849,1.0,4/21,5.94%,RPS27A;PSMB1;IQCE;SMURF1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.48484490061811936,1.1946215102079025,0.24093816631130063,0.5929114858829566,1.0,4/17,2.44%,CCK;DCC;SLITRK2;CNTN4
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.37330713941777677,1.1942399773010153,0.18161434977578475,0.5915814642028837,1.0,19/55,21.14%,MARCHF1;RPS27A;PSMB1;FBXL18;SMURF1;MKRN1;ANAPC1;KBTBD6;TRAF5;PSMB2;UBE2Q2;RNF20;FBXO31;AREL1;RNF8;FBXO38;TRAF6;TRIM69;FBXL7
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.35381944109443986,1.1935918855794243,0.15081206496519722,0.5910247755718906,1.0,19/85,13.72%,CUX1;HDAC9;RPS27A;POLR2B;KAT2B;PSMB1;FOXO1;MAPK3;NRG1;CTBP2;FZD6;HDAC3;SMAD3;KITLG;KSR1;MAML3;TPM4;STAT3;PSMB2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.42977969403338523,1.1933198367313884,0.20309050772626933,0.5895219723321085,1.0,8/29,10.94%,ATP6V0E1;FOXO1;MIOS;MAPK3;CASTOR2;LAMP2;SIRT1;PRKD1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.4720374825553384,1.1929902783947512,0.22410147991543342,0.5881199690711916,1.0,3/18,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.4934504652067384,1.192406805021437,0.23789473684210527,0.5830408601115027,1.0,3/15,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.4934504652067384,1.192406805021437,0.23789473684210527,0.5830408601115027,1.0,3/15,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.4934504652067384,1.192406805021437,0.23789473684210527,0.5830408601115027,1.0,3/15,6.44%,RPS27A;PSMB1;ANAPC1
prerank,KEGG_2021_Human__AMPK signaling pathway,0.4653338233743011,1.1920517957538301,0.22336065573770492,0.5818083145415587,1.0,5/18,8.10%,PPARGC1A;FOXO1;ADIPOR2;SIRT1;PRKAB2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.45851520042915916,1.1907831078677926,0.24532224532224534,0.5831142873709988,1.0,5/20,9.88%,ATP6V0E1;LZTS1;SIRT1;PRKAB2;GAPDH
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.4671286648711231,1.1891880626422677,0.21350762527233116,0.5850637256889537,1.0,3/19,5.94%,SF3B3;FOXO1;SMURF1
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.45939240085282734,1.1878967558256137,0.21019108280254778,0.5863634193124281,1.0,4/20,3.60%,RPS27A;IFT52;PSMB1;ADCY10
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.47691450828339416,1.1857729451116892,0.2260127931769723,0.5879474967532756,1.0,4/16,13.72%,RPS27A;PSMB1;UBA3;PSMB2
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.47691450828339416,1.1857729451116892,0.2260127931769723,0.5879474967532756,1.0,4/16,13.72%,RPS27A;PSMB1;UBA3;PSMB2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4560595138489256,-1.185451647263439,0.23843416370106763,1.0,1.0,5/24,6.70%,RYR3;RYR1;USP16;SLC1A2;ADCY8
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.4252543875001041,1.1836408395711862,0.22245762711864406,0.5917157693342415,1.0,9/28,11.98%,RPS14;RPL5;DHX29;GEMIN5;SRSF10;RPL10;RPS15;STRAP;GCFC2
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.4594128363025768,1.1831793813042346,0.2318840579710145,0.5907557160027662,1.0,2/18,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.39564075288889816,1.1830634956904253,0.19956140350877194,0.5889221895092334,1.0,12/37,9.04%,TIAM1;ARHGAP10;MCF2;ARHGAP24;BCAP31;RHOA;RASGRF2;ATP6AP1;ABCD3;ACBD5;PGRMC2;TMPO
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.496001357249306,1.1829667333297733,0.25949367088607594,0.5870668114092434,1.0,5/15,8.16%,PSRC1;USP2;MEIS2;LGMN;RPS15A
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.47020053600358613,-1.1828716926543674,0.22426470588235295,1.0,1.0,10/20,20.72%,DLC1;MET;TGFBR1;ARHGEF10L;TMEFF2;TPM1;ASAP3;PHLDB2;ARHGAP6;STMN1
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.49136936514568214,1.178746506767767,0.2567849686847599,0.5962134172968158,1.0,2/15,0.74%,PDZD2;RPS27A
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.49244516926243415,-1.1787115901706031,0.2411214953271028,1.0,1.0,8/18,23.50%,KIF3A;KIF26B;KIF27;KIF21B;ARFGAP3;COPB1;RAB18;KIF6
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2819144221622321,1.178699062395321,0.0821529745042493,0.5942257596000371,1.0,90/374,17.14%,CUX1;RORB;CUX2;HDAC9;NFIB;NR3C2;ZFPM2;RFX2;GLIS3;ZBTB7C;YWHAH;ID2;HSF2;WBP2NL;PSRC1;CREBL2;CCDC85B;CRY1;PPARGC1A;IRF2BPL;FOXO1;PRDM8;HBP1;ZHX2;MEIS2;FOXP2;BTG1;ZNF280C;JDP2;ZNF684;SP4;BRIP1;SRSF10;ZNF566;NRG1;ZNF341;ZNF678;MEIS1;POU3F2;TOX4;SIRT1;CTBP2;NUP107;HDAC3;ZNF439;PER1;SMAD3;HIPK2;NFE2L1;NAB1;PGBD1;ARID3A;TCEAL7;LIN9;CTCF;PRMT2;GABPA;KDM3A;LIN54;GCFC2;RBBP8;ZNF43;ZFP2;MYNN;STAT3;HIVEP2;ZNF391;ZNF354C;ZNF589;CNOT7;SIN3A;YY1AP1;IGSF1;ZNF143;ZBTB11;PLAGL1;SLC39A8;ZNF711;MTF1;TSHZ1;RNF20;ZFP14;TFDP1;PCGF6;ZNF302;ZNF577;ZNF521;PITHD1;BHLHE22;PER2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3550400688231268,1.1773364234216839,0.17647058823529413,0.5956989136638814,1.0,16/64,16.36%,SGCD;PMEPA1;ID2;SGCG;CALU;CDH2;ABI3BP;PLOD2;FSTL1;COL5A1;DPYSL3;FAP;TPM4;COL4A2;MEST;NOTCH2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.4621043190683034,1.1764244238003019,0.24342105263157895,0.5958471412821676,1.0,4/20,11.12%,RPS27A;LGMN;RFTN1;HSP90B1
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.4834968161863741,1.1760360049475147,0.24358974358974358,0.5864935042500938,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.4834968161863741,1.1760360049475147,0.24358974358974358,0.5864935042500938,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.4834968161863741,1.1760360049475147,0.24358974358974358,0.5864935042500938,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.4834968161863741,1.1760360049475147,0.24358974358974358,0.5864935042500938,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.4834968161863741,1.1760360049475147,0.24358974358974358,0.5864935042500938,1.0,3/16,6.44%,RPS27A;PSMB1;ANAPC1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.42118318313788433,-1.1756633213222933,0.22242990654205608,1.0,1.0,12/34,15.62%,SOX6;BMPR1B;GRIP1;HMCES;MCU;SLC6A6;DLG5;AR;LRP8;MARCHF5;ACVR1;PHLDB2
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.3959015255192307,1.1750988272931964,0.2296137339055794,0.5870674402008492,1.0,9/34,11.56%,KAT2B;NRP1;MAPK3;PPP3CC;POLB;ANAPC1;RAN;SMAD3;KRAS
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.43158246976678327,-1.1747011498185618,0.22030651340996169,1.0,1.0,8/34,12.18%,HSP90AA1;FGF9;MET;ERBB4;FGFR2;TGFBR1;ESR1;HIP1
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.4858444170469921,1.1735350282079242,0.2765957446808511,0.5890548828983934,1.0,2/15,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.3800427966826634,1.1731485391439793,0.20594965675057209,0.5880160124083506,1.0,14/48,16.22%,RPS27A;KAT2B;PSMB1;USP2;RHOA;SMAD3;USP30;STAM;PSMB2;ZRANB1;H2BC5;OTUD5;ABRAXAS2;CCP110
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.41743852606663023,1.1727147261470567,0.2071269487750557,0.5871040103351803,1.0,4/28,4.44%,RPS27A;PSMB1;RBMX;MAPK3
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.4560518911023333,1.170859808423657,0.2679738562091503,0.5900728947545185,1.0,3/19,3.96%,GPC5;GPC6;C1D
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.45564747428346447,1.168450146790628,0.24210526315789474,0.5943529440717564,1.0,7/18,18.46%,RPS27A;POLR2B;GTF2H3;ERCC4;POLR2I;POLE2;ERCC1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.4883822263309402,-1.1678142566645484,0.2641165755919854,1.0,1.0,3/17,9.38%,IL2RA;GHR;IL17D
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.3409201783846718,-1.1649254460062675,0.19173553719008266,1.0,1.0,25/125,11.72%,PRKG1;PDE1A;DGKG;PHACTR2;ITPR2;CAP1;KIF3A;CD63;MAFG;TRPC6;GNG2;PRKG2;KIF26B;GRB14;F5;DOCK10;KIF27;STXBP3;LHFPL2;SERPINE2;GNG7;KIF21B;PRKCH;TRPC7;LRP8
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.43426740308671014,1.164518654065543,0.2619047619047619,0.6024898615750397,1.0,9/23,10.64%,TOMM7;BCAP31;PEX1;TRAK2;SDCBP;LAMP2;EDEM1;FIS1;SPCS3
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.4417206519806826,-1.164158221346391,0.24504504504504504,1.0,1.0,3/28,1.76%,FRAS1;SV2C;LAMA2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.36212446884931043,1.1639622404858359,0.20047732696897375,0.601923600463924,1.0,25/57,21.74%,KAT2B;ID2;NEK7;HBP1;RPL23;SDCBP;SIRT1;RPS15A;SMAD3;HIPK2;LIN9;FAP;LIN54;STAT3;CKS2;YY1AP1;PLAGL1;RNF20;NOTCH2;PER2;CDC14B;RGCC;WDR12;RBBP4;MAEA
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.43619099243286824,1.1637041340247103,0.2605932203389831,0.6006033519588512,1.0,8/22,19.54%,RPS27A;POLR2B;GTF2H3;ERCC4;POLR2I;POLE2;ERCC1;LRIG3
prerank,KEGG_2021_Human__GABAergic synapse,-0.48386822460689594,-1.1631371785562445,0.2713472485768501,1.0,1.0,6/18,15.96%,GNG2;ADCY8;GABRG3;GNG7;GLUL;PRKCG
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.4778618588726648,1.1630329495697898,0.2636165577342048,0.6003662847112549,1.0,3/15,5.76%,RPS27A;POLR2B;GTF2H3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4435688889716985,1.1617153160971785,0.2510822510822511,0.6019962584370807,1.0,10/20,16.90%,TOR1AIP2;RANBP17;HIKESHI;NUP107;RAN;HEATR3;IPO8;STAT3;NUP155;APPL1
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.42071139147431186,-1.1606454421618015,0.25092250922509224,1.0,1.0,9/32,17.00%,PHACTR2;CAP1;CD63;F5;STXBP3;LHFPL2;ENDOD1;PRKCG;TGFB2
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.2915400020960817,1.1600882762006575,0.08310249307479224,0.6040020404322335,1.0,70/255,20.18%,THSD4;RPS27A;KAT2B;NR3C2;CHGA;PMEPA1;ST8SIA3;CNTN4;PSMB1;CALU;ST8SIA4;PPARGC1A;RAB5A;CDH2;TPST2;CASP8AP2;USP2;FBXL18;NUP210;FSTL1;SPTB;SEC24A;RBBP5;RHOA;B3GLCT;PARK7;SENP1;EDEM1;NUP107;KBTBD6;FEM1C;SMAD3;HIPK2;ADAMTS2;USP30;UBA3;HSP90B1;GALNT3;STAM;CHRDL1;COG2;PSMB2;UBE2Q2;ZRANB1;KLHL25;SIN3A;NEU3;ST6GAL2;H2BC5;OTUD5;NUP155;ABRAXAS2;RNF20;FBXO31;ADAMTS17;CCP110;NUB1;SAR1B;GALNT8;ADAMTSL1;RAB5B;RNF2;PIGZ;NFE2L2;TUBB4B;XRCC4;GCNT4;ST6GALNAC3;TRAF6;VCPIP1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.3241152503852569,1.1594928392231614,0.1547911547911548,0.6034959194370263,1.0,20/99,13.20%,CUX2;RPS7;KAT2B;RPL26;RPL5;ID2;PPARGC1A;MAPK3;RPL23;PARK7;GSN;SMAD3;GAPDH;FAM98B;CTCF;GABPA;KRAS;STAT3;STOX1;EIF3E
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.4726179456959773,1.1587739916976278,0.2799145299145299,0.6013358607118773,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.4726179456959773,1.1587739916976278,0.2799145299145299,0.6013358607118773,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,MSigDB_Hallmark_2020__Coagulation,0.4775539621343913,1.1583853120426564,0.275,0.6004021979916374,1.0,5/15,11.18%,ANXA1;LGMN;LAMP2;GSN;KLKB1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3527843750905333,1.1575706911726142,0.19413092550790068,0.6004874790623916,1.0,14/63,11.54%,RPS27A;TIAM1;GNA13;MCF2;FOXO1;MTCH2;RASGRF2;ANO6;SIRT1;PPID;FAM162A;CRADD;PRMT2;TCTN3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.48040740169944335,-1.1568586707278272,0.2476007677543186,1.0,1.0,6/18,16.62%,DPP10;ANK1;RAB3C;RAB11A;MRAP2;TSPAN14
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.30569353073528743,1.1555402216520252,0.15718157181571815,0.603728441578716,1.0,34/163,13.96%,KAT2B;RERG;KCNH1;PPM1D;ZBTB7C;ID2;TIAM1;GAREM1;MEIS2;BTG1;FTH1;TOB1;RHOA;RTKN2;NRG1;RPL23;SDCBP;LGMN;MEIS1;POU3F2;SIRT1;CTBP2;RPS15A;KITLG;KSR1;FAM98B;CTCF;KRAS;STAT3;STOX1;PTN;GML;CX3CL1;CNOT7
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.3358584552614892,-1.1530043409589374,0.2,1.0,1.0,32/116,16.64%,PDE1A;GNAL;CAMK2D;PDE7B;DGKG;ADORA1;PDE1C;RXFP1;ITPR2;PLEKHG5;TRPC6;RGS12;GRM8;GNG2;ARHGEF26;ADCY8;RGS20;ARHGEF10L;GNG7;PRKCH;TRPC7;ADCYAP1R1;OPRM1;HTR2C;ITSN1;GRK5;DGKK;GLP2R;PRKCQ;GRM4;PRKCG;RGSL1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.47268476154158295,1.151399180907615,0.2809224318658281,0.6126344352642857,1.0,3/15,8.14%,GK;SIRT1;GK5
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.33973395883205737,1.1504495061862072,0.20574162679425836,0.613150835861684,1.0,19/70,16.36%,RPS27A;ANXA1;ARHGAP10;FOXO1;FSTL1;SH3RF2;PARK7;RPL10;SIRT1;HDAC3;PPT1;HSP90B1;CAT;MRE11;UFM1;APIP;CX3CL1;BID;NOTCH2
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.396776665093357,1.1503862721701859,0.24380165289256198,0.6112938151712293,1.0,15/33,22.08%,NR3C2;PMEPA1;PPARGC1A;CASP8AP2;NUP210;PARK7;NUP107;HIPK2;SIN3A;NUP155;RNF2;XRCC4;HDAC2;NUP85;NDC1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.40034330693117537,-1.1483074527167563,0.2522851919561243,1.0,1.0,7/40,7.02%,PTPRD;RUNX1;SEMA3A;MET;TUBB2A;SH3RF1;MTPN
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2932382910596521,1.1473777175495696,0.13043478260869565,0.6169822635702699,1.0,54/212,16.50%,RORB;CUX2;RPS7;RPL5;ID2;ZNF451;CREBL2;PPARGC1A;DIP2A;PRDM8;C1D;TDRD7;MAPK3;BTG1;ZNF280C;TOB1;SRSF10;AFF2;ZNF341;RPL23;PARK7;LGMN;ZNF678;CGGBP1;SIRT1;ZNF507;GSN;NUP107;PER1;SMAD3;NAB1;FAM98B;CTCF;GABPA;KRAS;LIN54;GCFC2;STAT3;STOX1;NFKBIZ;CNOT7;YY1AP1;IGSF1;ZNF143;ZBTB11;SLC39A8;HNRNPH2;ATXN7L3B;GRSF1;ZNF711;RNF20;NOTCH2;WNT3;CRKL
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.4623879195854353,1.1469448664974642,0.2879120879120879,0.6160820284621159,1.0,9/17,21.58%,H2AZ2;GTF2H3;SIRT1;H3-3B;H2AZ1;SIN3A;H2BC5;SAP18;HDAC2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4371158794545006,1.145490618098322,0.28451882845188287,0.6180991064763935,1.0,8/21,13.72%,TIAM1;PSMB1;RHOA;SMURF1;FZD6;CCDC88C;AP2S1;PSMB2
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.47690372280728743,-1.1443205430290353,0.27041742286751363,1.0,1.0,4/15,6.06%,ADGRV1;CRYBG3;PCDH15;GRM8
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.37729397970807094,1.1439910069300054,0.24565217391304348,0.620272876695942,1.0,21/43,27.68%,ATP6V0E1;ATP5MG;NDUFB2;ATP6AP1;ATP5F1E;NDUFC1;NDUFC2;NDUFA4;ATP5PF;NDUFB11;COX7A1;NDUFAB1;COX10;ATP5PO;NDUFB8;ATP5F1C;COX5A;ATP5MC2;ATP5MC3;ATP5MF;UQCR11
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.4408894460397266,1.1438441822572605,0.2597938144329897,0.6186453151799871,1.0,2/19,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.3869536657664779,1.143060837231006,0.25389755011135856,0.6186340964428563,1.0,11/37,14.88%,RPS27A;KAT2B;PSMB1;H2AZ2;RBBP5;HIPK2;H3-3B;H2AZ1;PSMB2;SIN3A;H2BC5
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.4678495290386772,-1.142640141799234,0.29338103756708406,1.0,1.0,8/18,15.18%,SYT2;SYT12;SYT10;SYT17;NKAIN3;ATP1A1;SYT5;NOS1
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.3949999033139168,1.1425956587101151,0.251063829787234,0.6179419336993888,1.0,9/32,15.12%,RPS27A;PSMB1;NUP210;NUP107;RAN;AP1S2;AP2S1;PSMB2;NUP155
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.4688381837653961,1.1420247271699648,0.30879345603271985,0.6155205391659118,1.0,3/16,20.14%,RHOA;CXCL13;TRAF6
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.4688381837653961,1.1420247271699648,0.30879345603271985,0.6155205391659118,1.0,3/16,20.14%,RHOA;CXCL13;TRAF6
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.3604472895390487,-1.1409240411295674,0.2490842490842491,1.0,1.0,12/66,9.48%,PDE1A;CAMK2D;PDE1C;FGF9;ITPR2;ERBB4;FGFR2;PSMA4;EGR1;ADCY8;RRAGD;ESR1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.36471156843908675,-1.138806775762868,0.24545454545454545,1.0,1.0,12/63,5.36%,ROBO2;SLIT1;PARD3;CNTN6;LAMA2;HSP90AA1;SEMA3A;FGFR2;NEFH;SLIT3;DSCAML1;SEMA3E
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.3471301123627299,1.1374068747056219,0.2328159645232816,0.6255196082994937,1.0,32/62,28.92%,ATP6V0E1;ATP5MG;NDUFB2;DECR1;ATP6AP1;HADHB;ATP5F1E;HADHA;NDUFC1;FDX1;NDUFC2;NDUFA4;ATP5PF;MRPS30;DLST;MDH1;MAOB;NDUFAB1;COX10;MTRR;ATP5PO;NDUFB8;ATP5F1C;COX5A;AFG3L2;ATP5MC2;ATP5MC3;ATP5MF;UQCR11;SLC25A6;NDUFS3;MDH2
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.26754573782765906,1.1360898277622753,0.08454810495626822,0.6270807406922235,1.0,101/500,14.24%,PDZD2;FKBP5;HDAC9;GPC5;PDE3A;RPS27A;POLR2B;KAT2B;VIPR2;EDNRA;PRAG1;CHGA;TLE4;EDNRB;YWHAH;PMEPA1;ID2;RHOBTB1;TIAM1;IFT52;ANXA1;GNA13;PSMB1;NRP1;ARHGAP10;RARB;ATP6V0E1;MCF2;OSBPL11;MOB1B;RBMX;ARHGAP24;MOB1A;FOXO1;ADCY10;USP2;MAPKAPK5;BCAP31;H2AZ2;FSTL1;MAPK3;ALDH1A1;SPTB;PPP3CC;IQCE;TMOD3;RBBP5;RHOA;SMURF1;RASGRF2;NRG1;MKRN1;WNT2B;ATP6AP1;GFRA1;TRAK2;SENP1;MPP2;ABCD3;CTBP2;ACBD5;FZD6;NUP107;PDE10A;HDAC3;PRKAB2;PTPN3;CDC42EP3;PPID;PGRMC2;SMAD3;WASF2;TMPO;KITLG;KSR1;NAB1;NDEL1;CCDC88C;KLKB1;GALNT3;MAML3;H3-3B;STAM;KDM3A;CHRDL1;TPM4;PYGO1;H2AZ1;STAT3;ADRB1;POGLUT1;LAMA4;AP2S1;ARMCX3;PTN;PSMB2;CX3CL1;ZRANB1;COL4A2;SIN3A;MYL12B
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.47854483959732486,-1.1356943543272018,0.29766536964980544,1.0,1.0,4/15,14.34%,ADGRV1;BMPR1B;TWIST1;ACVR1
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.4258888589117276,1.134553388429922,0.2766884531590414,0.6291761935701553,1.0,6/23,9.00%,THSD4;ID2;MAPK3;RHOA;SMURF1;SMAD3
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.4528555660775288,1.1339699715515843,0.27729257641921395,0.6288329021361804,1.0,4/18,9.08%,TIAM1;PARK7;RAN;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.3359833829141436,1.1336220197726614,0.21136363636363636,0.6278255849308783,1.0,17/73,11.54%,RPS27A;TIAM1;GNA13;MCF2;EPHA7;FOXO1;MTCH2;BTG1;RASGRF2;ANO6;SIRT1;PPID;FAM162A;CRADD;FAP;PRMT2;TCTN3
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.46393322789121455,1.133191228143689,0.2851063829787234,0.6270918876081687,1.0,5/16,18.84%,SMCHD1;SIRT1;EYA4;RNF8;FBH1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.3415807784834193,-1.1318548311836483,0.25368248772504093,1.0,1.0,21/99,11.00%,DLC1;MCTP1;PLXNA4;SEMA3A;FGF9;PTPRK;ERBB4;CDH13;MITF;DACH1;ROR2;SEMA3E;TGFBR1;DOCK10;SERPINE2;MYLK;ROBO1;TMEFF2;PODXL;DLG5;TPM1
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.420416377107181,1.1318400814750589,0.29004329004329005,0.6288002434763937,1.0,7/24,13.76%,RPS27A;TOMM7;PARK7;LAMP2;PRKAB2;USP30;ATG16L1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.41464457313825576,1.1315007342436922,0.3056179775280899,0.6277723542411536,1.0,8/26,17.14%,PPARGC1A;ABCD2;ADIPOR2;ABCD3;ACBD5;GNPAT;LPIN2;PER2
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.4441337735324682,1.1309349703433889,0.2911392405063291,0.6273916661688317,1.0,3/18,5.76%,RPS27A;POLR2B;GTF2H3
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.4429086790584891,1.1300671091396555,0.30454545454545456,0.6277246331994646,1.0,11/19,28.80%,RPL26;RPL5;EIF3E;RPS4X;EIF2S3;RMND1;YTHDF2;METTL14;FMR1;RPS9;EIF4A3
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.46055353625719425,1.129580285374677,0.30062630480167013,0.6270958834188601,1.0,5/17,13.66%,PPARGC1A;HDAC3;LIN9;MED10;TXNRD1
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.4526448572051587,-1.1285772002510985,0.301707779886148,1.0,1.0,4/20,7.06%,AK5;GDA;UPP1;CMPK1
prerank,KEGG_2021_Human__Amoebiasis,-0.45490576472783284,-1.1284549940917812,0.3007518796992481,1.0,1.0,6/19,17.00%,GNAL;LAMA2;SERPINB9;LAMA3;PRKCG;TGFB2
prerank,KEGG_2021_Human__Lysine degradation,0.455461681169562,1.1276996658701886,0.32134831460674157,0.629938144042861,1.0,7/16,20.26%,PLOD2;ALDH7A1;DHTKD1;HADHA;DLST;SETD7;KMT5A
prerank,MSigDB_Hallmark_2020__Androgen Response,0.40532819416985744,1.1266675171964224,0.2800925925925926,0.6304882450456706,1.0,6/29,10.64%,INPP4B;FKBP5;PMEPA1;GSR;RRP12;SPCS3
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.3776252657166877,1.124416056879984,0.2591743119266055,0.6344138511612055,1.0,5/39,4.04%,GPC5;GPC6;NMRK1;C1D;TPK1
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.4571832032449681,1.1238498099560956,0.2791666666666667,0.6340074136614644,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.4478716412090067,1.123764832550568,0.30526315789473685,0.6322775969090213,1.0,2/17,2.58%,RPS27A;PSMB1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.36025765255972164,1.1233977050548771,0.273972602739726,0.6312878952703792,1.0,5/45,5.78%,FKBP5;ID2;TIAM1;DNAJC12;TOB1
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.44191729971753047,-1.1230277219880014,0.28982725527831094,1.0,1.0,8/23,19.42%,IL2RA;HSP90AA1;RUNX1;TGFBR1;IL17D;PRKCQ;JUN;AHR
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.4770147403280877,-1.1227761762401989,0.2981132075471698,1.0,1.0,7/15,31.76%,GREB1L;TGFBR1;PCSK5;TGFB2;SULF1;PROX1;SULF2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4373055986782526,1.1213370360989496,0.3103448275862069,0.6347940874027491,1.0,8/20,13.02%,PPARGC1A;DISP3;DECR1;ADIPOR2;HDAC3;PRKAB2;KDM3A;ADRB1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4020803049091337,1.1204400417747615,0.3006396588486141,0.6353405653327404,1.0,9/28,19.74%,ST8SIA3;ST8SIA4;PLOD2;TET3;POGLUT1;SLC39A8;SERP1;GALNT7;GCNT4
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.4569172339172584,1.1203439806197801,0.3057324840764331,0.633705893911465,1.0,8/16,15.78%,POLR2B;RBMX;DNA2;TOPBP1;RAN;HNRNPR;HNRNPH2;POLR2I
prerank,KEGG_2021_Human__Platelet activation,-0.45724864220355854,-1.119590406523839,0.30566037735849055,1.0,1.0,5/17,10.00%,PRKG1;ITPR2;PRKG2;ADCY8;MYLK
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.45005038027066857,1.1186163851199042,0.3049792531120332,0.6365762452291956,1.0,6/17,17.66%,MAPK3;PPP3CC;RHOA;KRAS;VAV3;NFATC3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.465278599372009,1.1185873765184182,0.3161290322580645,0.6347503980419827,1.0,4/15,6.54%,UTRN;MINK1;RHOA;EPHA3
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.39183373909003444,1.117695873274522,0.2824074074074074,0.6351308104314919,1.0,7/32,8.56%,RPS27A;POLR2B;GTF2B;NUP210;GTF2H3;NUP107;RAN
prerank,MSigDB_Hallmark_2020__DNA Repair,0.4153541327668205,1.1150253284823146,0.29910714285714285,0.6400259021015048,1.0,9/27,12.34%,GTF2B;BCAP31;POLB;GTF2H3;SDCBP;AK3;NME3;EIF1B;ERCC4
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.4584613305543549,1.1149254460460267,0.30128205128205127,0.6383566670918889,1.0,3/15,4.44%,RPS27A;POLR2B;MAPK3
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.40951369176942437,-1.11188636965065,0.3192660550458716,1.0,1.0,9/29,10.00%,RYR3;RYR1;ITPR2;GNG2;EGR1;ADCY8;TGFBR1;GNG7;MYLK
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3683190530663135,1.1102995177119068,0.2813852813852814,0.6485771301051809,1.0,13/40,18.28%,ZNF451;C1D;TOB1;AFF2;CGGBP1;ZNF507;CTCF;STOX1;NFKBIZ;ATXN7L3B;ZNF711;LDLR;ADNP2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.4789683702752646,-1.1101327075909748,0.32386363636363635,1.0,1.0,6/15,15.90%,MCTP1;MCU;EIF2AK3;HRH1;NOS1;NUDT4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.3769770706782465,-1.1100772208170115,0.27617328519855594,1.0,1.0,5/43,3.52%,DLC1;HSP90AA1;CHRNA7;FGF9;ERBB4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4277410522791246,1.1094420546343013,0.30131004366812225,0.6490868715624133,1.0,10/19,26.74%,RPS27A;PSMB1;STOX1;PSMB2;NFE2L2;EGLN3;PSMA1;PSME4;PSMA5;EPAS1
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.3812522694073382,1.109407454778876,0.2857142857142857,0.6472686120170018,1.0,7/34,8.56%,RPS27A;POLR2B;GTF2B;NUP210;GTF2H3;NUP107;RAN
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.4105466124068095,1.1092956946010009,0.3002159827213823,0.6456903080278,1.0,7/23,14.88%,RPS27A;PSMB1;H2AZ2;H3-3B;H2AZ1;PSMB2;H2BC5
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.3993615156296533,1.1088070284381968,0.31981981981981983,0.6451846227295116,1.0,13/28,23.62%,PMEPA1;NEK7;MZT2B;NUP107;CEP135;NDEL1;CCP110;TUBB4B;TUBG2;DCTN1;NUP85;TUBGCP5;CENPE
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.43049336239236363,1.1082222333691298,0.345372460496614,0.642957002031953,1.0,7/20,14.88%,KAT2B;H2AZ2;MAPK3;GTF2H3;H3-3B;H2AZ1;H2BC5
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.43049336239236363,1.1082222333691298,0.345372460496614,0.642957002031953,1.0,7/20,14.88%,KAT2B;H2AZ2;MAPK3;GTF2H3;H3-3B;H2AZ1;H2BC5
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.448772458871005,1.1079861032527267,0.3044397463002114,0.6417751814628707,1.0,5/15,17.38%,SEC24A;RAN;LIN9;INSIG2;SAR1B
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.41870485203300195,1.1051838030647663,0.31385281385281383,0.6469200640011977,1.0,8/21,15.52%,TIAM1;MCF2;PGRMC2;WASF2;TMPO;ARMCX3;VAV3;VRK2
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.4406415399808098,-1.1039026294942549,0.32592592592592595,1.0,1.0,4/21,9.48%,FGF9;ERBB4;FGFR2;ESR1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.39876236126501663,1.1031488856457972,0.3068893528183716,0.6503701453782391,1.0,7/26,13.98%,RPS27A;PSMB1;ABCD2;ABCB10;ABCD3;PSMB2;ABCC3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.32294687627821117,1.1018340257410337,0.27045454545454545,0.652128035569831,1.0,37/81,27.00%,RPS27A;ZNF451;NUP210;SMURF1;MKRN1;SIRT1;NUP107;UBA3;UFM1;SUMO3;UBE2Q2;KLHL25;H2BC5;NUP155;RNF20;NUB1;AREL1;RNF8;FBH1;KIAA1586;NFE2L2;VCPIP1;TRIM69;FBXL7;RRAGA;NUP85;NDC1;TRIM54;UBE2D1;PEX5;FBXO2;RNF212;UBE2M;MDM2;EPAS1;NUP88;RNF212B
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.4445318466744079,1.1012190140756692,0.34698275862068967,0.6519052279069204,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.31671075743152716,-1.1011832603428877,0.25426621160409557,1.0,1.0,32/124,16.64%,PDE1A;GNAL;CAMK2D;PDE7B;DGKG;ADORA1;PDE1C;RXFP1;ITPR2;PLEKHG5;TRPC6;RGS12;GRM8;GNG2;ARHGEF26;ADCY8;RGS20;ARHGEF10L;GNG7;PRKCH;TRPC7;ADCYAP1R1;OPRM1;HTR2C;ITSN1;GRK5;DGKK;GLP2R;PRKCQ;GRM4;PRKCG;RGSL1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4393321690461347,-1.1002882047702578,0.32209737827715357,1.0,1.0,7/20,16.26%,SH3RF1;GPX1;TGFBR1;HSPA1A;AR;ACVR1;CFLAR
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.345904461367545,1.0999030147415767,0.3103448275862069,0.6534684152545809,1.0,13/52,15.78%,RPS27A;POLR2B;PSMB1;GTF2B;NUP210;GTF2H3;NUP107;RAN;AP1S2;AP2S1;PSMB2;NUP155;POLR2I
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.39076813258683835,-1.0984339225776782,0.3113207547169811,1.0,1.0,8/35,13.18%,CAMK2D;RYR3;RYR1;ITPR2;SCN1A;KCNK1;SCN7A;WWTR1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.41033414446073435,-1.0978621926415948,0.3108348134991119,1.0,1.0,8/29,12.56%,SPOCK3;ARHGAP18;PLXNA4;FGF9;ERBB4;DOCK10;SERPINE2;TWIST1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.44815488495890654,-1.097710780794902,0.3229571984435798,1.0,1.0,4/19,4.88%,PARD3;SKAP2;TEAD1;MITF
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.47617872806381334,-1.0976177339478739,0.3399638336347197,1.0,1.0,6/16,15.68%,HNRNPA2B1;HSPA1A;PCBP3;ALKBH5;SRSF7;NUDT21
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3946018846714675,1.0968876578589324,0.3118279569892473,0.6592549825164342,1.0,7/28,14.22%,ID2;PSMB1;HDAC3;PRKAB2;RUBCNL;PSMB2;SIN3A
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.3385672411744846,1.0960327003564683,0.2813186813186813,0.6596966135485602,1.0,18/56,16.14%,POLR2B;SF3B3;SMU1;PPARGC1A;RBMX;CPSF2;GEMIN5;GTF2H3;CWF19L1;SRSF10;DHX35;SRSF3;GCFC2;HNRNPR;UBL5;HNRNPH2;POLR2I;DNAJC8
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.37525927120365665,-1.0959166734715353,0.2964824120603015,1.0,1.0,15/42,20.22%,MAN1A1;GSTO1;ELOVL5;PAPSS2;UPP1;SLC6A6;ESR1;ETS2;TDO2;CROT;PDLIM5;TGFB2;UGDH;NPC1;GCLC
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.4161901211349646,1.0954986388508519,0.32967032967032966,0.6591517181011805,1.0,6/23,13.72%,RPS27A;PSMB1;BRIP1;GSR;TXNRD1;PSMB2
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.3244221877647678,1.0945257092828866,0.29069767441860467,0.6598161332510414,1.0,16/68,20.74%,VIPR2;EDNRA;CHGA;EDNRB;ANXA1;WNT2B;FZD6;ADRB1;CX3CL1;WNT3;CXCL13;OPRD1;RAMP1;PTH2R;TRHR;OPN3
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.44681357873996175,1.0928764150664165,0.3235908141962422,0.6623218191419608,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.4652969549059867,-1.0924979035092564,0.3408239700374532,1.0,1.0,5/16,9.72%,CCT3;CCT2;TUBB2A;GNG2;GNG7
prerank,KEGG_2021_Human__Chagas disease,-0.4581219676732848,-1.0924908741087958,0.3358070500927644,1.0,1.0,5/15,18.56%,GNAL;TGFBR1;CFLAR;TGFB2;JUN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.37986927798945463,1.0923934300408504,0.3093681917211329,0.6617394581523033,1.0,9/32,12.46%,PDE3A;RPS27A;USP9Y;RHOA;SMURF1;SIRT1;SMAD3;LPXN;TWSG1
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.4550981627563807,-1.0910707988923838,0.3712686567164179,1.0,1.0,9/18,15.30%,SLIT3;TRPC6;DSCAML1;RGMA;NCK1;ROBO1;TRPC7;TRPC5;PRKCQ
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.39966695387879536,1.0903822497924465,0.3177966101694915,0.6654183300328013,1.0,6/25,13.72%,RPS27A;PSMB1;BRIP1;GSR;TXNRD1;PSMB2
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.44746582065913404,1.0901821197624593,0.35044642857142855,0.664044291119945,1.0,8/17,26.22%,RHOA;NUP107;NDEL1;NUP85;RHOB;CENPE;FMNL3;DIAPH3
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.3920884324944591,1.0901257282183237,0.32662192393736017,0.66237562830103,1.0,9/27,16.50%,ZFPM2;MAPK3;RHOA;SIRT1;KRAS;STAT3;NOTCH2;WNT3;CRKL
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.4331974655529598,-1.0899609065585234,0.33783783783783783,1.0,1.0,1/19,0.16%,GRID2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.3522086503231208,-1.0897193263353528,0.3053571428571429,1.0,1.0,10/58,5.36%,ROBO2;SLIT1;CNTN6;LAMA2;PLXNA4;SEMA3A;PTPRM;SLIT3;DSCAML1;SEMA3E
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.3866169963083477,-1.0890694663645841,0.30943396226415093,1.0,1.0,13/40,21.46%,HSP90AA1;FGF9;MET;ERBB4;FGFR2;TGFBR1;ESR1;HIP1;RACK1;BANK1;SEMA5A;FGF5;EGFR
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3795183425144015,1.0879620171854059,0.3023758099352052,0.6660338762974601,1.0,8/33,18.62%,ANXA1;PARK7;NFKBIZ;CX3CL1;AREL1;MACIR;MGST2;IL15
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.35488964351353675,1.0857129826818654,0.32819383259911894,0.6682065874725218,1.0,11/43,15.52%,RPS27A;PMEPA1;PSMB1;ANAPC1;NUP107;RAN;TMPO;NDEL1;PSMB2;NUP155;VRK2
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.35488964351353675,1.0857129826818654,0.32819383259911894,0.6682065874725218,1.0,11/43,15.52%,RPS27A;PMEPA1;PSMB1;ANAPC1;NUP107;RAN;TMPO;NDEL1;PSMB2;NUP155;VRK2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4079950667936584,1.085385111803288,0.328159645232816,0.6673128315915263,1.0,8/24,12.46%,RPS27A;USP9Y;RHOA;SMURF1;SIRT1;SMAD3;LPXN;TWSG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4359828836823028,1.083831826779849,0.35095137420718814,0.6694538702783759,1.0,8/16,23.62%,SEC24A;LGMN;KLC2;AP1S2;AP2S1;SAR1B;DCTN1;CENPE
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.40787183786765463,-1.0837855328968224,0.33090909090909093,1.0,1.0,9/28,15.70%,HSP90AA1;NASP;CDKN2D;PHF8;CHMP4B;CUL4B;ACVR1;CCNH;TPD52L1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.40358658084958626,1.0836400855182502,0.3252032520325203,0.6681213020433517,1.0,4/25,8.18%,INPP4B;RAB5A;EFR3B;MTMR6
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.4571375233901598,1.0830856779475933,0.36607142857142855,0.6677904489314294,1.0,2/15,0.64%,GPC5;GPC6
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.39752393587031704,1.0823958132288118,0.32894736842105265,0.6677196298410263,1.0,7/24,11.36%,YWHAH;ABCD2;ALDH1A1;ABCD3;HSD11B2;FIS1;CAT
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.34878060230760194,1.0817700011742755,0.30666666666666664,0.6674550911548217,1.0,20/46,26.74%,RPS27A;PSMB1;FBXL18;RBBP5;KBTBD6;FEM1C;UBA3;PSMB2;KLHL25;FBXO31;NUB1;NFE2L2;FBXL7;PSMA1;UBE2D1;FBXO2;PSME4;UBE2M;PSMA5;EPAS1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.441324889140238,1.0814134923232916,0.3677685950413223,0.6665963402378644,1.0,5/16,7.76%,ANXA1;NRP1;MINK1;RHOA;GSN
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.3948634365820751,1.0795084197983178,0.3383947939262473,0.6696665455940484,1.0,7/25,17.88%,RPS27A;PSMB1;LIN9;LIN54;PSMB2;TFDP1;POLE2
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.4174678559576624,1.0791179257834465,0.34347826086956523,0.6688509115180323,1.0,10/21,16.44%,ID2;MAPK3;WNT2B;MEIS1;FZD6;SMAD3;KRAS;STAT3;PCGF6;WNT3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.4317002471054151,-1.077756276026606,0.3712686567164179,1.0,1.0,8/21,16.22%,MCTP1;CRACD;HSPA1A;TMEFF2;AR;RUBCN;ABCA7;DNAJA4
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.35450243592843667,1.0777220501393223,0.33783783783783783,0.6708573667970595,1.0,15/42,20.74%,RPL26;RPL5;PPARGC1A;ABCB10;PARK7;DNA2;SIRT1;SMAD3;EIF3E;RPS4X;GIPC1;APPL1;LDLR;RGCC;OPN3
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.38768058819898216,1.0773996838772535,0.32397408207343414,0.6699360884002209,1.0,7/28,13.72%,RPS27A;KAT2B;PSMB1;SMURF1;SMAD3;MAML3;PSMB2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.44959206047405037,-1.0768099361062027,0.3626373626373626,1.0,1.0,6/16,19.44%,CDH13;SEMA3E;ROBO1;CCBE1;SEMA5A;GPLD1
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.375510049458973,1.0765117839685432,0.3333333333333333,0.6704192688379527,1.0,12/34,21.70%,CYP7B1;TPST2;ALDH1A1;ACSS2;FDX1;MGST1;MAOB;MGST2;SLC35D1;CYP3A4;CYB5B;MTRR
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4441412441284059,1.0759237886312845,0.3347457627118644,0.6702514144781664,1.0,5/15,18.62%,CALY;ANXA1;SYNGR3;BID;IL15
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.36562968478773294,1.0756917426111512,0.32532751091703055,0.6690759076070121,1.0,10/35,17.84%,RPS27A;SMURF1;ANAPC1;PCYOX1;FEM1C;KLHL25;RNF20;NUB1;AREL1;RNF8
prerank,KEGG_2021_Human__Phagosome,0.4033900426785105,1.0742466807013509,0.3652173913043478,0.6709934839872861,1.0,4/23,7.46%,ATP6V0E1;RAB5A;ATP6AP1;LAMP2
prerank,KEGG_2021_Human__Endocytosis,-0.35780144481109744,-1.0742152114836205,0.3490566037735849,1.0,1.0,14/49,16.66%,PARD3;IL2RA;IQSEC3;ARPC5L;FGFR2;TGFBR1;HSPA1A;RAB11A;CHMP4B;PIP5K1B;ASAP3;GRK5;ARFGAP3;SNX2
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.39317352019868274,-1.073822611354395,0.3742690058479532,1.0,1.0,14/31,23.10%,CAMK2D;RYR3;RYR1;ITPR2;ADCY8;MYLK;MYL6;PRKCG;CALM3;JUN;CAMK1G;EEF2K;EGFR;CACNG5
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.41596597888185044,1.0734363969987666,0.35470941883767537,0.6712907226627994,1.0,11/19,27.00%,ZNF451;NUP210;NUP107;SUMO3;NUP155;KIAA1586;NUP85;NDC1;RNF212;NUP88;RNF212B
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.41681127233835835,1.0732828992630266,0.35443037974683544,0.6699476861326268,1.0,2/18,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.441916872274047,1.0728508071330662,0.38412017167381973,0.669378247624127,1.0,8/16,23.76%,RPS27A;RHOA;ZRANB1;OTUD5;TRAF6;VCPIP1;OTUD7B;UBE2D1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.3521368061248075,1.0702354814949957,0.359375,0.6744706163560318,1.0,18/40,22.40%,PRAG1;DCC;RETREG3;CDH2;EPHA3;DPYSL3;NDEL1;PRKD1;SCN1B;PTN;CX3CL1;ZDHHC15;NTNG1;RIT2;RTN4IP1;HDAC2;RTN4RL2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3479468678734249,-1.069922743465582,0.32798573975044565,1.0,1.0,13/58,15.30%,RUNX1;POLR3G;EGR1;HSPD1;POLR2K;EIF2AK3;HSPA1A;IL17D;HAVCR2;CCBE1;TWIST1;TXK;PRKCQ
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.4136383062973689,1.0690518201953512,0.3847826086956522,0.6757306393734775,1.0,3/20,4.44%,RPS27A;POLR2B;MAPK3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4383461400535707,1.06840744485082,0.3926247288503254,0.6757068152880917,1.0,7/17,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFA4;NDUFB11;NDUFAB1;NDUFB8
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.4492630737285609,1.0669304798428687,0.38202247191011235,0.6777516449093012,1.0,6/15,20.14%,MAPK3;PPP3CC;KRAS;STAT3;NFATC3;TRAF6
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3927083334795627,-1.0669107578794184,0.38419117647058826,1.0,1.0,5/28,5.34%,HNRNPU;MET;ERBB4;FGFR2;ROR2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3472080203070657,-1.0664520150975407,0.3537037037037037,1.0,1.0,19/58,23.52%,GRID2;PTPRK;TBC1D12;CD63;RAB23;STXBP3;RRAGD;COX18;ITSN1;SNX8;SH3PXD2B;ARFGAP3;NPHP1;CNTLN;RAB18;EGFR;RAB22A;RAB21;STX3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4384080497793536,1.0662819400321377,0.34810126582278483,0.677594243288595,1.0,8/15,23.62%,SEC24A;LGMN;KLC2;AP1S2;AP2S1;SAR1B;DCTN1;CENPE
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.3730128661663169,-1.0657798838678356,0.36231884057971014,1.0,1.0,6/37,4.56%,CAMK2D;ANK1;ITPR2;MET;ERBB4;CD63
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4055667803711174,-1.0642660832828033,0.3747534516765286,1.0,1.0,8/24,12.72%,RYR3;GNG2;EGR1;ADCY8;ESR1;AR;ATP1A1;HRH1
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.43608078397743755,1.0635517701660735,0.3693304535637149,0.6829349381137018,1.0,2/15,2.58%,RPS27A;PSMB1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3943155097174201,1.0614291487613814,0.37815126050420167,0.6868029297770859,1.0,8/25,7.90%,HSPH1;DNAJB6;NUP210;MAPK3;HIKESHI;RPA1;SIRT1;NUP107
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.39237165358542897,-1.0607963990284055,0.3820840950639854,1.0,1.0,4/28,6.62%,LRP1B;SLC35F3;KIF3A;SLC22A25
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.29952299729501586,1.0597003145633759,0.31797235023041476,0.6896168483019232,1.0,21/99,9.04%,PRAG1;RHOBTB1;TIAM1;GNA13;ARHGAP10;MCF2;OSBPL11;RBMX;ARHGAP24;BCAP31;TMOD3;RHOA;RASGRF2;ATP6AP1;SENP1;ABCD3;ACBD5;CDC42EP3;PGRMC2;WASF2;TMPO
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.42762928115448917,-1.0586091053885704,0.3653483992467043,1.0,1.0,5/20,10.48%,SDK1;CDH13;CDHR3;CDH4;CDH6
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.4256155221711301,1.0578269779592262,0.38427947598253276,0.6927521045942404,1.0,4/16,7.52%,ANXA1;MAPK3;PARK7;SIRT1
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.3744455164987872,1.0569040917163017,0.37579617834394907,0.6933057743331297,1.0,5/28,7.90%,PDZD2;RPS27A;NUP210;MAPK3;NUP107
prerank,KEGG_2021_Human__RNA transport,0.37218210132714963,1.056699484777051,0.360082304526749,0.6920567805132959,1.0,13/30,18.34%,PHAX;NUP210;GEMIN5;PAIP1;NUP107;RAN;STRAP;EIF1B;EIF3E;SUMO3;NUP155;EIF2S3;SAP18
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.44599975345613674,-1.0565492917013195,0.36496350364963503,1.0,1.0,4/15,6.82%,HSP90AA1;ITPR2;BRK1;NCK1
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.41415415085060603,1.0558421091578685,0.3807531380753138,0.6907633700971523,1.0,9/17,26.74%,RPS27A;PSMB1;PSMB2;EGLN3;PSMA1;UBE2D1;PSME4;PSMA5;EPAS1
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.41415415085060603,1.0558421091578685,0.3807531380753138,0.6907633700971523,1.0,9/17,26.74%,RPS27A;PSMB1;PSMB2;EGLN3;PSMA1;UBE2D1;PSME4;PSMA5;EPAS1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2675088711769448,1.0539099019875324,0.30978260869565216,0.6940587115868094,1.0,52/243,15.66%,RORB;RPS27A;KAT2B;NFIB;ZFPM2;GLIS3;YWHAH;ID2;HSF2;WBP2NL;PSRC1;ZNF451;CREBL2;RARB;PPARGC1A;IRF2BPL;RBMX;FOXO1;H1-10;MAPK3;MEIS2;PARK7;SENP1;MEIS1;POU3F2;SIRT1;CTBP2;ZNF507;TET3;HDAC3;PER1;SMAD3;HIPK2;MED10;WDR75;CTCF;PRKD1;PRMT2;GABPA;MAML3;KDM3A;H2AZ1;STAT3;CX3CL1;SIN3A;ASXL3;ZNF143;PLAGL1;ZNF711;MTF1;RNF20;TFDP1
prerank,KEGG_2021_Human__Colorectal cancer,0.41937955711400254,1.0537021946728953,0.39293598233995586,0.6928586331604277,1.0,5/19,11.56%,DCC;MAPK3;RHOA;SMAD3;KRAS
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.33345886510396205,1.0534283165793217,0.33958333333333335,0.6917617546059343,1.0,17/51,16.14%,POLR2B;SF3B3;SMU1;RBMX;CPSF2;GEMIN5;CWF19L1;SRSF10;DHX35;STRAP;SRSF3;GCFC2;HNRNPR;UBL5;HNRNPH2;POLR2I;DNAJC8
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4132667435655379,1.0530761024607604,0.3898989898989899,0.6909750690409734,1.0,3/20,8.18%,INPP4B;RAB5A;MTMR6
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.4017159854855282,1.052188606775097,0.3625,0.6914668747343351,1.0,8/21,17.18%,MAPK3;ASAP2;GSN;MARCKSL1;WASF2;VAV3;CRKL;LIMK1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.3939576780321236,-1.051868208480342,0.37362637362637363,1.0,1.0,13/28,24.60%,TENM4;RUNX1;PTPRM;HDGFL3;RAB11A;TENM1;TGFB2;UGDH;ERCC6;ETV1;STMN1;STX3;ALK
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.35000990990080283,1.0504778807950983,0.3524229074889868,0.6941786312127293,1.0,7/39,5.92%,PDE3A;EDNRA;EDNRB;GNA13;MAPK3;PPP3CC;RHOA
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.32249713531669794,1.0502947926495945,0.36486486486486486,0.6929346787382414,1.0,20/59,17.32%,RPS27A;TLE4;PSMB1;H2AZ2;RBBP5;RHOA;SMURF1;WNT2B;CTBP2;FZD6;CCDC88C;H3-3B;PYGO1;H2AZ1;AP2S1;PSMB2;ZRANB1;H2BC5;WNT3;VPS26A
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.36754100055820554,1.0501333005030333,0.36147186147186144,0.6916248696243019,1.0,13/30,24.80%,RPS27A;PSMB1;MAPK3;MKRN1;HDAC3;PSMB2;RNF2;RRAGA;HDAC2;RBBP4;PSMA1;RRAGB;PSME4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3983888498263306,1.04993273332006,0.37639198218262804,0.69045831710664,1.0,4/23,5.76%,RPS27A;PSMB1;RPA1;GTF2H3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.4267775630187245,1.0493776567126618,0.4053452115812918,0.6901572467318727,1.0,2/16,1.54%,RPL26;RPL5
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.45897110503261085,-1.0493407291634411,0.4018018018018018,1.0,1.0,3/15,6.54%,PID1;HNRNPU;CDKN2D
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3858561291908148,1.0490886950212757,0.3935483870967742,0.6891837902527885,1.0,3/24,4.44%,RPS27A;PSMB1;MAPK3
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.4275679246496271,1.0484487577312605,0.41431670281995664,0.689179280199058,1.0,8/16,21.58%,H2AZ2;GTF2H3;H3-3B;H2AZ1;SIN3A;H2BC5;SAP18;HDAC2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.31920716182867587,1.0482001936587373,0.3506787330316742,0.6882061840894812,1.0,15/66,13.76%,RFX2;RPS23;IFT52;NEK7;DHX29;TMOD3;GSN;HDAC3;BBIP1;FAM161A;UBAP2L;TCTN3;STAM;TTC26;ATG16L1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.32227000376230897,-1.0471907658135067,0.37213403880070545,1.0,1.0,31/84,22.10%,PRKG1;CAMK2D;BMPR1B;ACVR1C;ERBB4;FGFR2;PRKG2;TGFBR1;EIF2AK3;PRKCH;CDK18;GRK5;ACVR1;TXK;PRKCQ;CCNH;PRKCG;ROS1;STK33;TGFB2;TRIB2;CDK15;CAMK1G;TGFBR3;WNK3;EEF2K;EGFR;TBK1;SBK1;RELN;CHEK1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3855692508949572,-1.0461796871786706,0.3538175046554935,1.0,1.0,9/29,21.18%,BCO2;PDHA1;GOT2;AOAH;CROT;ALDH1A2;DLD;NPC1;LDHA
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.42442840955184974,1.045659929742548,0.40461215932914046,0.6929880322969234,1.0,5/17,18.04%,FLVCR1;FTH1;ATP6AP1;SLC39A8;SLC31A1
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.399362982883037,1.045519703148775,0.375,0.6916733853146994,1.0,6/22,13.76%,RPS27A;TOMM7;PARK7;PRKAB2;USP30;ATG16L1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.38110824732842924,-1.0450153577468095,0.381294964028777,1.0,1.0,14/31,35.48%,PHACTR2;CD63;F5;LHFPL2;ENDOD1;TGFB2;TMSB4X;ANXA5;VEGFD;PROS1;PECAM1;CD36;TTN;ABCC4
prerank,KEGG_2021_Human__Renin secretion,-0.4309722928705688,-1.043845785083936,0.3821782178217822,1.0,1.0,5/17,6.46%,PDE1A;ADORA1;PDE1C;ITPR2;PRKG2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.4388131148114845,1.043718763605443,0.40764331210191085,0.6947123522343247,1.0,3/16,2.32%,UTRN;SGCD;SGCG
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3906285728940714,1.043518900717384,0.40298507462686567,0.6935675921454654,1.0,9/25,20.66%,PRELID2;ABCD2;ABCD3;SPNS2;ABCC3;CHKA;LDLR;ABCA1;PLEKHA3
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.3864005237292032,1.0419235718980446,0.38672768878718533,0.6958244753738222,1.0,7/22,18.16%,THSD4;B3GLCT;ADAMTS2;GALNT3;ADAMTS17;NOTCH2;ADAMTSL1
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.3988337669283443,1.0409973951923022,0.40794979079497906,0.6964983600232915,1.0,7/20,17.06%,FOXO1;MAPK3;SMAD3;KRAS;STAT3;COL4A2;PLCB4
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.4287685794886811,1.039329106568375,0.4176954732510288,0.6992035752065121,1.0,4/15,10.10%,TIAM1;RAN;HIPK2;TXN
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.42118667556692363,1.0389970227564453,0.41252699784017277,0.6983646421632579,1.0,12/17,29.42%,ATP5MG;ATP5F1E;ATP5PF;APOOL;ATP5PO;ATP5F1C;AFG3L2;ATP5MC2;ATP5MC3;ATP5MF;DNAJC11;LETM1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.4158316738978577,-1.038878391389206,0.42441860465116277,1.0,1.0,9/19,21.46%,EIF2S1;PTPRK;CDKN2D;GPX1;PARP1;USP1;RHBDD1;ERCC6;EGFR
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4195706301604736,1.0376979404112614,0.41458333333333336,0.7001013738631673,1.0,4/16,11.82%,CYP7B1;SOAT1;INSIG2;FDX1
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.4161498704376414,1.0376715267060257,0.3951612903225806,0.6985072001347393,1.0,2/16,2.58%,RPS27A;PSMB1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.27016277940391487,1.0345182305836649,0.3601036269430052,0.7047176668700367,1.0,40/184,15.66%,RORB;RPS27A;KAT2B;NFIB;ZFPM2;GLIS3;HSF2;ZNF451;RARB;PPARGC1A;IRF2BPL;RBMX;FOXO1;MAPK3;MEIS2;PARK7;SENP1;MEIS1;POU3F2;SIRT1;CTBP2;ZNF507;TET3;HDAC3;PER1;SMAD3;HIPK2;MED10;PRKD1;GABPA;MAML3;H2AZ1;STAT3;CX3CL1;SIN3A;ASXL3;ZNF143;PLAGL1;MTF1;TFDP1
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.3101890422135841,1.033030429004714,0.38009049773755654,0.7066836515839791,1.0,14/69,9.64%,RPS27A;PSMB1;FOXO1;MAPKAPK5;MAPK3;SPTB;RASGRF2;NRG1;GFRA1;MPP2;PTPN3;CDC42EP3;KITLG;KSR1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3992576638156624,1.031170184302751,0.4136460554371002,0.7097991188542889,1.0,4/20,10.84%,KAT2B;PPM1D;CGGBP1;CTCF
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.4022887043168022,-1.0310124160584162,0.40409683426443205,1.0,1.0,7/24,15.18%,CAMK2D;NEFL;STAC;SHISA6;HOMER1;OPRM1;NOS1
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.36988159130545256,-1.030570424099451,0.3897338403041825,1.0,1.0,12/36,21.46%,HSP90AA1;CHRNA7;FGF9;GSTO1;ADCY8;ESR1;AR;PRKCG;JUN;AHR;FGF5;EGFR
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.31459892212120444,1.0302952236054876,0.3922018348623853,0.7102439343894155,1.0,11/63,12.68%,RORB;PDE3A;FOXO1;BRINP3;MAPK3;RHOA;EPHA3;CPEB1;PRKD1;HSP90B1;H2AZ1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.34708807993751145,-1.0302612091375598,0.4036697247706422,1.0,1.0,8/49,4.88%,PARD3;MYO1B;JHY;SKAP2;TEAD1;PARVB;NEFH;MITF
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.37585071130479536,1.0296041833547525,0.4089935760171306,0.7105298306235933,1.0,5/26,16.68%,EDNRA;BCAP31;FIS1;TRPC3;CXCL13
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.31934268603239,1.028989725710883,0.4200426439232409,0.7105894763689727,1.0,13/56,12.68%,FKBP5;POLR2B;KAT2B;PMEPA1;RARB;H2AZ2;MAPK3;ALDH1A1;HDAC3;PPID;H3-3B;KDM3A;H2AZ1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29354217104669816,1.0286376454377542,0.38064516129032255,0.7097773318507504,1.0,21/88,14.48%,POLR2B;TIAM1;NRP1;ATP6V0E1;EPHA7;FOXO1;MAPK3;EPHA10;RHOA;NRG1;EPHA3;ATP6AP1;SDCBP;EPHA6;WASF2;PRKD1;GALNT3;STAT3;AP2S1;COL4A2;VAV3
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.37561816470928633,-1.0284394135587063,0.41035120147874304,1.0,1.0,10/28,11.78%,GREB1;HSP90AA1;RUNX1;ERBB4;TLE3;POLR2K;POLR2A;ESR1;SMC1A;SMC3
prerank,KEGG_2021_Human__Melanoma,-0.4266998498528653,-1.028020036246995,0.40540540540540543,1.0,1.0,3/17,4.88%,FGF9;MET;MITF
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4177866986175033,1.027805794263549,0.37020316027088035,0.710256972836394,1.0,2/16,0.64%,GPC5;GPC6
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.37748422632756445,-1.027373843671664,0.42363636363636364,1.0,1.0,7/30,17.00%,PHACTR2;CAP1;CD63;F5;LHFPL2;ENDOD1;TGFB2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.34478629191722604,1.0266046108390843,0.40987124463519314,0.7115759316708106,1.0,8/40,10.94%,PDE3A;GAREM1;ANXA1;NRP1;CPNE3;LGMN;SMAD3;PRKD1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3265475744178436,1.023037604101798,0.3940677966101695,0.7187336414727413,1.0,16/49,16.14%,POLR2B;SF3B3;SMU1;RBMX;CPSF2;GEMIN5;CWF19L1;SRSF10;DHX35;SRSF3;GCFC2;HNRNPR;UBL5;HNRNPH2;POLR2I;DNAJC8
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.3740873956977998,-1.022633832609067,0.40804597701149425,1.0,1.0,12/30,25.06%,CAMK2D;HNRNPU;HSP90AA1;CDH13;HIP1;PRKCQ;ROS1;MELTF;SSRP1;EBAG9;TFRC;RASGRP2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4319932925209301,-1.0226180527017812,0.4246823956442831,1.0,1.0,4/16,16.90%,RUNX1;CYLD;CFLAR;RACK1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.3787719304483407,1.022312605472135,0.40540540540540543,0.71885732578966,1.0,2/25,0.64%,GPC5;GPC6
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3050024262837201,1.0211151976799235,0.3954022988505747,0.7201054314726617,1.0,16/70,15.72%,PSMB1;CALU;RAB5A;CDH2;FBXL18;FSTL1;RBBP5;KBTBD6;FEM1C;UBA3;HSP90B1;CHRDL1;PSMB2;KLHL25;FBXO31;RAB11B
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.39369929762705097,1.0206135215055065,0.42094017094017094,0.7197700043666255,1.0,2/19,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.3894503474224167,1.0195202534853491,0.4089935760171306,0.7209398674278154,1.0,5/20,6.04%,TIAM1;GNA13;MCF2;RHOA;RASGRF2
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.39374339265834624,-1.0166905250108136,0.4157088122605364,1.0,1.0,8/23,20.08%,CAMK2D;ITPR2;ADCY8;ATP1A1;PRKCG;CALM3;CAMK1G;NR4A2
prerank,MSigDB_Hallmark_2020__Hypoxia,0.32342624635644657,1.0157131482157173,0.4236111111111111,0.7291173980159715,1.0,10/51,11.88%,PPARGC1A;TPST2;BTG1;PDK1;GBE1;COL5A1;CCNG2;FAM162A;GAPDH;KDM3A
prerank,KEGG_2021_Human__Prion disease,-0.32176874252019516,-1.0155234676857074,0.411231884057971,1.0,1.0,17/70,16.82%,RYR3;RYR1;EIF2S1;ITPR2;PSMA4;TUBB2A;EGR1;MCU;UQCRQ;EIF2AK3;HSPA1A;CYCS;NDUFB1;GRIN3A;COX7B;NDUFB10;SDHB
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.29749414224338444,-1.015484520380376,0.3921232876712329,1.0,1.0,34/112,21.98%,ADGRV1;HSP90AA1;FGF9;MET;TFG;ERBB4;FGFR2;CDH13;PLEKHG5;ROR2;GSDME;TGFBR1;DDX21;GPR89A;RRAGD;ESR1;DLG5;HIP1;LGALS1;ROR1;GRM4;CFLAR;BCAR3;REL;RACK1;TGFB2;SEMA5A;PDGFD;TRIM5;FGF5;TNFRSF19;EGFR;TBK1;RELN
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4193371293401972,1.0143670709776889,0.4318181818181818,0.7308591943605877,1.0,4/16,5.92%,CDH2;CDH20;KIRREL3;RHOA
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.3603969166919282,1.0125527045412335,0.43478260869565216,0.733940275697961,1.0,6/28,10.76%,KIRREL3;RTKN2;WNT2B;MEIS1;KITLG;HIPK1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.41132800376068185,1.0120228949576702,0.42857142857142855,0.7335866019784418,1.0,7/17,15.78%,POLR2B;NUP210;NUP107;IPO8;STAT3;NUP155;POLR2I
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.38389482564665434,1.011809020091556,0.44842105263157894,0.7325418390384243,1.0,2/21,2.58%,RPS27A;PSMB1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3342263062003549,1.011548041436237,0.4366812227074236,0.731580720702482,1.0,13/39,17.76%,ID2;DIP2A;PARK7;SDCBP;LGMN;SIRT1;STOX1;CNOT7;RIN3;NOTCH2;CRKL;OPRD1;LDLR
prerank,KEGG_2021_Human__Hepatitis C,0.3655648535220613,1.008639188005425,0.4272930648769575,0.7376203085727474,1.0,11/26,20.14%,YWHAH;MAPK3;CLDN16;KRAS;STAT3;EIF3E;BID;LDLR;IFNAR1;CD81;TRAF6
prerank,MSigDB_Hallmark_2020__E2F Targets,0.33165317547639206,1.0083748471930525,0.43254817987152033,0.7366332001534532,1.0,11/41,13.56%,PPM1D;RPA1;RAD51C;NUP107;RAN;TMPO;CTCF;MRE11;H2AZ1;CKS2;MMS22L
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.40345365736768035,1.0065276490153237,0.44251626898047725,0.7396313072926646,1.0,6/18,14.88%,KAT2B;H2AZ2;MYO1E;H3-3B;H2AZ1;H2BC5
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.3191325935254863,1.0059827966419497,0.4676724137931034,0.7392821048945608,1.0,8/54,8.24%,GPC5;GPC6;WHRN;C1D;CTBP2;KCNN2;GSN;MYO1E
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.41006771644354395,1.0053793711017676,0.45901639344262296,0.7391591384797056,1.0,9/15,26.46%,SEC24A;LGMN;AP1S2;AP2S1;SAR1B;DCTN1;CENPE;CTSB;AP2A1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.39034248849186814,-1.005182965166395,0.437984496124031,1.0,1.0,3/21,5.72%,HNRNPU;RUNX1;PSMA4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3650937328164579,1.004951342876695,0.46373626373626375,0.7386880257985264,1.0,4/26,4.36%,TENT2;POLR2B;RBMX;RNASEH2B
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.32922213727306215,1.004552447887314,0.4166666666666667,0.737964295617678,1.0,7/44,7.84%,RPS27A;CHGA;ST8SIA3;ST8SIA4;SPTB;SEC24A;EDEM1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.36928952232847395,1.004543356989815,0.4451901565995526,0.7363356507256277,1.0,11/25,26.62%,RPS27A;PSMB1;PSMB2;CNOT7;ANP32A;YTHDF2;HSPB1;PSMA1;PSME4;FMR1;PSMA5
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4229178326518256,-1.0033970189942238,0.45636363636363636,1.0,1.0,2/17,6.38%,PID1;GSDME
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4083188940225418,1.0027080487452174,0.4394904458598726,0.7394366149927509,1.0,4/16,9.92%,BCAP31;LGMN;SIRT1;FIS1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2890558575189355,1.0021233002177388,0.4497816593886463,0.7392653003512997,1.0,24/83,15.48%,RORB;CREBL2;PPARGC1A;PRDM8;MAPKAPK5;BTG1;ZNF280C;GEMIN5;SRSF10;ZNF341;ZNF678;RPL10;NUP107;NAB1;LIN54;GCFC2;STAT3;YY1AP1;IGSF1;ZNF143;METAP1;ZBTB11;SLC39A8;RNF20
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.41856274115640263,1.001517484003678,0.4506172839506173,0.7392086630871302,1.0,6/16,11.94%,SMCHD1;MEIS2;MEIS1;HIPK2;HIPK1;CHRDL1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.35165702988142694,1.0012610939628124,0.437636761487965,0.738181510450457,1.0,13/30,19.82%,PPARGC1A;FOXO1;PARK7;GSR;PRKD1;CAT;STOX1;TXNRD1;VRK2;GPX3;ADNP2;NFE2L2;ETV5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2954272130093296,1.0011561648246572,0.4433497536945813,0.7368247790712952,1.0,16/73,13.06%,CUX2;RPS7;RPL5;ID2;PPARGC1A;MAPK3;RPL23;PARK7;GSN;SMAD3;FAM98B;CTCF;GABPA;KRAS;STAT3;STOX1
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.3176608934862793,1.0006846640416347,0.44537815126050423,0.7363640511849648,1.0,19/54,19.62%,IFT52;PPARGC1A;ATP5MG;ACSS2;HDAC3;PRKAB2;ATP5F1E;BBIP1;CEP135;LIN9;GABPA;TCTN3;TTC26;ATP5PF;CCT8;CCP110;APOOL;TFB1M;TUBB4B
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.36673456283367395,-0.9998196594248016,0.4359925788497217,1.0,1.0,10/32,17.68%,PID1;PARD3;NCK1;TWIST1;WWTR1;TAF7;RACK1;CALM3;TRIB2;CHP1
prerank,KEGG_2021_Human__Adherens junction,-0.4270609693227499,-0.9997719255843476,0.4725897920604915,1.0,1.0,4/15,7.40%,PARD3;MET;PTPRM;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.42064797930446984,-0.9994793701555117,0.4510166358595194,1.0,1.0,5/16,17.24%,FGFR2;RAB11A;KLHL13;RACK1;CALM3
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.3321906078955296,0.9989763941161932,0.45227272727272727,0.7391097269296627,1.0,14/40,21.66%,KAT2B;H2AZ2;RBBP5;HDAC3;KDM3A;H2AZ1;H2BC5;SAP18;SETD7;COPRS;KMT5A;PRMT7;HDAC2;RBBP4
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.422491587191016,-0.9987818502406733,0.4584837545126354,1.0,1.0,12/16,39.28%,STAC;TPM1;NOS1;SCN4B;KCNQ1;TNNT2;ATP1A2;RCSD1;TTN;SMPX;MYH3;SCN2B
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3971422523335698,-0.9980999327256997,0.46632124352331605,1.0,1.0,7/20,19.24%,CHRNA7;RPL13A;EIF2AK3;ABCA7;CNOT9;RACK1;SAMD4A
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.33125173855701423,0.9979942204498956,0.45454545454545453,0.7399736709959566,1.0,9/39,18.28%,RORB;BRINP3;RHOA;EPHA3;MGST1;H2AZ1;WNT3;CXCL13;ADNP2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.4026909116439976,0.9969674830089073,0.4692144373673036,0.7410738703523871,1.0,4/18,14.16%,RPS27A;LGMN;FAP;ZRANB1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.2781508919376006,0.9967787164837996,0.4289340101522843,0.7399348293940851,1.0,22/109,13.96%,ZFPM2;ID2;TIAM1;GAREM1;DISP3;MEIS2;RTKN2;NRG1;RPL23;SDCBP;LGMN;MEIS1;POU3F2;SIRT1;RPS15A;KITLG;FAM98B;KRAS;STOX1;PTN;CX3CL1;CNOT7
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.28590728178823743,0.9963736649159243,0.4663677130044843,0.7392938581816421,1.0,32/87,24.80%,MARCHF1;RPS27A;PSMB1;FBXL18;RNF208;SMURF1;MKRN1;SH3RF2;SIRT1;RNF141;PSMB2;UBE2Q2;KLHL25;H2BC5;RNF20;FBXO31;NUB1;AREL1;RNF8;FBH1;NFE2L2;TRAF6;VCPIP1;TRIM69;FBXL7;RRAGA;TRIM54;PSMA1;UBE2D1;PEX5;FBXO2;PSME4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.31583029554533226,-0.9962560976007575,0.4288135593220339,1.0,1.0,17/60,19.22%,CHRNA7;ERBB4;FGFR2;ROR2;GSDME;ROBO1;OPRM1;ABCA7;HTR2C;TENM1;ROR1;TPD52L1;GRM4;BCAR3;TGFB2;PDGFD;TRIM5
prerank,KEGG_2021_Human__Insulin resistance,0.4038255734527302,0.9960925731820051,0.4573804573804574,0.7383568306795671,1.0,5/15,17.08%,PPARGC1A;FOXO1;PRKAB2;STAT3;TBC1D4
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4063870714904071,-0.9954432582848292,0.4400749063670412,1.0,1.0,8/18,28.68%,RAB11A;KLHL13;CALM3;CHEK1;USP51;MYO19;DBF4;MAP9
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.40037685376293347,0.9951691547046414,0.4701834862385321,0.7390082168806883,1.0,2/16,1.54%,RPL26;RPL5
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3431612218163213,0.9945568213593288,0.45454545454545453,0.7389144124334491,1.0,4/34,2.96%,TENT2;SF3B3;SMU1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.30314759768813,0.9941564095808701,0.4366812227074236,0.7382361968189812,1.0,15/64,14.22%,ID2;TIAM1;CREBL2;CDH2;BRINP3;BTG1;RHOA;ATP6AP1;SDCBP;SMAD3;KITLG;SUCO;PRKD1;PTN;SIN3A
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.3654117304447461,0.9925779914552755,0.4596949891067538,0.740487662281722,1.0,6/25,9.00%,RPS27A;PMEPA1;MAPK3;RHOA;SMURF1;SMAD3
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.3835565919192909,0.9922736799437395,0.4780793319415449,0.7396596724340386,1.0,2/19,2.58%,RPS27A;PSMB1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3430818573316711,0.9916148932316645,0.4503171247357294,0.7397649185232853,1.0,5/36,8.18%,INPP4B;CEPT1;RAB5A;CPNE3;MTMR6
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.3750712909416871,0.991492114828855,0.4668141592920354,0.7384752031424118,1.0,6/23,13.92%,RPS27A;RHOBTB1;SMURF1;ANAPC1;UBA3;UBE2Q2
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.37423435320217413,0.9900089234116113,0.45982142857142855,0.7404992234172664,1.0,9/22,23.34%,HDAC9;PARK7;SIRT1;PRMT2;SIN3A;EYA4;PRMT7;HDAC2;BRMS1L
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.27636426266294045,-0.9898187574543147,0.46645367412140576,1.0,1.0,41/154,22.32%,CAMK2D;RYR3;RYR1;EIF2S1;RUNX1;PCSK6;SLC9A9;ASIC2;SLC1A2;TRPC6;PSMA4;SLC2A3;GNG2;ADCY8;ACO1;ATP8B2;SLC17A6;MCU;PCSK5;SLC6A6;RAB11A;GNG7;TRPC7;TRPC5;ABCA7;SLCO4C1;SLC47A2;ATP2C2;STEAP2;ATP6V0D1;ABCF1;NGB;MAIP1;MRS2;SLC9C1;WNK3;PSMD2;PSMC6;MCUB;SLC5A8;ANO4
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.43143640598798166,-0.9882183826467739,0.47735849056603774,1.0,1.0,1/15,1.08%,IL2RA
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.39405133213539867,-0.9873705720840307,0.46972477064220186,1.0,1.0,9/21,21.74%,CAMK2D;TGFBR1;EIF2AK3;PRKCH;PRKCQ;PRKCG;CAMK1G;TBK1;SBK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.40653880436662265,0.9870362593553155,0.45322245322245325,0.7464789774891136,1.0,5/15,19.88%,ANXA1;VAV3;IL15;CD276;CD81
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.39095075550688535,0.9856569581378852,0.45243619489559167,0.7484241765579388,1.0,7/19,13.02%,PPARGC1A;DECR1;ADIPOR2;HDAC3;PRKAB2;KDM3A;ADRB1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.3534246067096616,-0.9853707885107664,0.44074074074074077,1.0,1.0,13/33,26.08%,CAMK2D;ERBB4;FGFR2;EIF2AK3;GRK5;TXK;STK33;WNK3;EEF2K;EGFR;ALK;STK24;EPHB1
prerank,KEGG_2021_Human__Drug metabolism,-0.40853699702053803,-0.9853394879756289,0.4811320754716981,1.0,1.0,3/18,7.06%,GSTO1;UPP1;CMPK1
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.32704968645169274,0.9840648804927321,0.4789356984478936,0.7506706682414072,1.0,10/43,14.22%,RPS27A;PSMB1;BRIP1;HDAC3;GSR;LIN9;STAT3;TXNRD1;PSMB2;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.39864271331497425,-0.9832152879269921,0.4780114722753346,1.0,1.0,9/20,23.04%,SH3RF1;GPX1;TGFBR1;HSPA1A;AR;ACVR1;CFLAR;NR4A2;HERPUD1
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.36447061315566204,0.9828590365426693,0.47956989247311826,0.7506289271162555,1.0,11/23,26.62%,RPS27A;PSMB1;UBA3;PSMB2;NFATC3;TRAF6;PSMA1;UBE2D1;PSME4;UBE2M;PSMA5
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.36447061315566204,0.9828590365426693,0.47956989247311826,0.7506289271162555,1.0,11/23,26.62%,RPS27A;PSMB1;UBA3;PSMB2;NFATC3;TRAF6;PSMA1;UBE2D1;PSME4;UBE2M;PSMA5
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.37359432265239967,-0.9824488270356879,0.4658040665434381,1.0,1.0,11/26,21.74%,CAMK2D;PARP2;TGFBR1;PARP1;EIF2AK3;PRKCH;PRKCQ;PRKCG;CAMK1G;TBK1;SBK1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.3415514200424894,0.981732596359338,0.48523206751054854,0.7517199186810355,1.0,8/34,20.14%,RPS27A;PSMB1;SMAD3;STAT3;PSMB2;PTPN5;PTPN18;TRAF6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.38642088082411796,-0.9814234171779018,0.45179584120982985,1.0,1.0,3/20,4.36%,GHR;ERBB4;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.340703400830575,0.9809178065846945,0.4889380530973451,0.7521076496599259,1.0,3/32,4.60%,GPC5;PSMB1;LRRK1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.41531580099532334,0.9797130067912703,0.49141630901287553,0.7520078348444726,1.0,5/15,10.94%,ATP6V0E1;MIOS;MAPK3;CASTOR2;PRKD1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.41531580099532334,0.9797130067912703,0.49141630901287553,0.7520078348444726,1.0,5/15,10.94%,ATP6V0E1;MIOS;MAPK3;CASTOR2;PRKD1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.4019673729584058,0.9796839972136379,0.49443207126948774,0.7505043153906484,1.0,5/15,15.26%,NEK7;RHOA;HDAC3;TOGARAM2;ABRAXAS2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.35555813194305264,-0.9795027946257339,0.4804270462633452,1.0,1.0,8/31,15.10%,GNAL;RXFP1;GRM8;ADCY8;ADCYAP1R1;GRK5;GLP2R;ADGRL4
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3441613630232457,-0.9785109487920859,0.4936936936936937,1.0,1.0,8/39,8.78%,HSP90AA1;CHRNA7;MET;ERBB4;FGFR2;ROR2;CCT2;HNRNPA2B1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3565434249080804,-0.978497587601303,0.47882136279926335,1.0,1.0,8/33,11.08%,BMPR1B;RUNX1;GCM1;FGFR2;TGFBR1;SLC6A6;PURB;AR
prerank,KEGG_2021_Human__Lysosome,0.3774129591184022,0.9779956732722349,0.4669509594882729,0.7530336193816527,1.0,7/22,11.10%,MFSD8;ATP6AP1;LGMN;LAMP2;PPT1;AP1S2;HEXB
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.34648113343768655,0.9776461424722487,0.4642082429501085,0.7523008305808453,1.0,6/29,11.94%,CALU;CDH2;FSTL1;HSP90B1;KLKB1;CHRDL1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.4225991955423467,-0.9767822586421366,0.5113207547169811,1.0,1.0,6/15,21.52%,RCHY1;HSPA1A;ELOB;RACK1;TRIB2;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.40136582736156867,-0.9765679968870761,0.5009041591320073,1.0,1.0,3/18,6.70%,CLSTN2;CHRNA7;ADCY8
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.4131887981912389,-0.9759639063744764,0.48161764705882354,1.0,1.0,5/15,12.24%,NEFL;NPTX2;SHISA6;BEGAIN;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3257300732108978,0.975870563430569,0.5102040816326531,0.7551651888762291,1.0,7/38,8.60%,PDE3A;MAPKAPK5;RTKN2;SIRT1;PDE10A;DEPTOR;PER1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3962876567824048,0.9756222616369026,0.4808510638297872,0.7542552872213124,1.0,4/17,10.94%,CHGA;PPARGC1A;PARK7;PRKD1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.32683580489809855,0.9745687860486576,0.48096192384769537,0.7552436950426193,1.0,13/39,17.66%,GNA13;MAPK3;PPP3CC;RHOA;TRAF5;KRAS;STAT3;CX3CL1;BID;CRKL;GNA12;PLCB4;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.2806603655479421,0.9724753374906412,0.515970515970516,0.7587670250153248,1.0,9/95,3.44%,RORB;NFIB;YWHAH;ID2;WBP2NL;PSRC1;CREBL2;PPARGC1A;FOXO1
prerank,KEGG_2021_Human__Necroptosis,-0.36757156793530416,-0.9714932935827313,0.49038461538461536,1.0,1.0,8/27,16.26%,CAMK2D;HSP90AA1;CYLD;PARP1;CHMP4B;GLUL;PYGB;CFLAR
prerank,KEGG_2021_Human__Parkinson disease,-0.3078376948903408,-0.9714569513196032,0.4981949458483754,1.0,1.0,12/71,11.42%,GNAL;CAMK2D;RYR3;EIF2S1;ITPR2;PSMA4;TUBB2A;MCU;UQCRQ;EIF2AK3;CYCS;NDUFB1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.41250805952150255,-0.9709057897785169,0.4918032786885246,1.0,1.0,3/16,5.36%,SDK1;CHRNA7;SEMA3E
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.39097634064257286,0.9706532889678303,0.5106837606837606,0.7617118111380103,1.0,9/16,20.20%,GNA13;MAPK3;RHOA;KRAS;BID;GNA12;OPRD1;PLCB4;SPTLC3
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.35191949159348085,-0.9705120700604678,0.4739776951672863,1.0,1.0,10/32,20.60%,DPP10;ANK1;LIN7C;RAB3C;RAB11A;SH3PXD2B;MRAP2;TSPAN14;NPC1;WNK3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3541205294692273,0.970250063506408,0.46540880503144655,0.7611130691291257,1.0,6/25,9.02%,TIAM1;ARHGAP10;FGD6;GSN;MYO1E;WASF2
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.3501492725392658,0.9687593592194575,0.5010845986984815,0.7633338316635239,1.0,7/26,17.88%,RPS27A;PSMB1;LIN9;LIN54;PSMB2;TFDP1;POLE2
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,0.3869205408626344,0.968644799747315,0.4811529933481153,0.7620683918847758,1.0,3/17,5.76%,POLR2B;GTF2B;GTF2H3
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.39336303796546007,0.9683074176692895,0.4967741935483871,0.7613675287662973,1.0,9/17,22.72%,NUP210;NUP107;FIS1;NUP155;AK4;COX7A1;NUP85;NDC1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.3808405198949998,-0.9679803968241462,0.5,1.0,1.0,3/22,4.36%,LRRC4C;PID1;FGFR2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.38812998085728084,-0.9675553497754136,0.4864864864864865,1.0,1.0,7/19,30.98%,FGFR2;ALDH1A2;ANXA4;MEOX2;GRHL2;DAG1;PROX1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.40121236899673784,-0.9644299320112195,0.5038759689922481,1.0,1.0,6/16,17.00%,BMPR1B;NUP93;TGFBR1;ACVR1;RBPMS;TGFB2
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3015801324314649,0.9628705978934565,0.5182648401826484,0.7730475825111514,1.0,9/47,11.30%,PPM1D;PVT1;BTG1;TOB1;RAD51C;RPS12;HDAC3;FAM162A;PRMT2
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.3461825876648288,0.9628043326527287,0.5183585313174947,0.7716654537316241,1.0,10/27,17.06%,TIAM1;MAPK3;RHOA;KRAS;STAT3;CX3CL1;VAV3;CRKL;CXCL13;PLCB4
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.28466519173266946,-0.9623304604787752,0.5187165775401069,1.0,1.0,26/109,17.24%,CAMK2D;RYR3;NEFM;RYR1;EIF2S1;DNAH14;CHRNA7;ITPR2;NEFL;NEFH;PSMA4;TUBB2A;GPX1;MCU;UQCRQ;EIF2AK3;CYCS;NDUFB1;HIP1;COX7B;NOS1;ATXN1L;PRKCG;NDUFB10;SDHB;CALM3
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.40718225047094586,-0.960482723489774,0.5218978102189781,1.0,1.0,2/16,2.52%,PRKG1;PLXNA4
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.38752423950244896,0.9596505778539071,0.5125523012552301,0.7760664460627179,1.0,6/16,15.78%,POLR2B;NUP210;NUP107;IPO8;NUP155;POLR2I
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.38752423950244896,0.9596505778539071,0.5125523012552301,0.7760664460627179,1.0,6/16,15.78%,POLR2B;NUP210;NUP107;IPO8;NUP155;POLR2I
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3048851948964757,0.9588197469618345,0.5550660792951542,0.7766485788061817,1.0,12/51,12.70%,RFX2;IFT52;NRP1;FGD6;MINK1;SDCBP;ANO6;GSN;BBIP1;FAM161A;TCTN3;TTC26
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4040789476483109,-0.9581050173342366,0.5087719298245614,1.0,1.0,10/15,29.12%,PTPRK;PTPRM;FGFR2;ROBO1;TGFB2;TGFBR3;MCC;SULF1;SCG2;CAV1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.39538994382802517,-0.9577176365488567,0.5146771037181996,1.0,1.0,2/15,2.28%,SOX6;RUNX1
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.37216371862444697,0.9576244362737352,0.5315315315315315,0.7764704293277851,1.0,3/18,10.56%,THSD4;B3GLCT;ADAMTS2
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.37216371862444697,0.9576244362737352,0.5315315315315315,0.7764704293277851,1.0,3/18,10.56%,THSD4;B3GLCT;ADAMTS2
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.3332483293172622,0.9570995003454001,0.5092165898617511,0.7762296251849801,1.0,8/33,16.22%,RPS27A;PSMB1;USP2;SMAD3;USP30;PSMB2;H2BC5;CCP110
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.39519487329083636,-0.956942891004749,0.5045372050816697,1.0,1.0,5/18,8.10%,XYLT1;HS3ST2;HS3ST4;HS6ST3;NDST1
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.3878212213727694,0.9561857226312005,0.4857142857142857,0.776907132614746,1.0,3/16,5.76%,POLR2B;GTF2B;GTF2H3
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.34235597433174986,0.9550058663910236,0.4933920704845815,0.7782998594758596,1.0,12/27,23.86%,RHOA;NUP107;RAN;NDEL1;RMDN1;TOGARAM2;EFHC1;ABRAXAS2;TUBG2;NUP85;CENPE;PLK2
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.3937564559319876,0.9546252437835054,0.5229166666666667,0.7777569114743669,1.0,5/15,14.22%,BRIP1;HDAC3;LIN9;STAT3;SIN3A
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.3528415692698162,0.954016263483549,0.5365344467640919,0.7777288741222934,1.0,2/25,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.3578379918373589,-0.953980432472029,0.49063670411985016,1.0,1.0,5/27,11.80%,FGF9;ERBB4;FGFR2;ESR1;PIP5K1B
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.3578379918373589,-0.953980432472029,0.49063670411985016,1.0,1.0,5/27,11.80%,FGF9;ERBB4;FGFR2;ESR1;PIP5K1B
prerank,KEGG_2021_Human__Spliceosome,-0.3755004514837834,-0.9531816965727682,0.5018382352941176,1.0,1.0,6/21,10.10%,HNRNPU;PRPF6;SNRPA1;HSPA1A;SRSF7;CWC15
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.2864219114254314,-0.9530461346280541,0.5452991452991452,1.0,1.0,19/96,11.42%,NEFM;EIF2S1;DNAH14;ERBB4;NEFL;SLC1A2;NEFH;NUP93;PSMA4;TUBB2A;GPX1;NUP210L;MCU;HNRNPA2B1;UQCRQ;EIF2AK3;SRSF7;CYCS;NDUFB1
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.3269584762467662,-0.9526042366080015,0.5174311926605505,1.0,1.0,13/41,11.78%,GREB1;HSP90AA1;RUNX1;ERBB4;KCNH8;TLE3;GNG2;POLR2K;POLR2A;ESR1;GNG7;SMC1A;SMC3
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.35550693256959875,-0.9506796049843326,0.5204778156996587,1.0,1.0,8/27,16.00%,RYR3;RYR1;CHRNA7;TRPC6;TRPC7;TRPC5;GRIN3A;ATP2C2
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.3695864713000167,-0.9505707897291157,0.5173076923076924,1.0,1.0,10/24,17.70%,PRKG1;ITPR2;ADCY8;MYLK;PRKCH;MYL6;PRKCQ;PRKCG;CALM3;CALD1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.32672726349065384,0.9500217536141968,0.5498938428874734,0.7859548826672668,1.0,8/34,7.90%,HSPH1;DNAJB6;NUP210;MAPK3;HIKESHI;RPA1;SIRT1;NUP107
prerank,KEGG_2021_Human__Wnt signaling pathway,0.33777094239111355,0.949850628156526,0.5267857142857143,0.7848119539293019,1.0,7/30,9.00%,TLE4;PPP3CC;RHOA;WNT2B;CTBP2;FZD6;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.2945683494389652,-0.9496931071497682,0.5745454545454546,1.0,1.0,20/73,17.00%,DLC1;BMPR1B;ACVR1C;PTPRK;ERBB4;CDH13;ROR2;GSDME;CDKN2D;HSPA1A;DLG5;AR;OPRM1;SFRP4;TENM1;RBM5;ST18;ADAMTS8;ALDH1A2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.41140859772744776,-0.9492962938655576,0.5300970873786408,1.0,1.0,2/15,5.36%,PTPRM;SEMA3E
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.3339312489400984,-0.9488105933561004,0.5340501792114696,1.0,1.0,8/39,11.60%,CAMK2D;RYR3;RYR1;ASIC2;TRPC6;ATP8B2;TRPC7;TRPC5
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.34706314039921865,-0.9477791857382861,0.49818181818181817,1.0,1.0,10/31,13.22%,PARD3;BMPR1B;DRAP1;ACVR1C;SRFBP1;TGFBR1;PARP1;CCNK;WWTR1;LTBP1
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.29192328606572476,0.9474668296586947,0.5481651376146789,0.7890845520695905,1.0,8/62,7.90%,GPC5;GPC6;RPS27A;PHKA2;NUP210;ALDH1A1;GBE1;NUP107
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.38372333403175474,-0.947457316049313,0.4846846846846847,1.0,1.0,2/19,1.84%,SPOCK3;COL19A1
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.3449539271262127,0.9471949194693621,0.5541666666666667,0.7881764207410795,1.0,5/25,11.94%,CALU;CDH2;FSTL1;HSP90B1;CHRDL1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.37741581111993344,0.9470355143060637,0.5264227642276422,0.7869864823118156,1.0,6/16,20.68%,CYP7B1;LGMN;FDX1;SRD5A1;SLC22A24;CYP3A4
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.3911939970873826,-0.9462225620637739,0.5435606060606061,1.0,1.0,3/17,6.82%,CAMK2D;ERBB4;NCK1
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.34972859269110596,-0.9446713942564053,0.5027522935779817,1.0,1.0,9/29,14.58%,PDE1A;PDE7B;RXFP1;GNG2;ADCY8;GNG7;ADCYAP1R1;GRK5;GLP2R
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.31846229837021867,0.9445827889538259,0.5369565217391304,0.7916348499761308,1.0,5/37,7.90%,RPS27A;PSMB1;NUP210;SLC24A4;NUP107
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.31274187719293317,-0.9439413006594903,0.5333333333333333,1.0,1.0,11/54,11.08%,DLC1;BCL11B;GREB1;MPPED2;ELOVL5;PAPSS2;SVIL;SYT12;ELOVL2;PODXL;AR
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.3472305594239897,-0.9439119567671462,0.56,1.0,1.0,6/32,8.08%,CHRNA7;SLC9A9;SLC1A2;TRPC6;KCNN3;SLC17A6
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3977058032700262,-0.9434785300493829,0.5081967213114754,1.0,1.0,8/16,21.46%,SYT2;MTPN;TGFBR1;SYT17;TGFB2;CPNE9;RASAL1;EGFR
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.3560768101539131,0.943044806295231,0.5096359743040685,0.7938895978603201,1.0,9/23,21.54%,NRP1;RAB5A;MAPK3;AP2S1;RAB11B;RINT1;RAB5B;RIT2;ITGAV
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.31267915669715574,0.9428863167796601,0.5327510917030568,0.7927309128104734,1.0,12/41,16.36%,CASP8AP2;H2AZ2;MEIS2;SRSF10;MEIS1;SMAD3;TMPO;CTCF;H2AZ1;CKS2;TFDP1;NOTCH2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.36368436957572386,-0.9426818064413105,0.5328185328185329,1.0,1.0,8/25,16.90%,DLC1;HSPD1;EIF2AK3;CYCS;ROBO1;HIP1;CFLAR;RACK1
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.38959771047632197,0.9426704770711261,0.5396145610278372,0.7916992919762013,1.0,2/16,6.76%,ATP6V0E1;ATP6AP1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3255920642734903,-0.9424885905731225,0.5359712230215827,1.0,1.0,15/40,23.86%,DLC1;IL2RA;HSPD1;DHCR24;PARP1;PRUNE2;TRPC5;HIP1;PAWR;CFLAR;AHR;TNFRSF19;CHEK1;ARHGEF6;TNFRSF10B
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.3370249997079961,-0.942309376028164,0.5375939849624061,1.0,1.0,9/36,16.20%,ITPR2;GNG2;ADCY8;GABRG3;SLC17A6;GNG7;NDUFB1;PRKCG;NDUFB10
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2444962727882747,0.9413824814360939,0.6458852867830424,0.7933048174321359,1.0,47/189,17.64%,PRAG1;PPM1D;ST8SIA3;NEK7;ANXA1;PSMB1;PHKA2;CALU;ST8SIA4;KRT10;RAB5A;CDH2;FBXL18;PLOD2;FSTL1;MAPK3;PPP3CC;RBBP5;MINK1;PDK1;PARK7;SIRT1;MTMR6;PTPN3;KBTBD6;FEM1C;HIPK2;FAM20B;HIPK1;PRKD1;UBA3;HSP90B1;CHRDL1;UST;UBL5;PSMB2;PRRT1;KLHL25;METAP1;VRK2;FBXO31;RAB11B;PTPN5;SERP1;LIMK1;NUB1;PTPN18
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2947750846402755,0.9408128123688944,0.5584988962472406,0.793279559909893,1.0,24/56,27.14%,PSMB1;SMURF1;ANAPC1;SIRT1;KBTBD6;FEM1C;PSMB2;ZRANB1;KLHL25;RNF20;NUB1;AREL1;RNF8;NFE2L2;FBXL7;MAEA;PSMA1;OTUD7B;UBE2D1;NSFL1C;PSME4;MDM2;PSMA5;RNF144B
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.33738985331564747,0.9405044305097273,0.5368663594470046,0.7924477886334237,1.0,6/28,10.14%,NRP1;NUP210;SDCBP;SIRT1;NUP107;CCDC88C
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3809805607959311,-0.940048362589287,0.5234375,1.0,1.0,6/21,10.26%,ACVR1C;SH3RF1;CDKN2D;GPX1;DHCR24;CYCS
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3424316069674757,0.9396091888258743,0.5355555555555556,0.793075354976948,1.0,11/24,26.74%,RPS27A;PSMB1;STOX1;PSMB2;NFE2L2;EGLN3;DNAJB1;PSMA1;PSME4;PSMA5;EPAS1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.30175809278458327,-0.9394906594567307,0.5553571428571429,1.0,1.0,14/64,14.90%,SOX6;ESRRG;BMPR1B;ZNF516;GHR;LRPAP1;TGFBR1;HMCES;PRKCH;TWIST1;ABCA7;WWTR1;ACVR1;TXK
prerank,KEGG_2021_Human__Pathways in cancer,-0.27558256063704917,-0.9384775092846345,0.5837742504409171,1.0,1.0,20/116,11.08%,CAMK2D;IL2RA;LAMA2;HSP90AA1;RUNX1;FGF9;MET;TFG;GSTO1;FGFR2;PLEKHG5;MITF;GNG2;ADCY8;TGFBR1;ESR1;LAMA3;GNG7;CYCS;AR
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.35356432833432805,0.9375457687335018,0.5590200445434298,0.7967903760919752,1.0,5/25,12.18%,SGCD;SGCG;CACNB4;PRKAB2;TPM4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.3667020156095297,-0.9370014409708972,0.5173674588665448,1.0,1.0,12/24,33.68%,ROBO1;TENM1;SPRY3;TPD52L1;TRIB2;PDGFD;EGFR;EZH2;IL34;PDGFC;TSG101;PIK3CG
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.3067186323207166,0.9367028956265506,0.5642201834862385,0.7974259312491236,1.0,8/39,9.04%,TIAM1;GNA13;ARHGAP10;MCF2;ARHGAP24;RASGRF2;WASF2;TMPO
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.38439390742852764,0.9366427463389981,0.5456431535269709,0.7960473557608038,1.0,6/17,11.94%,MEIS2;MEIS1;COL5A1;HIPK2;HIPK1;CHRDL1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.3142350838004733,-0.936117302435618,0.5469613259668509,1.0,1.0,14/50,16.28%,PARD3;SKAP2;TFG;TEAD1;TLE3;MITF;ADCY8;F5;MCU;PLEKHA7;BCL9;SH3PXD2B;CAND2;ELOB
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.3040207141316239,0.9359821921140554,0.5783410138248848,0.7962449494866476,1.0,5/44,3.80%,INPP4B;NFIB;NEK7;NRP1;MIOS
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.383766437579457,-0.935170225550256,0.5441767068273092,1.0,1.0,5/17,15.96%,ITPR2;GPX1;ADCY8;ATP1A1;PRKCG
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.34097905722623095,0.9349718427792983,0.5555555555555556,0.7970678395279708,1.0,8/25,19.54%,RPS27A;POLR2B;GTF2H3;ERCC4;POLR2I;POLE2;ERCC1;LRIG3
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.3423738720901111,0.9345414957339404,0.5584988962472406,0.7966298460645957,1.0,5/24,9.04%,TIAM1;MCF2;PGRMC2;WASF2;TMPO
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.37083721280732757,0.9339889336162348,0.5661605206073753,0.7964014187790618,1.0,3/17,8.02%,RPS27A;SIRT1;HDAC3
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.3184277430511012,-0.9337393731042191,0.5599250936329588,1.0,1.0,7/41,10.26%,CAMK2D;EIF2S1;HSP90AA1;HSPD1;EIF2AK3;HSPA1A;CYCS
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.28554367394348307,0.9327679952421295,0.5727272727272728,0.7979508029959145,1.0,13/58,17.04%,RPS27A;PPARGC1A;RTKN2;PARK7;SMAD3;HIPK2;TRAF5;PRKD1;STAT3;EDA;CX3CL1;TFDP1;OPRD1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.3506435855918315,-0.9321719741665192,0.541970802919708,1.0,1.0,8/28,17.20%,PRKG1;PLXNA4;DOCK10;ASAP3;GPR137B;BCAR3;RACK1;DOCK11
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3456909467175836,-0.9321021136592108,0.5647969052224371,1.0,1.0,13/27,29.76%,ADGRV1;PCDH15;GSDME;USP53;LHFPL3;ROR1;COL11A1;KCNQ1;DCDC2;PIEZO2;USH2A;EML2;KCNE1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.3627741461273966,-0.9319671909137842,0.546617915904936,1.0,1.0,13/24,35.48%,SLC1A2;SLC2A3;SLC6A6;SLC24A3;TFRC;SLC22A8;ATP1A2;SLC7A5;SLC16A1;CD36;SLC7A1;SLC27A4;ABCC4
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.3462641845061061,-0.9315855837767582,0.5658153241650294,1.0,1.0,10/27,17.24%,DGKG;PIK3C2G;ITPR2;IPMK;PIP5K1B;MTMR8;DGKK;PIK3C2B;PRKCG;CALM3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.37693695325913024,-0.9308412451072298,0.5344506517690876,1.0,1.0,6/18,13.16%,SLIT1;SEMA3A;SLIT3;SEMA3E;ROBO1;SEMA4B
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.300272990200058,0.9302000999025419,0.5802997858672377,0.8026085749746857,1.0,14/47,16.14%,POLR2B;SF3B3;RBMX;NUP210;CPSF2;SRSF10;NUP107;SRSF3;GCFC2;HNRNPR;HNRNPH2;NUP155;POLR2I;DNAJC8
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.2803167702337286,0.9299518918291803,0.6044444444444445,0.8016386646546235,1.0,17/73,14.16%,CHGA;TOR1AIP2;ARHGAP10;PPARGC1A;FGD6;ABCD2;PEX1;PARK7;ABCD3;PPID;FAM161A;PRKD1;GABPA;SURF4;TTC29;COG2;ZRANB1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.30067290687327825,0.929170351094236,0.5944055944055944,0.8018652918261239,1.0,8/42,9.00%,RERG;PSRC1;CCDC85B;BTG1;SDCBP;SIRT1;PPT1;SMAD3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.38675571838393163,0.9287648784761275,0.5460385438972163,0.8013624571775056,1.0,2/15,3.12%,NRP1;CDH2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3469329295085804,0.9282895910405813,0.5681341719077568,0.8010117170584867,1.0,6/22,19.40%,ANXA1;FOXO1;STAT3;OTUD5;GPX3;IFNAR1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.3622278283922896,-0.9280267588443547,0.5557620817843866,1.0,1.0,4/24,9.48%,FGF9;ERBB4;FGFR2;ESR1
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.33584158251501406,-0.9274277063135993,0.5296167247386759,1.0,1.0,4/35,4.88%,BCL11B;RUNX1;MET;MITF
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.30184014933450576,0.9273129213216922,0.5765765765765766,0.801680059793428,1.0,10/41,14.92%,TTC39B;TIAM1;NRP1;MYO1E;HIPK2;ARL4A;TWSG1;NFKBIZ;PLAGL1;SLC39A8
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.29170225167628533,-0.9272796723881989,0.5559502664298401,1.0,1.0,19/70,17.56%,PRKG1;CAMK2D;BMPR1B;DGKG;ACVR1C;PRKG2;TGFBR1;EIF2AK3;PRKCH;CDK18;GRK5;DGKK;ACVR1;TXK;PRKCG;ROS1;TGFB2;TRIB2;CDK15
prerank,KEGG_2021_Human__Human papillomavirus infection,0.28882244651211186,0.9271552866944457,0.5622119815668203,0.8004664582807743,1.0,18/60,21.58%,ATP6V0E1;FOXO1;BCAP31;MAPK3;WNT2B;ATP6AP1;FZD6;MAML3;KRAS;LAMA4;COL4A2;NOTCH2;WNT3;ITGA9;IFNAR1;TUBG2;ITGAV;HDAC2
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.3765589160613708,0.9269590353238507,0.5797413793103449,0.7993962927961225,1.0,6/15,15.12%,NUP210;NUP107;RAN;FAM98B;RTCB;NUP155
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.3940693884140931,-0.9262822070188107,0.5319548872180451,1.0,1.0,2/16,5.10%,CNTN5;LYPD5
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.3636534810201024,0.9262760408290872,0.5664488017429193,0.7996010471481516,1.0,7/18,17.08%,TIAM1;ARHGAP24;TBC1D2B;CCDC125;TBC1D9B;CXCL13;TBC1D4
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.3483657286742735,-0.9262181635543397,0.546112115732369,1.0,1.0,11/30,21.98%,RYR1;ITPR2;PSMA4;MCU;CYCS;GRIN3A;ATXN1L;PRKCG;PSMD2;PSMC6;RELN
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.31802195913903336,0.9247155837690602,0.5820568927789934,0.8018930979071569,1.0,7/34,6.04%,TIAM1;GNA13;ARHGAP10;MCF2;ARHGAP24;RHOA;RASGRF2
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.3467654984787286,-0.9246415913200632,0.541970802919708,1.0,1.0,3/30,5.32%,LRRC4C;PTPRM;CDH4
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.35984135192966055,0.9245765832799915,0.565410199556541,0.8007064407020315,1.0,7/20,20.58%,ANO6;SLC37A3;ANO2;SLC37A1;LRRC8A;SLC6A1;SLC12A2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.328507072736357,0.9243295487328874,0.5565819861431871,0.7997270518604619,1.0,3/28,5.02%,UTRN;EDNRA;TMOD3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3795937996218889,0.9241899405961445,0.5572354211663066,0.7985281158674578,1.0,1/16,0.36%,PRELID2
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.34278241680290567,0.9235083575536618,0.5773195876288659,0.798779210811102,1.0,2/23,2.58%,RPS27A;PSMB1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.35546957078587194,0.922673841744205,0.5462012320328542,0.7990836719633866,1.0,7/22,16.56%,MTCH2;RPA1;LAMP2;TRAM2;TTC26;TRAM1;SERP1
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,-0.37600303280329533,-0.9225379849853542,0.5855513307984791,1.0,1.0,3/19,5.64%,COL24A1;COL19A1;COL21A1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.35808578833018717,0.9222578534426125,0.5605749486652978,0.798584318384775,1.0,3/20,4.40%,ANXA1;TDRD7;FSTL1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3152087722591699,0.9177991612034745,0.5874439461883408,0.8076728040236131,1.0,10/34,14.12%,TIAM1;CALY;GTF2B;NRG1;TMEM35A;NUP107;SMAD3;POMP;AP2S1;PSMG2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.35453138079652813,-0.9170725473997864,0.5754189944134078,1.0,1.0,9/23,17.26%,RUNX1;BRK1;GPX1;TGFBR1;AR;HRK;RACK1;TGFB2;MTLN
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.3740097060267846,-0.9162037658416206,0.5753676470588235,1.0,1.0,2/18,0.96%,DLC1;ARHGAP18
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3494140741653043,-0.9158527829844079,0.5682656826568265,1.0,1.0,6/25,9.62%,CHRNA7;NCK1;DHCR24;LRPAP1;HSPA1A;CHMP4B
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.37512149699669417,0.9144850520687068,0.581858407079646,0.814063642863059,1.0,3/15,7.52%,FOXO1;LAMP2;SIRT1
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.3766948945622327,0.9141319054453032,0.579520697167756,0.8134392691254306,1.0,5/16,14.48%,RHOA;CLDN16;JAM2;MYL12B;VAV3
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.31048860898825154,0.91342784646754,0.6093418259023354,0.8136318918792568,1.0,8/34,9.04%,TIAM1;GNA13;ARHGAP10;MCF2;ARHGAP24;RASGRF2;CDC42EP3;TMPO
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.38391186599664845,-0.9126079445870123,0.5577689243027888,1.0,1.0,7/16,23.44%,RAB3C;RAB23;RAB11A;RAB37;RAB18;RAB22A;RAB21
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.3552443675137224,-0.9123230820273075,0.5656934306569343,1.0,1.0,6/23,11.60%,RYR3;RYR1;ASIC2;TRPC6;TRPC7;TRPC5
prerank,Reactome_2022__Immune System R-HSA-168256,-0.23910258713439755,-0.9118751135210957,0.7112903225806452,1.0,1.0,57/300,17.22%,DLC1;PRKG1;CAMK2D;IL2RA;BCL11B;TRIM36;HSP90AA1;ITPR2;RCHY1;GHR;CAP1;GSTO1;KCNH8;POLR3G;KIF3A;CD63;CCT2;NUP93;PSMA4;BRK1;SLC2A3;EGR1;GSDME;SH3RF1;NCK1;NKIRAS1;CYLD;SNRPA1;POLR2K;UBE3B;TRIM4;HNRNPA2B1;HSPA1A;POLR1D;HAVCR2;CPPED1;OPRM1;NUP42;FBXW8;TWIST1;DCAF1;MOSPD2;PGM1;SLCO4C1;GNS;PYGB;TXK;RAB37;PRKCQ;RLIM;ELOB;COPB1;REL;KLHL13;TSPAN14;FBXO7;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.2659627128482478,-0.9108957010465054,0.6381578947368421,1.0,1.0,34/109,20.40%,DLC1;PLXNA4;PTPRK;ERBB4;CDH13;SLIT3;ROR2;GSDME;CDKN2D;NCK1;LRPAP1;EIF2AK3;HSPA1A;CHMP4B;PODXL;DLG5;SERTAD2;AR;OPRM1;SFRP4;MARCHF5;TENM1;RBM5;NOS1;ST18;ADAMTS8;ALDH1A2;RACK1;TGFB2;SEMA5A;TGFBR3;GPLD1;FABP3;PLXNA1
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.3251793781144633,-0.9107531959230281,0.5572519083969466,1.0,1.0,9/34,10.10%,ELAVL2;HNRNPU;PRPF6;SNRPA1;POLR2K;POLR2A;HNRNPA2B1;SRSF7;CWC15
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.34304575910356155,0.9105145980628747,0.5767634854771784,0.8185469685116525,1.0,7/23,10.22%,MINK1;SH3RF2;SDCBP;HDAC3;PER1;HIPK2;TRAF5
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.32625112380424554,0.9090771900447893,0.6150627615062761,0.8204703039506485,1.0,7/28,7.90%,HSPH1;DNAJB6;NUP210;MAPK3;HIKESHI;SIRT1;NUP107
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.33635318708503215,-0.9089174826647766,0.5747747747747748,1.0,1.0,6/30,9.64%,COL24A1;COL19A1;COL21A1;ADAMTS3;TGFBR1;LAMA3
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.35962696983589065,-0.9087425465711035,0.5742753623188406,1.0,1.0,7/19,19.40%,BMPR1B;XYLT1;ALG5;GCNT1;NPC1;B3GALNT2;CHST11
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.3548534874870691,-0.9086267167327176,0.5604982206405694,1.0,1.0,12/23,35.48%,SLC1A2;SLC2A3;SLC6A6;SLC24A3;TFRC;SLC22A8;ATP1A2;SLC7A5;SLC16A1;SLC7A1;SLC27A4;ABCC4
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.28380513166994,-0.9083231253488991,0.6284153005464481,1.0,1.0,19/71,19.92%,DLC1;HSP90AA1;CAP1;CD63;CCT2;SLC2A3;HSPA1A;CPPED1;MOSPD2;PGM1;SLCO4C1;GNS;PYGB;RAB37;COPB1;TSPAN14;YPEL5;SNAP25;RAB18
prerank,KEGG_2021_Human__Oocyte meiosis,0.36468352004333654,0.9082407595968394,0.5762004175365344,0.8208349565552255,1.0,6/17,9.26%,YWHAH;MAPK3;PPP3CC;STAG3;ANAPC1;CPEB1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.340955910922136,-0.908084006345039,0.5683836589698046,1.0,1.0,7/28,12.58%,SLC9A9;ASIC2;SLC6A6;SCN1A;KCNK1;SCN7A;ATP1A1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.28139924610508094,-0.908038627078827,0.6259124087591241,1.0,1.0,13/76,9.48%,ELAVL2;SOX6;ESRRG;ZNF331;ZNF516;DRAP1;GCM1;MITF;TGFBR1;NFIA;POLR2A;HMGN5;ESR1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.33650084695471383,-0.9076121983566715,0.5928853754940712,1.0,1.0,12/27,29.76%,ADGRV1;PCDH15;GSDME;USP53;LHFPL3;ROR1;COL11A1;KCNQ1;DCDC2;USH2A;EML2;KCNE1
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.3222262171155465,-0.9075981052667784,0.55893536121673,1.0,1.0,9/35,10.10%,ELAVL2;HNRNPU;PRPF6;SNRPA1;POLR2K;POLR2A;HNRNPA2B1;SRSF7;CWC15
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.34405122706066527,0.9075967120925699,0.6128364389233955,0.820943957685698,1.0,2/21,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.3526966782541109,0.9073558104467898,0.5936842105263158,0.8155642270392299,1.0,2/19,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.3526966782541109,0.9073558104467898,0.5936842105263158,0.8155642270392299,1.0,2/19,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.3526966782541109,0.9073558104467898,0.5936842105263158,0.8155642270392299,1.0,2/19,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.3526966782541109,0.9073558104467898,0.5936842105263158,0.8155642270392299,1.0,2/19,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.31539287125311194,0.9072544973478722,0.5813953488372093,0.8142982809642116,1.0,9/29,19.78%,THSD4;B3GLCT;ADAMTS2;GALNT3;ADAMTS17;GALNT8;ADAMTSL1;GCNT4;ST6GALNAC3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.32544736339827374,0.9071359996841221,0.6029106029106029,0.81305453025174,1.0,8/29,11.34%,PPARGC1A;TOMM7;BCAP31;PARK7;TRAK2;FIS1;USP30;GABPA
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.33625085635303886,-0.9070918189380037,0.5960144927536232,1.0,1.0,6/30,8.10%,XYLT1;HS3ST2;HS3ST4;PAPSS2;HS6ST3;NDST1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.3762283167033719,0.9066136865520681,0.5904139433551199,0.8127543788812631,1.0,3/16,6.76%,ATP6V0E1;MAPK3;ATP6AP1
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.34038251187978286,-0.9052629438881061,0.6124763705103969,1.0,1.0,10/27,19.46%,HSP90AA1;CCT3;KIF3A;CCT2;RAB11A;PDE6D;WDR35;NPHP1;CNGB1;RAB3IP
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3573741244705648,-0.9030779858465066,0.5958188153310104,1.0,1.0,10/21,30.22%,CHRNA7;RMDN3;HTR2C;ATP2C2;SLC24A3;TMCO1;PKHD1;CAV1;SLC8A3;SLC8B1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.30878872923129663,0.9025804300246052,0.5945378151260504,0.8204834166508438,1.0,14/35,26.62%,PSMB1;SMURF1;SIRT1;KBTBD6;FEM1C;PSMB2;AREL1;NFE2L2;MAEA;PSMA1;NSFL1C;PSME4;MDM2;PSMA5
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.37524230570153416,0.9023348162411738,0.6072186836518046,0.8195980225076441,1.0,3/15,5.92%,KCNH1;PLCH2;RHOA
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.3778970940681996,-0.901798728360312,0.5767195767195767,1.0,1.0,10/17,30.22%,CHRNA7;RMDN3;HTR2C;ATP2C2;SLC24A3;TMCO1;PKHD1;CAV1;SLC8A3;SLC8B1
prerank,KEGG_2021_Human__Huntington disease,0.26199836940223875,0.9015947546818756,0.6644295302013423,0.8198596303405097,1.0,29/86,23.22%,POLR2B;DNAL1;PSMB1;PPARGC1A;NDUFB2;ATP5F1E;KLC2;DNAI1;NDUFC1;NDUFC2;AP2S1;NDUFA4;PSMB2;SIN3A;ATP5PF;POLR2I;NDUFB11;PLCB4;GPX3;DNAH10;TUBB4B;COX7A1;NDUFAB1;DCTN1;HDAC2;ATP5PO;NDUFB8;ATP5F1C;PSMA1
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.29562903326343704,-0.9015530067097982,0.6185185185185185,1.0,1.0,8/59,6.46%,CAMK2D;IL2RA;FGF9;ERBB4;NEFL;FGFR2;PSMA4;PRKG2
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.2931248176264393,-0.9006438641685961,0.6245421245421245,1.0,1.0,8/60,6.46%,CAMK2D;IL2RA;FGF9;ERBB4;NEFL;FGFR2;PSMA4;PRKG2
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.3646303645032188,-0.8997092896384904,0.5719626168224299,1.0,1.0,4/19,6.82%,HSP90AA1;ITPR2;BRK1;NCK1
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.3431442259888656,0.8990616858564726,0.6042105263157894,0.8242735261492016,1.0,2/21,4.44%,RPS27A;MAPK3
prerank,KEGG_2021_Human__Hippo signaling pathway,0.30842400683773896,0.8990035072163717,0.6564551422319475,0.8229108028834143,1.0,7/34,9.00%,YWHAH;ID2;MOB1B;MOB1A;WNT2B;FZD6;SMAD3
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.36268330797862103,0.8987717435766821,0.5819327731092437,0.8219181052956591,1.0,8/17,34.00%,CLEC2D;CD81;PIANP;KLRD1;CD99;CD247;CD96;NCR3LG1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3697437420856719,0.8987109133328779,0.5982721382289417,0.8191116739039204,1.0,2/15,5.54%,INPP4B;PLCH2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3697437420856719,0.8987109133328779,0.5982721382289417,0.8191116739039204,1.0,2/15,5.54%,INPP4B;PLCH2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.32593903410851605,-0.8986599323070431,0.5908289241622575,1.0,1.0,8/32,14.84%,SPTLC1;GSTO1;ELOVL5;PCSK5;ELOVL2;PCTP;GCNT1;ABHD3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.28673830687774493,0.8983526426469737,0.6293706293706294,0.8184324674715354,1.0,6/48,5.76%,POLR2B;GLIS3;CREBL2;GTF2B;RBMX;GTF2H3
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.3438745636791798,0.8977100986369272,0.5949895615866388,0.8184240590070394,1.0,6/21,8.10%,PHKA2;PPARGC1A;FOXO1;PPP3CC;SIRT1;PRKAB2
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.3532920593679661,0.8954481325202128,0.611353711790393,0.8223967228817288,1.0,6/18,19.80%,VIPR2;WNT2B;FZD6;WNT3;RAMP1;PTH2R
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.27470260374723593,0.894433233859316,0.6774941995359629,0.8231407371366013,1.0,10/56,14.16%,CUX2;KAT2B;NRP1;SIRT1;CTBP2;CRADD;MAML3;STAT3;POGLUT1;ZRANB1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.3119195999529332,-0.8941901115760257,0.6204933586337761,1.0,1.0,7/38,11.60%,RYR1;CALB1;TRPC6;ADCY8;ESR1;TRPC7;TRPC5
prerank,KEGG_2021_Human__Tuberculosis,0.33430542149086184,0.8939840791695403,0.6105263157894737,0.8227928601494876,1.0,7/25,9.64%,RAB5A;MAPK3;PPP3CC;RHOA;ATP6AP1;LAMP2;KSR1
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.36759244849719863,0.8929364470661757,0.5979166666666667,0.8237857949085293,1.0,5/15,15.78%,POLR2B;NUP210;NUP107;NUP155;POLR2I
prerank,KEGG_2021_Human__Melanogenesis,0.35360529661716905,0.8924019611917072,0.6263048016701461,0.8235137914779197,1.0,8/18,17.06%,EDNRB;MAPK3;WNT2B;FZD6;KITLG;KRAS;WNT3;PLCB4
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.3335484073216215,-0.8904469312730299,0.5933852140077821,1.0,1.0,3/27,3.66%,BMPR1B;HSP90AA1;GSTO1
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.3028787912921406,-0.8902563574526862,0.6336996336996337,1.0,1.0,12/45,16.64%,DGKG;ITPR2;TRPC6;GNG2;GNG7;PRKCH;TRPC7;HTR2C;GRK5;DGKK;PRKCQ;RGSL1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.36933975859009166,-0.8899914817650953,0.6083650190114068,1.0,1.0,2/18,5.36%,PTPRM;SEMA3E
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.3083001116241159,-0.8899645138544864,0.6236363636363637,1.0,1.0,2/42,2.80%,PTPRD;PLCH1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3594988527980465,0.8896294433604887,0.5995623632385121,0.8282332772911467,1.0,8/17,26.62%,PSMB1;KRAS;PSMB2;TRAF6;PSMA1;PSME4;KLRD1;PSMA5
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2695532558701867,0.8894491143365268,0.6636971046770601,0.827211422115871,1.0,12/66,11.56%,RPS27A;PSMB1;MAPK3;SPTB;MINK1;RASGRF2;NRG1;GFRA1;PTPN3;KITLG;KSR1;KRAS
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.2937835835193114,-0.8887599956166883,0.6417391304347826,1.0,1.0,8/52,14.02%,RUNX1;SLC9A9;SLC1A2;SLC2A3;SLC17A6;SLC6A6;SLCO4C1;SLC47A2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.34187431419187764,-0.888630560694199,0.6064638783269962,1.0,1.0,7/25,21.46%,ROR2;PIP5K1B;TWIST1;ROR1;TGFB2;PDGFD;EGFR
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.31994090732523695,0.8885656924195028,0.6407563025210085,0.8277981412804432,1.0,5/28,20.14%,RHOA;OTUD5;CXCL13;IFNAR1;TRAF6
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.35176178689004123,0.8877540316326334,0.6257796257796258,0.8281351979170886,1.0,6/18,20.50%,RPS27A;SOAT1;AP2S1;SAR1B;LDLR;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.36502134177840634,0.8876214313522299,0.6354581673306773,0.8269831578571615,1.0,5/15,10.22%,MINK1;SH3RF2;SDCBP;HIPK2;TRAF5
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.2978902606834699,0.8870589552177289,0.6520787746170679,0.8267011700461432,1.0,3/38,4.60%,GPC5;PSMB1;LRRK1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.26118943724184585,-0.8858926760451602,0.6778169014084507,1.0,1.0,18/118,9.48%,BCL11B;LAMA2;HSP90AA1;PCSK6;FGF9;ITPR2;PTPRK;ERBB4;KCNH8;FGFR2;BRK1;EGR1;NCK1;GABRG3;PCSK5;POLR2K;POLR2A;ESR1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3603921263348596,0.8852993793959472,0.631578947368421,0.8277794087374735,1.0,8/16,26.62%,PSMB1;KRAS;PSMB2;TRAF6;PSMA1;PSME4;KLRD1;PSMA5
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3603921263348596,0.8852993793959472,0.631578947368421,0.8277794087374735,1.0,8/16,26.62%,PSMB1;KRAS;PSMB2;TRAF6;PSMA1;PSME4;KLRD1;PSMA5
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3122078478583423,0.8852458513331153,0.6337078651685393,0.826460295501937,1.0,9/33,12.46%,RPS27A;USP9Y;MAPK3;RHOA;SMURF1;SIRT1;SMAD3;LPXN;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3590601796403847,0.8852127432586411,0.5991379310344828,0.8251025041946595,1.0,5/17,9.98%,NRP1;CDC42EP3;DPYSL3;WASF2;NDEL1
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.3663900799992405,0.8845380531572031,0.6405228758169934,0.8252003204875697,1.0,3/16,9.70%,ID2;MAPK3;NAB1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.23768916207611554,0.8845121368802589,0.7545691906005222,0.8238350191348611,1.0,26/140,11.58%,RPS27A;TIAM1;ANXA1;GNA13;ARHGAP10;MCF2;FOXO1;FSTL1;MTCH2;RASGRF2;SH3RF2;PARK7;RPL10;ANO6;SIRT1;HDAC3;PPID;PPT1;FAM162A;CRADD;HSP90B1;PRMT2;CAT;MRE11;TCTN3;UFM1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.3618030971685337,0.8833102292584528,0.6314655172413793,0.8250746889197051,1.0,2/16,5.54%,INPP4B;PLCH2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.3362660832754456,-0.8822779678510873,0.6188747731397459,1.0,1.0,4/25,8.98%,SLC9A9;SLC1A2;SLC17A6;SLC6A6
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.31609748751348316,0.8820202451142592,0.6204690831556503,0.8265367543060954,1.0,4/28,4.66%,CHGA;ST8SIA3;SPTB;SEC24A
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.326326477130387,-0.8819294666415771,0.6390977443609023,1.0,1.0,6/28,9.56%,ADGRV1;PTPRM;NEFH;HDGFL3;DOCK10;RAB11A
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.2754830657524859,-0.8813362893526817,0.6899641577060932,1.0,1.0,8/84,6.38%,PID1;IL2RA;HNRNPU;HSP90AA1;GHR;RPL13A;EGR1;GSDME
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.26755623169516096,0.8812112444696811,0.6825396825396826,0.8269363041775156,1.0,23/65,24.80%,RPS27A;PSMB1;FBXL18;SEC24A;SMURF1;MKRN1;ANAPC1;KBTBD6;UBA3;PSMB2;UBE2Q2;KLHL25;FBXO31;SAR1B;AREL1;TRIM69;FBXL7;ITGAV;HERC3;PSMA1;UBE2D1;FBXO2;PSME4
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.3197380824098271,0.8810687648343116,0.6391304347826087,0.8258103940805942,1.0,4/25,10.94%,RORB;ATP6AP1;SUCO;PRKD1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.34669026524766017,0.8804266003037171,0.6130346232179226,0.8258276678102078,1.0,10/18,26.62%,PSMB1;FBXL18;PSMB2;FBXO31;FBXO38;FBXL7;PSMA1;FBXO2;PSME4;PSMA5
prerank,KEGG_2021_Human__Tight junction,-0.3334707162923761,-0.8798594014258196,0.6127819548872181,1.0,1.0,3/27,2.86%,PARD3;RUNX1;ARPC5L
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.29059057009944017,0.8796333212820096,0.6818181818181818,0.8261742518607379,1.0,8/38,9.88%,GNA13;MAPK3;SEC24A;RHOA;CLDN16;MYO1E;WASF2;GAPDH
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.3276928342302398,-0.8792161891235649,0.6333333333333333,1.0,1.0,14/28,30.10%,COL24A1;COL19A1;COL21A1;ATP1A1;COL12A1;COL11A1;COL28A1;KCNQ1;COL4A1;DPP4;COL5A2;ATP1A2;SLC8A3;COL27A1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3655558081596686,-0.8782953112105449,0.6116152450090744,1.0,1.0,6/17,13.20%,MET;CRACD;GPX1;NCK1;TENM1;TOGARAM1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.3300222498841151,-0.8767475776861123,0.6433691756272402,1.0,1.0,6/26,14.58%,RXFP1;GNG2;ADCY8;HAVCR2;ADCYAP1R1;GLP2R
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.34630488207360377,0.8761269387634795,0.6381156316916489,0.8322702497229154,1.0,4/18,10.10%,MINK1;NRG1;PARK7;TXN
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3665526456649645,-0.8750723955423327,0.6015180265654649,1.0,1.0,6/15,12.80%,MCTP1;CDH13;LRPAP1;HIP1;RUBCN;ABCA7
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.33183428409689186,0.8750276636780108,0.6844349680170576,0.8332918956322435,1.0,4/22,5.92%,RHOBTB1;ARHGAP10;FGD6;RHOA
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3194840994880179,0.8748954815010807,0.6666666666666666,0.83219068530271,1.0,9/27,20.14%,ANXA1;RHOA;DPYSL3;SMAD3;STAT3;PTPN5;NUB1;PTPN18;TRAF6
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.29883138430619993,0.8736220373867127,0.6651884700665188,0.8336514605407622,1.0,8/35,12.18%,RHOBTB1;TMOD3;RHOA;GSN;MYO1E;MARCKSL1;DPYSL3;TPM4
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.29816167504209157,-0.8736185275059665,0.6731107205623902,1.0,1.0,5/42,6.70%,PARD3;FGF9;MET;FGFR2;ADCY8
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.31412468007883415,-0.8734879207196597,0.6303501945525292,1.0,1.0,14/35,22.10%,ITPR2;GNG2;GNG7;CYCS;CUL4B;DCAF1;PRKCG;ELOB;CALM3;JUN;TRIM5;AP1B1;TBK1;CHEK1
prerank,KEGG_2021_Human__Shigellosis,0.2923697448346626,0.873430020443311,0.6659751037344398,0.8326802422781706,1.0,12/43,17.06%,RPS27A;FOXO1;MAPK3;RHOA;PPID;WASF2;TRAF5;H3-3B;ATG16L1;MYL12B;CRKL;PLCB4
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.35567281006670887,0.873265036630338,0.6422764227642277,0.8316442842869067,1.0,4/17,9.92%,EDNRB;BCAP31;PPP3CC;FIS1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.3696485718864001,-0.8728349705378733,0.6375711574952562,1.0,1.0,3/15,7.40%,MET;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.35268014429409533,0.8723609355148855,0.6292372881355932,0.8321689788650661,1.0,3/17,5.94%,FOXO1;ABCB10;SMURF1
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.3118801234126868,0.8721051148159708,0.6471861471861472,0.8313384075456817,1.0,1/30,0.02%,CUX1
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.29023431856110715,-0.8715526031837094,0.6605839416058394,1.0,1.0,11/50,13.86%,CAMK2D;RYR3;RYR1;ITPR2;SCN1A;KCNK1;MYLK;SCN7A;TPM1;WWTR1;MYL6
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.3043131157063379,0.8711175491554393,0.6359832635983264,0.832029880435327,1.0,3/29,4.44%,RPS27A;PSMB1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.31811504707333865,-0.8704690861553216,0.6685082872928176,1.0,1.0,13/32,24.58%,TFG;PLEKHG5;DDX21;GPR89A;LGALS1;ROR1;CFLAR;REL;TRIM5;TNFRSF19;TBK1;TNFRSF10B;TFRC
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.34908087505703095,0.8699030948223493,0.6446808510638298,0.833196643045622,1.0,5/18,11.56%,MAPK3;PPP3CC;RHOA;KSR1;KRAS
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.376673060879376,-0.8695004792364193,0.6238532110091743,1.0,1.0,1/15,0.46%,DLC1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3434623244370736,-0.8693789119298386,0.6329113924050633,1.0,1.0,4/21,18.22%,ROR2;ROR1;TGFB2;PDGFD
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.2844643465309639,-0.8688065476713621,0.6527050610820244,1.0,1.0,5/54,3.52%,PID1;HSP90AA1;CHRNA7;FGF9;ERBB4
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3487801182544932,0.86802680093586,0.6688741721854304,0.8358248156937504,1.0,3/17,12.98%,ANXA1;PARK7;STAT3
prerank,KEGG_2021_Human__Focal adhesion,-0.29672752874183744,-0.8676484807441225,0.6738351254480287,1.0,1.0,20/45,33.20%,LAMA2;MET;PARVB;LAMA3;MYLK;PIP5K1B;PRKCG;PDGFD;JUN;ITGA7;EGFR;RELN;COL4A1;ITGA1;CAV1;VEGFD;ITGA4;PDGFC;ITGB1;ITGA6
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.361788807026593,-0.8675405459028179,0.6496212121212122,1.0,1.0,6/18,16.26%,SH3RF1;TGFBR1;CYLD;AR;ACVR1;CFLAR
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.269609442470692,0.8675254506683361,0.7086956521739131,0.8355091735644599,1.0,8/59,9.06%,RPS27A;PSMB1;FOXO1;MAPK3;NRG1;MKRN1;HDAC3;KITLG
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.34571826763826946,0.865197424106938,0.6508620689655172,0.839399685648766,1.0,5/18,9.00%,TIAM1;LDLRAD4;EPHA3;SDCBP;SMAD3
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.36424008567213806,0.8647382665043132,0.6595289079229122,0.8389981379768511,1.0,6/15,22.78%,NRP1;RHOA;LPXN;NTNG1;ITGAV;NTN4
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.31716173231974426,0.8628388321312039,0.6688741721854304,0.841594544712306,1.0,8/24,16.24%,NUP210;TRMT13;NUP107;RAN;FAM98B;RTCB;NUP155;TRMT61B
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.3194363651159705,0.8626630336366692,0.6724890829694323,0.8405771336071786,1.0,3/26,2.82%,SGCD;SGCG;CACNB4
prerank,KEGG_2021_Human__Toxoplasmosis,-0.3598489072229466,-0.8600316580218332,0.6517690875232774,1.0,1.0,4/17,10.26%,LAMA2;HSPA1A;LAMA3;CYCS
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.3352442364427415,-0.859465040848965,0.643979057591623,1.0,1.0,12/24,30.22%,CHRNA7;RMDN3;ATP1A1;HTR2C;ATP2C2;SLC24A3;TMCO1;PKHD1;ATP1A2;CAV1;SLC8A3;SLC8B1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.34358757807155926,-0.8593760791034979,0.6636029411764706,1.0,1.0,5/20,11.00%,PTPRM;HDGFL3;MNS1;RAB11A;TPM1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.273498948299112,-0.8585862528584077,0.6963350785340314,1.0,1.0,6/70,7.32%,SPOCK3;COL24A1;LAMA2;COL19A1;COL21A1;ADAMTS3
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.28255140706182935,-0.8580565651727089,0.6941391941391941,1.0,1.0,17/59,21.62%,EIF2S1;ZNF331;ZNF26;ZNF595;EIF2AK3;ZNF140;ZNF528;SRSF7;CYCS;ZNF850;ZNF431;ZNF184;ZNF98;ZNF573;ZNF569;ZNF208;TBK1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.340654564362939,0.8566502959543082,0.6781115879828327,0.8518321997751271,1.0,6/19,19.54%,RPS27A;GTF2H3;ERCC4;POLE2;ERCC1;LRIG3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.34810531963745894,0.8563860615448806,0.6536082474226804,0.8509552372708513,1.0,4/17,9.00%,USP9Y;MAPK3;SMURF1;SMAD3
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.3313119582896575,-0.8554400507086933,0.6748582230623819,1.0,1.0,4/22,6.70%,GCM1;ITPR2;EGR1;ADCY8
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.3167141310751351,-0.854115696163493,0.6628787878787878,1.0,1.0,6/27,9.72%,PRKG1;ITPR2;PSMA4;GNG2;PRKG2;GNG7
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.34182806170243457,-0.8539808943656128,0.6703499079189686,1.0,1.0,8/19,26.22%,ITPR2;HMGCR;TGFB2;KCNG2;SNAP25;MYO18A;DPP4;EXPH5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.365800926811218,-0.8537583283795448,0.644808743169399,1.0,1.0,5/15,20.40%,PLXNA4;CDH13;PODXL;SEMA5A;PLXNA1
prerank,KEGG_2021_Human__Pancreatic secretion,0.3476460087579819,0.8535158778319005,0.6688311688311688,0.8554954258290505,1.0,2/17,5.92%,CCK;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.29978416676917957,-0.8520140263006838,0.6808905380333952,1.0,1.0,10/36,16.90%,DLC1;ACVR1C;HSPD1;EIF2AK3;CYCS;ROBO1;HIP1;ST18;CFLAR;RACK1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.2723201487908002,0.8512668548757965,0.7446808510638298,0.8589436911933873,1.0,6/48,10.14%,GPC5;TLE4;PSMB1;LRRK1;FZD6;CCDC88C
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.33495116630353,0.84964381860248,0.6595744680851063,0.860772422751659,1.0,3/18,8.02%,KAT2B;SIRT1;HDAC3
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.2483224614085304,0.8481514318487459,0.812933025404157,0.8624535417591072,1.0,17/80,14.18%,RPS27A;RHOBTB1;COL14A1;DNAJB6;PLOD2;TMOD3;RHOA;COL23A1;COL5A1;GSN;MYO1E;MARCKSL1;CCDC88C;ADAMTS2;TPM4;CRIPT;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.2602432706385886,0.8477391699184389,0.7540229885057471,0.8619379904239116,1.0,6/58,6.86%,SEMA6D;TIAM1;NRP1;CPNE3;SH3RF2;SDCBP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3452550985104902,0.8472391290488926,0.6703786191536748,0.8616381048564921,1.0,3/16,12.40%,PDK1;HIPK2;SELENOK
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.22630526280492191,0.8468909142420747,0.8811188811188811,0.8610483069806932,1.0,28/157,15.00%,PDZD2;RPS27A;CHGA;PSMB1;ATP6V0E1;MAPK3;CPNE3;FTH1;RHOA;SDCBP;LGMN;ANO6;LAMP2;GSN;MYO1E;WASF2;UBA3;HEXB;HSP90B1;MRE11;SURF4;NDUFC2;MGST1;PSMB2;VAV3;CCT8;COLEC10;OTUD5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.3335836193605857,-0.8465153597195987,0.7,1.0,1.0,9/22,33.68%,ROBO1;TENM1;TPD52L1;PDGFD;EGFR;EZH2;IL34;PDGFC;PIK3CG
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.26900907457241025,0.8450816385161333,0.7542016806722689,0.8633941183258927,1.0,12/49,17.76%,RPS27A;TOR1AIP2;TMEM33;RAB5A;PPT1;STAM;AP2S1;NUP155;REEP3;SERP1;SAR1B;LDLR
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.3337853465726186,-0.8436685030723854,0.6520912547528517,1.0,1.0,5/21,16.44%,ANK1;TFG;F5;ARFGAP3;COPB1
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.32680657463218815,0.8436412808394982,0.7037037037037037,0.8649009498841217,1.0,2/22,1.18%,VIPR2;CHGA
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.3562535516932195,-0.8434202256823643,0.6593806921675774,1.0,1.0,3/15,14.02%,RUNX1;SLC6A6;SLC47A2
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.2728284778122449,-0.8432073236783417,0.7420494699646644,1.0,1.0,12/54,17.00%,CAMK2D;GYS1;TGFBR1;PDHA1;PARP1;UQCRQ;NDUFB1;COX7B;PRKCG;NDUFB10;SDHB;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.27082453294764264,-0.8417305928097083,0.7435456110154905,1.0,1.0,7/58,5.34%,HSP90AA1;CHRNA7;FGF9;MET;ERBB4;FGFR2;ROR2
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.3460972003322206,0.8411186192184822,0.6553911205073996,0.8685852254057458,1.0,7/15,22.08%,NUP210;CPSF2;NUP107;SRSF3;NUP155;NUP85;NDC1
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.34600447332398776,0.8400039474908344,0.6872246696035242,0.8692388039934033,1.0,6/17,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFB11;NDUFAB1;NDUFB8
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2774856961624632,-0.8399935275468303,0.7324723247232472,1.0,1.0,16/52,19.46%,HSP90AA1;JHY;KIF3A;FNBP1L;RAB23;KIF27;RAB11A;CFAP54;TOGARAM1;PDE6D;ATP6V0D1;WDR35;NPHP1;CFAP43;CNGB1;RAB3IP
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28827277824690567,0.8398075057429075,0.7437641723356009,0.8682244346093025,1.0,7/35,13.88%,RPS27A;RTKN2;TRAF5;PRKD1;STAT3;EDA;CX3CL1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.31527659157847343,-0.8397872410306372,0.6860254083484574,1.0,1.0,7/27,14.58%,RXFP1;ITPR2;GNG2;ADCY8;GNG7;ADCYAP1R1;GLP2R
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.30749071531402966,0.8396994576324488,0.7274725274725274,0.8669973044393062,1.0,9/26,20.06%,SLC22A10;CA5B;MGST1;SLC39A8;SLC25A42;LRRC8A;SLC16A2;SLC22A9;SLC22A24
prerank,MSigDB_Hallmark_2020__Complement,-0.28957727501489994,-0.8396695875180566,0.7247191011235955,1.0,1.0,8/43,11.82%,DGKG;USP16;CDH13;GNG2;F5;DOCK10;HSPA1A;L3MBTL4
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.2627760915430361,0.8371734794016482,0.7674943566591422,0.8707284879791237,1.0,12/54,15.68%,RPS27A;PSMB1;FBXL18;SMURF1;MKRN1;ANAPC1;KBTBD6;UBA3;PSMB2;UBE2Q2;KLHL25;FBXO31
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.3087125346850073,0.8367508569512622,0.6900212314225053,0.8701518162355582,1.0,2/22,2.58%,RPS27A;PSMB1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.32148086572809303,0.8365275598655205,0.717948717948718,0.867834609721506,1.0,2/21,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.32148086572809303,0.8365275598655205,0.717948717948718,0.867834609721506,1.0,2/21,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.3089347260332791,0.8364136689908414,0.7190775681341719,0.8666291327600633,1.0,2/25,4.44%,RPS27A;MAPK3
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.3264938298425849,-0.8362221286652345,0.6877394636015326,1.0,1.0,4/25,7.32%,COL24A1;COL19A1;COL21A1;ADAMTS3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.2887330489585282,0.8344414071764921,0.7644444444444445,0.8691051029064529,1.0,11/36,16.66%,YWHAH;HSPH1;ALDH1A1;DECR1;ADIPOR2;HADHB;XIST;H2AZ1;METAP1;DLST;MDH1
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.29609442022919835,0.8333557064205612,0.7422037422037422,0.8698018280504034,1.0,9/30,20.14%,NEK7;MAPK3;RHOA;TXN;TRAF5;ATG16L1;PLCB4;IFNAR1;TRAF6
prerank,KEGG_2021_Human__Hepatitis B,0.3032432113509174,0.8330107723429523,0.7270742358078602,0.8690722124390632,1.0,9/28,20.14%,MAPK3;ATP6AP1;SMAD3;KRAS;STAT3;BID;NFATC3;IFNAR1;TRAF6
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.3321016333808893,-0.8319229258937184,0.70817843866171,1.0,1.0,4/19,8.66%,FGF9;FGFR2;POLR2K;POLR2A
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.31241772367068804,0.8304159564614496,0.7226890756302521,0.872869960700122,1.0,4/24,4.78%,BCAP31;SPTB;SEC24A;ERGIC2
prerank,KEGG_2021_Human__Serotonergic synapse,-0.3494665026053885,-0.8294177087469066,0.6776061776061776,1.0,1.0,5/16,15.96%,ITPR2;GNG2;GNG7;HTR2C;PRKCG
prerank,KEGG_2021_Human__Cushing syndrome,0.30556962496468676,0.8268882925279954,0.7366167023554604,0.8782944104937203,1.0,5/25,7.60%,CACNA1G;MAPK3;RBBP5;WNT2B;FZD6
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.26837209912664195,0.8265869814069844,0.7671232876712328,0.877484002233498,1.0,15/46,21.56%,TIAM1;GNA13;MAPK3;RHOA;GSN;WASF2;KRAS;MYL12B;VAV3;CRKL;GNA12;LIMK1;ITGA9;ITGAV;MYH14
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3413459506239661,-0.8260777991776117,0.6998158379373849,1.0,1.0,4/16,8.66%,FGF9;FGFR2;POLR2K;POLR2A
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.32629340821758945,0.8249790125222418,0.7139959432048681,0.8790007461272586,1.0,5/18,10.22%,MINK1;SH3RF2;SDCBP;HIPK2;TRAF5
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.28195041092800177,-0.8249742585006768,0.7350746268656716,1.0,1.0,8/42,18.02%,RUNX1;CHRNA7;PTPRM;SEMA3E;TWIST1;GLUL;TGFB2;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.28127430885011173,-0.8244401196754024,0.7460595446584939,1.0,1.0,13/47,18.22%,SEMA3A;CDH13;ROR2;SEMA3E;TGFBR1;MYLK;PODXL;TWIST1;SEMA4B;ACVR1;RACK1;SEMA5A;PDGFD
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.29838740612009207,0.8240578836176831,0.738562091503268,0.8793511301576014,1.0,12/28,24.80%,PSMB1;RAD51C;CEP135;STOX1;PSMB2;KCNH5;CCP110;TUBB4B;DCTN1;FBXL7;PSMA1;PSME4
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.2984510970600021,0.8237105323998809,0.7394957983193278,0.8786529290367495,1.0,6/27,10.88%,DECR1;ACBD5;HADHB;PRKAB2;PPT1;HADHA
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.3007825366576335,-0.8235582250593151,0.7452830188679245,1.0,1.0,13/31,27.28%,MET;ERBB4;FGFR2;ROR2;ROR1;ROS1;EEF1A2;EGFR;RELN;ALK;EPHB1;CCN1;MERTK
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.302801362515612,0.8228166075221026,0.7442827442827443,0.8788709289044954,1.0,9/24,26.62%,PSMB1;MAPK3;PSMB2;VAV3;NFATC3;TRAF6;PSMA1;PSME4;PSMA5
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.3405058158679475,0.8223474889627588,0.7215189873417721,0.8783511823226897,1.0,8/16,22.08%,NUP210;NUP107;NUP155;SLC37A1;MDH1;PFKM;NUP85;NDC1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.3089770005446872,0.8221474529272697,0.713216957605985,0.8773205769364334,1.0,12/21,28.80%,TOB1;CPEB1;GAPDH;EIF3E;CNOT7;CAPRIN1;YTHDF2;IGFBP5;METTL14;FMR1;PAIP2;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.30601613085097124,-0.8202636825509745,0.73992673992674,1.0,1.0,13/28,35.44%,GHR;ERBB4;LRP8;ACVR1;BANK1;RELN;NOX4;RIPK2;IL34;PECAM1;IL6R;TEC;NEDD9
prerank,KEGG_2021_Human__Amphetamine addiction,-0.34711100952645924,-0.8187371540904561,0.7024952015355086,1.0,1.0,5/15,18.56%,CAMK2D;GRIN3A;PRKCG;CALM3;JUN
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3387753696840231,0.8186513434944322,0.7078189300411523,0.8824772474445531,1.0,3/15,13.54%,NRP1;PRKD1;PTN
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.3056933457880511,-0.8181102305973289,0.7304832713754646,1.0,1.0,10/28,23.76%,UQCRQ;CYCS;NDUFB1;COX18;COX7B;TIMMDC1;NDUFB10;SDHB;UQCR10;UQCRC1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.2762174346676085,0.8180030272433597,0.7587719298245614,0.882190076071599,1.0,13/36,19.82%,PPARGC1A;FOXO1;MAPK3;PARK7;GSR;PRKD1;CAT;TXNRD1;VRK2;GPX3;ADNP2;NFE2L2;ETV5
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.3038656026778048,0.8170436928634532,0.7441860465116279,0.8826514946414266,1.0,9/23,26.62%,PSMB1;MAPK3;PSMB2;VAV3;NFATC3;TRAF6;PSMA1;PSME4;PSMA5
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.33984753018196145,0.8165651693320382,0.7167019027484144,0.8821233663592803,1.0,7/15,16.86%,ABCD2;SDCBP;ABCD3;ACBD5;FIS1;TRAM1;ZDHHC15
prerank,KEGG_2021_Human__Salmonella infection,-0.27291666196156245,-0.8162257130857524,0.7723880597014925,1.0,1.0,8/46,10.88%,HSP90AA1;PIK3C2G;ARPC5L;TUBB2A;BRK1;ARHGEF26;CYCS;PODXL
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.29283646985668993,0.815924955752742,0.7389473684210527,0.8818772114920249,1.0,2/28,2.70%,HDAC9;ST8SIA4
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.33743761933578453,-0.8152684707345464,0.6863117870722434,1.0,1.0,4/18,16.26%,CYLD;PARP1;PRKCQ;CFLAR
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.3314616082749161,0.8138251297651398,0.709051724137931,0.884339525651942,1.0,8/16,22.08%,NUP107;RAN;TMPO;NUP155;VRK2;TUBB4B;NUP85;NDC1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.27715979983119776,0.8136492425869435,0.7871396895787139,0.8833411601881908,1.0,4/37,5.68%,HDAC9;NFIB;ALDH1A1;LDLRAD4
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.2759126222132218,0.8134448610725504,0.7775280898876404,0.8823653707476423,1.0,10/34,17.08%,TIAM1;ARHGAP24;TBC1D2B;NDEL1;CCDC125;TBC1D9B;ADRB1;CX3CL1;CXCL13;TBC1D4
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.3087946981417779,0.8132542371955197,0.7388535031847133,0.8813796593707051,1.0,6/20,20.34%,ANXA1;FOXO1;HSP90B1;STAT3;OPRD1;NDN
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.28701573324122787,0.8125461313077177,0.7642105263157895,0.8812465343872187,1.0,9/32,21.06%,RPS27A;MAPK3;PPP3CC;KRAS;STAT3;BID;NFATC3;IFNAR1;PREX1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.35096957562819703,-0.812453299835434,0.7153558052434457,1.0,1.0,3/15,7.12%,RYR1;MET;DHCR24
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.2374086472285185,-0.8112381680365962,0.8807495741056218,1.0,1.0,17/119,12.56%,CAMK2D;IL2RA;BCL11B;HSP90AA1;GHR;GSTO1;KCNH8;NUP93;PSMA4;EGR1;NKIRAS1;SNRPA1;HNRNPA2B1;HAVCR2;OPRM1;NUP42;TWIST1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.28685212483556066,-0.8103756547700384,0.7695167286245354,1.0,1.0,11/38,25.02%,SKAP2;CAP1;CDH4;LAMA3;CDH6;TRO;EGFR;ARHGEF6;MAP3K20;CTNNA1;CDH11
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.28632540586919003,-0.8086093616305889,0.7571428571428571,1.0,1.0,9/36,18.22%,CHRNA7;ERBB4;FGFR2;ROR2;OPRM1;ABCA7;HTR2C;ROR1;PDGFD
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.3326767095888692,0.8084523666838479,0.7247706422018348,0.8874000343956752,1.0,9/17,23.92%,PRKD1;HEXB;SPNS2;NEU3;GALC;SPTLC3;SPTSSB;ORMDL1;ACER2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.3379129494980563,-0.8078779692988527,0.7121212121212122,1.0,1.0,3/17,4.60%,ARHGAP29;CDH13;PLEKHG5
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.283347880355015,0.807547470140214,0.7610062893081762,0.8877072433908492,1.0,4/31,11.12%,RPS27A;MAPK3;LGMN;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3026750436424155,-0.8057609978209914,0.7631578947368421,1.0,1.0,4/30,7.40%,FGF9;FGFR2;CDH13;TGFBR1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.32772518466107103,-0.805087548893665,0.7218045112781954,1.0,1.0,4/18,9.94%,PHF8;RAB11A;CHMP4B;SMC1A
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2861637027672518,0.8035261414421366,0.7758241758241758,0.8933681660696785,1.0,5/27,11.30%,ID2;SIRT1;FZD6;TCEAL7;PRMT2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3302356818002994,0.8029885593772519,0.7431578947368421,0.8929452206628544,1.0,5/16,17.30%,TPST2;AK3;RAN;AK4;AMPD3
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.23377608132282604,0.8021527624735738,0.8899521531100478,0.8930006969232681,1.0,13/79,15.84%,THSD4;COL14A1;PLOD2;COL23A1;COL5A1;GSN;ADAMTS2;KLKB1;LAMA4;JAM2;COL4A2;SLC39A8;ADAMTS17
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.32694404802191807,0.8020169461154082,0.7648401826484018,0.8918575649458849,1.0,4/16,9.64%,RHOA;SIRT1;CCNG2;KSR1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.3075787367409826,0.800638740334049,0.7478070175438597,0.8927485331046628,1.0,6/21,20.58%,ANO6;SLC26A8;ANO2;LRRC8A;SLC6A1;SLC12A2
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.29015322101857,-0.8002508892591205,0.751412429378531,1.0,1.0,5/33,9.04%,EIF2S1;HSP90AA1;MAN1A1;EIF2AK3;HSPA1A
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.3343522776496554,-0.7990739550331206,0.7393715341959335,1.0,1.0,3/15,6.44%,ARPC5L;MET;ARHGEF26
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.3432567178070425,-0.7970035649760567,0.7206703910614525,1.0,1.0,5/15,16.90%,GSDME;TGFBR1;CYLD;TPD52L1;RACK1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.33708717202600424,-0.7967406784316357,0.74,1.0,1.0,3/17,5.42%,HSP90AA1;CCT3;CCT2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3368152100734318,-0.7953613351643727,0.7611650485436893,1.0,1.0,2/15,2.36%,BMPR1B;PCSK6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.3255313542674525,-0.7952487870559046,0.7216890595009597,1.0,1.0,2/16,4.36%,ERBB4;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.2927177505438987,0.7952307778183193,0.7817796610169492,0.8992812510688611,1.0,5/24,10.94%,BTG1;SIRT1;HIPK2;HIPK1;PRKD1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.2927177505438987,0.7952307778183193,0.7817796610169492,0.8992812510688611,1.0,5/24,10.94%,BTG1;SIRT1;HIPK2;HIPK1;PRKD1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.2648279615564747,0.7944916858099422,0.8310502283105022,0.8991949775135374,1.0,13/40,23.92%,ATP6V0E1;FOXO1;PRKAB2;GAPDH;PRKD1;STAT3;VPS26A;VPS29;RRAGA;HSPB1;RRAGB;PLK2;ACER2
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2769959192516295,0.7943286507812554,0.7724425887265136,0.8981104732784428,1.0,4/32,10.44%,PSRC1;RHOA;SIRT1;DIRAS1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3043022157181866,-0.7932657072337417,0.7610619469026548,1.0,1.0,5/23,14.58%,RXFP1;GNG2;ADCY8;ADCYAP1R1;GLP2R
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.25671346917706245,-0.7919705344582241,0.8250460405156538,1.0,1.0,10/58,8.98%,ARPC5L;SKAP2;ELOVL5;POLR3G;PSMA4;SLC2A3;HSPD1;STARD4;DHCR24;SLC6A6
prerank,MSigDB_Hallmark_2020__Myogenesis,0.26062298497526243,0.7906475821241418,0.8243559718969555,0.9030978928032428,1.0,12/40,20.52%,KCNH1;SGCD;SGCG;ATP6AP1;GSN;KIFC3;COL4A2;GPX3;PFKM;MYOM1;HSPB8;COX7A1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.2448307506326003,0.7903433574840381,0.8648648648648649,0.9022474605023807,1.0,8/51,11.18%,TRHDE;SENP1;LGMN;BACE2;SPCS3;FAP;UBA3;KLKB1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3021918260700348,0.7903028433446861,0.7645788336933045,0.900920579626126,1.0,9/20,22.76%,RAB5A;LAMP2;PPT1;STAM;AP2S1;COG2;GALC;ABCA1;OCRL
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.31596520659679245,0.7897895563542059,0.7407407407407407,0.9003963080312575,1.0,5/18,10.08%,NUP210;CPSF2;NUP107;RAN;SRSF3
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.32662317437962024,0.7888648449937878,0.7532467532467533,0.9005868421000401,1.0,4/15,14.88%,H2AZ2;H3-3B;H2AZ1;H2BC5
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.23296201588419665,-0.7875422487087039,0.8916518650088809,1.0,1.0,25/115,16.66%,DLC1;ANK1;HSP90AA1;MAN1A1;TFG;SYT2;KIF3A;FNBP1L;SYT12;KIF26B;F5;KIF27;STXBP3;RAB11A;CHMP4B;KIF21B;GOLIM4;RIN2;HIP1;ITSN1;GNS;TPD52L1;ARFGAP3;COPB1;SNX2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.2813591202714103,0.7865888517288071,0.8146551724137931,0.9030308528709822,1.0,12/28,26.62%,RPS27A;PSMB1;PAIP1;PSMB2;ANP32A;YTHDF2;HSPB1;PSMA1;PSME4;METTL14;FMR1;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.328053172962364,-0.7856482581584586,0.7637362637362637,1.0,1.0,3/16,14.34%,BMPR1B;WWTR1;ACVR1
prerank,KEGG_2021_Human__Ras signaling pathway,0.25051177506106315,0.7839070771821892,0.8755555555555555,0.9061135187618429,1.0,8/51,11.56%,TIAM1;RAB5A;MAPK3;RHOA;RASGRF2;KITLG;KSR1;KRAS
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.24831992474486786,0.7837632275837202,0.8633405639913232,0.9049604569351206,1.0,21/57,20.50%,YWHAH;ATP6V0E1;RAB5A;HIKESHI;ATP6AP1;LAMP2;PPT1;TBC1D2B;ARL4A;HSP90B1;TBC1D9B;RAB11B;TBC1D4;VPS26A;SAR1B;RAMP1;SNX31;DNAJC27;RAB5B;VPS29;ABCA1
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.2242824403646258,0.7833449333565065,0.9162790697674419,0.9042374751971683,1.0,21/104,18.60%,CUX1;RPS27A;YWHAH;RAB5A;SPTB;SEC24A;FTH1;PRKAB2;MYO1E;AP1S2;STAM;SURF4;AP2S1;COG2;RIN3;ACBD3;TBC1D4;SAR1B;LDLR;RINT1;RAB5B
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.2938606220500103,-0.7830468713756757,0.7693726937269373,1.0,1.0,4/29,7.32%,COL24A1;COL19A1;COL21A1;ADAMTS3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.2884856313513463,-0.7828429649387145,0.7743119266055046,1.0,1.0,6/29,15.76%,RXFP1;GNG2;ADCY8;ADCYAP1R1;GLP2R;AOAH
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.23803626066342748,0.7812003071508246,0.8928571428571429,0.906404463339911,1.0,10/65,15.84%,THSD4;COL14A1;COL23A1;COL5A1;ADAMTS2;LAMA4;JAM2;COL4A2;SLC39A8;ADAMTS17
prerank,KEGG_2021_Human__Breast cancer,0.2887303622361588,0.7801959265101603,0.7991169977924945,0.9067552239672421,1.0,6/24,16.44%,MAPK3;WNT2B;FZD6;KRAS;NOTCH2;WNT3
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.2755758975071141,-0.7801036632330031,0.8121546961325967,1.0,1.0,15/33,30.42%,CAMK2D;ADCY8;SCN7A;TPM1;ATP1A1;CALM3;SCN4B;CACNG5;KCNQ1;TNNT2;ATP1A2;KCNE1;SLC8A3;CREB5;PPP2CB
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.33261883263188113,-0.7783766874529269,0.7803468208092486,1.0,1.0,3/16,5.36%,SEMA3A;ERBB4;SEMA3E
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.3034469040569098,-0.7776778444315966,0.7959927140255009,1.0,1.0,9/22,24.82%,DGKG;PIP5K1B;DGKK;PRKCG;PDGFD;JUN;EGFR;WASF3;DGKH
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.27253390443173514,-0.7734496793849358,0.8161764705882353,1.0,1.0,9/37,14.58%,RXFP1;ITPR2;BRK1;GNG2;ADCY8;NCK1;GNG7;ADCYAP1R1;GLP2R
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.31230712165242214,-0.7718936486674556,0.7605363984674329,1.0,1.0,6/20,20.68%,MITF;TGFBR1;CYLD;TGFB2;JUN;FOSL2
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.2832813706026881,-0.7714691801520357,0.8173258003766478,1.0,1.0,5/31,8.14%,BCL11B;PCSK6;KCNH8;EGR1;PCSK5
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.3189381642503961,-0.7708428901108507,0.7607142857142857,1.0,1.0,3/18,18.58%,LAMA2;TGFB2;ITGA7
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.237368575445351,-0.7702989354428275,0.9138240574506283,1.0,1.0,19/76,19.92%,HSP90AA1;CAP1;CD63;CCT2;SLC2A3;HSPA1A;STXBP3;CPPED1;MOSPD2;PGM1;SLCO4C1;GNS;PYGB;RAB37;COPB1;TSPAN14;YPEL5;SNAP25;RAB18
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.237368575445351,-0.7702989354428275,0.9138240574506283,1.0,1.0,19/76,19.92%,HSP90AA1;CAP1;CD63;CCT2;SLC2A3;HSPA1A;STXBP3;CPPED1;MOSPD2;PGM1;SLCO4C1;GNS;PYGB;RAB37;COPB1;TSPAN14;YPEL5;SNAP25;RAB18
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.23835327459745173,-0.7654877136034918,0.8787346221441125,1.0,1.0,25/72,24.66%,RYR3;SLC9A9;ASIC2;KCNH8;TRPC6;KCNN3;SLC6A6;SCN1A;KCNK1;TRPC7;SCN7A;TRPC5;ATP1A1;ATP2C2;ATP6V0D1;KCNG2;KCNAB3;SCN4B;SLC9C1;KCNN1;KCNK13;SLC24A3;KCNQ1;SLC39A11;TMCO1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.2352309037550348,-0.7642846610403095,0.926391382405745,1.0,1.0,19/77,19.92%,HSP90AA1;CAP1;CD63;CCT2;SLC2A3;HSPA1A;STXBP3;CPPED1;MOSPD2;PGM1;SLCO4C1;GNS;PYGB;RAB37;COPB1;TSPAN14;YPEL5;SNAP25;RAB18
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.2827732043231526,0.7637537477506953,0.8305439330543933,0.9307875475678085,1.0,4/23,10.94%,NRP1;LGMN;SIRT1;PRKD1
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.2853132881782401,0.7626252507733321,0.84375,0.9310550252409387,1.0,6/27,14.22%,ZFPM2;RAB5A;RAD51C;AK3;H3-3B;SIN3A
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.293856019493458,-0.7611338361834762,0.7882797731568998,1.0,1.0,5/24,9.72%,RXFP1;GNG2;ADCY8;TGFBR1;GNG7
prerank,KEGG_2021_Human__Insulin secretion,-0.3081125055553835,-0.7608239372472944,0.7927063339731286,1.0,1.0,8/18,21.32%,CAMK2D;KCNN3;ADCY8;ADCYAP1R1;ATP1A1;PRKCG;SNAP25;KCNN1
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.27520055690602796,0.7603820712375629,0.8293736501079914,0.9330382091469168,1.0,9/27,20.80%,ID2;MAPK3;RHOA;NAB1;STAT3;AP2S1;CRKL;RIT2;DUSP3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.31414608263628874,0.7598050715530953,0.8294736842105264,0.9325243478415097,1.0,3/15,13.72%,PSMB1;SIRT1;PSMB2
prerank,KEGG_2021_Human__Gastric cancer,0.27721352386790743,0.759483786765981,0.8208616780045351,0.9316126249433793,1.0,6/25,11.56%,RARB;MAPK3;WNT2B;FZD6;SMAD3;KRAS
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.282815921832312,-0.7593806043513948,0.8249097472924187,1.0,1.0,5/32,13.10%,HSP90AA1;LRP8;HIP1;LGALS1;HS1BP3
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.30923183877817145,-0.7584343478691901,0.8176470588235294,1.0,1.0,3/18,6.70%,ITPR2;GHR;ADCY8
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.28937840144456506,-0.7574644166842545,0.8416370106761566,1.0,1.0,5/24,14.58%,RXFP1;GNG2;ADCY8;ADCYAP1R1;GLP2R
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.22614513268615263,-0.7563605370530375,0.9170896785109983,1.0,1.0,12/99,12.56%,CAMK2D;IL2RA;HSP90AA1;GHR;GSTO1;PSMA4;EGR1;SNRPA1;HNRNPA2B1;LRP8;OPRM1;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2758094853721039,-0.7551405124740103,0.8285714285714286,1.0,1.0,8/31,14.20%,TLE3;PSMA4;CYLD;SHISA6;BICC1;SFRP4;WWTR1;ANKRD6
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.2384850537303397,0.7547647055125932,0.8943820224719101,0.9371153924128014,1.0,16/51,22.94%,MTCH2;TOB1;DECR1;GBE1;ADIPOR2;CCNG2;ARL4A;CAT;LAMA4;GPX3;HSPB8;REEP5;ABCA1;NDUFAB1;ATP5PO;QDPR
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3160541344511009,0.7545265374828747,0.8172268907563025,0.936053066776888,1.0,2/15,5.94%,FOXO1;SMURF1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.2604342677294695,-0.7540166717292942,0.8524904214559387,1.0,1.0,7/43,17.40%,IL2RA;ADORA1;ADCY8;IL17D;HRH1;REL;ABCF1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.2796757494522735,0.753535391886001,0.8533916849015317,0.9361063927869572,1.0,6/25,12.40%,TMEM33;BCAP31;RASGRF2;HSP90B1;UFM1;SELENOK
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.26751859496684843,0.7534317943365533,0.875,0.9348409392803019,1.0,10/28,19.50%,MAPK3;WNT2B;FZD6;SMAD3;KRAS;MGST1;TXNRD1;WNT3;MGST2;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3033653790965418,0.7534062701707771,0.8240343347639485,0.9334826875475769,1.0,7/17,24.12%,RHOA;GIPC1;CDC14B;CEP120;RGCC;BTC;NSFL1C
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.30415110467277745,-0.7527084646070454,0.7996389891696751,1.0,1.0,3/20,8.14%,PCSK6;ADAMTS3;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.28492674405026247,0.7508062310782022,0.8379629629629629,0.9358264999052356,1.0,4/20,13.96%,EDNRB;TOB1;GAPDH;CNOT7
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.22007954025734616,-0.7491193801328109,0.9594155844155844,1.0,1.0,18/119,14.58%,PARD3;BMPR1B;TENM4;CHRNA7;FGF9;ERBB4;FGFR2;MTPN;TGFBR1;HMGN5;SLC6A6;TPM1;AR;ABCA7;RNF187;WWTR1;GRK5;GLP2R
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.25076149684562377,0.7489333241016544,0.8847058823529412,0.9370513183472226,1.0,7/37,13.72%,TLE4;PSMB1;FZD6;HMGXB4;CCDC88C;NXN;PSMB2
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.29433366413977724,0.7483705033663761,0.8271604938271605,0.9363788468073823,1.0,8/19,22.08%,PMEPA1;NUP210;NUP107;NUP155;RNF2;XRCC4;NUP85;NDC1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.2865930146234178,-0.7473663091876127,0.8348294434470377,1.0,1.0,6/24,20.22%,GSTO1;PAPSS2;UGDH;CHST1;CHST11;GCLC
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.29525838211745953,0.7463778158706204,0.8247863247863247,0.9378299972314583,1.0,4/18,17.58%,ANXA1;PARK7;APPL1;AREL1
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.3036509901426397,0.7459640086319805,0.8119469026548672,0.9370176657040051,1.0,5/17,21.54%,COL23A1;JAM2;COL4A2;ITGA9;ITGAV
prerank,KEGG_2021_Human__TNF signaling pathway,0.29227132841725656,0.7457439483074179,0.8389121338912134,0.9359226739178161,1.0,4/20,18.62%,MAPK3;TRAF5;CX3CL1;IL15
prerank,KEGG_2021_Human__Influenza A,-0.30154775789217947,-0.7456262967396625,0.8003875968992248,1.0,1.0,3/20,10.26%,EIF2S1;RAB11A;CYCS
prerank,KEGG_2021_Human__Alzheimer disease,0.21478407130652322,0.7446826778334507,0.9477272727272728,0.9358921336539632,1.0,21/89,17.06%,PSMB1;MAPK3;PPP3CC;NDUFB2;WNT2B;FZD6;PPID;ATP5F1E;KLC2;BACE2;GAPDH;NDUFC1;KRAS;NDUFC2;NDUFA4;PSMB2;ATP5PF;BID;NDUFB11;WNT3;PLCB4
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.2889549735529525,-0.74295545245211,0.8312159709618875,1.0,1.0,5/24,10.92%,ASIC2;SLC6A6;SCN1A;KCNK1;SCN7A
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.31634098192993476,-0.7428268501831198,0.8351648351648352,1.0,1.0,5/15,18.28%,TRPC6;TRPC7;TRPC5;ATP2C2;MELTF
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.22338937261063363,0.7420211775044907,0.9527186761229315,0.9381515952447905,1.0,10/67,15.84%,THSD4;COL14A1;COL23A1;COL5A1;ADAMTS2;LAMA4;JAM2;COL4A2;SLC39A8;ADAMTS17
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2867983253888563,0.7418983532919396,0.840958605664488,0.9369360905272586,1.0,6/19,17.04%,CREBL2;PARK7;TXN;PRKD1;STOX1;OPRD1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.29076132716571074,-0.7393060765743484,0.8198874296435272,1.0,1.0,9/21,21.62%,HSP90AA1;NCK1;TENM1;NOS1;CNOT9;BCAR3;RACK1;EGFR;TBK1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.27306579520499963,0.7388445140419387,0.8577680525164114,0.9396064411373637,1.0,3/23,9.50%,NMRK1;TPK1;MTHFD2L
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30396964985019004,0.7387988670361554,0.8306122448979592,0.938305445752717,1.0,5/16,14.48%,NRP1;RHOA;WASF2;PRKD1;VAV3
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.2931250831087623,-0.7375873257296989,0.8389513108614233,1.0,1.0,4/20,10.56%,EIF2S1;PTPRK;PARP1;CUL4B
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.2699107630151903,0.7366868658224751,0.8466522678185745,0.9396804107200483,1.0,5/26,11.56%,FKBP5;KRT10;MAPK3;HSP90B1;KRAS
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.3119828304697569,-0.7339072728417917,0.84,1.0,1.0,6/16,24.72%,PTPRK;GPX1;TPM1;JUN;EGFR;STK24
prerank,KEGG_2021_Human__Thermogenesis,0.2336359969782766,0.7338222481351192,0.9103139013452914,0.9418877474270323,1.0,19/55,23.18%,PPARGC1A;ATP5MG;ADCY10;NDUFB2;PRKAB2;ATP5F1E;NDUFC1;KRAS;KDM3A;NDUFC2;NDUFA4;ATP5PF;NDUFB11;COX7A1;NDUFAB1;COX10;ATP5PO;NDUFB8;ATP5F1C
prerank,MSigDB_Hallmark_2020__Glycolysis,0.24078481467091653,0.7327115262069989,0.910828025477707,0.9419172939519032,1.0,10/42,16.92%,PHKA2;PLOD2;ALDH7A1;AK3;COL5A1;FAM162A;TXN;COG2;MDH1;AK4
prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.302212764384867,-0.7314220874180094,0.8125,1.0,1.0,8/16,30.70%,SLC1A2;SLC17A6;ATP6V0D1;SNAP25;STX3;CLTA;CLTCL1;UNC13C
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.2882844677178348,0.7307314692340751,0.8287671232876712,0.943150445022165,1.0,5/18,18.32%,CEPT1;CHKA;GNPAT;LPIN2;LYPLA1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.297873728162817,-0.7304960034494425,0.8276515151515151,1.0,1.0,4/21,10.36%,SPTLC1;ELOVL5;ARV1;ELOVL2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.2810604422155403,-0.7297209633584718,0.85,1.0,1.0,10/25,24.66%,RYR3;TRPC6;MCU;TRPC7;TRPC5;ATP2C2;MAIP1;MCUB;SLC24A3;TMCO1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.29663498458856336,-0.7297155165915256,0.8540925266903915,1.0,1.0,6/20,19.44%,HSP90AA1;LIN28B;TWIST1;MTLN;TRIM5;GPLD1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.29527769791827135,-0.7284434761970273,0.850909090909091,1.0,1.0,7/19,23.52%,PLXNA4;CDH13;PODXL;TPM1;SEMA5A;PLXNA1;STX3
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,-0.2949989465748757,-0.7277587898656902,0.857976653696498,1.0,1.0,4/20,5.36%,HSP90AA1;PLXNA4;SEMA3A;SEMA3E
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.28666686457621116,-0.7269813671228759,0.861328125,1.0,1.0,7/21,14.30%,PIK3C2G;PLCH1;MINPP1;IPMK;PIP5K1B;MTMR8;PIK3C2B
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.25145006245436025,-0.7268629877434322,0.9047619047619048,1.0,1.0,17/42,28.82%,TFG;PLEKHG5;DDX21;GPR89A;ESR1;LGALS1;ROR1;CFLAR;REL;TRIM5;TNFRSF19;TBK1;TNFRSF10B;TFRC;SQSTM1;RIPK2;ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2737864663935136,-0.725254873792531,0.8438661710037175,1.0,1.0,8/28,17.26%,HSP90AA1;BRK1;PARP1;ESR1;CUL4B;HRK;RACK1;MTLN
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.2711610412179649,0.7211070513456365,0.888646288209607,0.953213064893781,1.0,7/23,22.78%,NRP1;RHOA;LPXN;NTNG1;ITGAV;YTHDF2;NTN4
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.2918394318455679,-0.720220339853284,0.8301526717557252,1.0,1.0,7/19,24.58%,CAMK2D;PDHA1;PRKCG;ELOB;LDHA;EGFR;TFRC
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.22054526861994372,-0.7201881582274524,0.9448275862068966,1.0,1.0,23/84,21.98%,HSP90AA1;CHRNA7;FGF9;GHR;ERBB4;TGFBR1;LRP8;TENM1;ACVR1;RBPMS;NOS1;CNOT9;BCAR3;RACK1;TGFB2;CALM3;BANK1;PDGFD;FGF5;WNK3;EGFR;TBK1;RELN
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.2906887702219386,0.7197622667845701,0.8859060402684564,0.9533583852523154,1.0,4/17,15.78%,POLR2B;GTF2H3;FANCI;POLR2I
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.27573646803956575,0.7192820800897015,0.8849372384937239,0.9525589032375441,1.0,7/21,21.06%,MCF2;PGRMC2;TMPO;VAV3;VRK2;ARHGDIG;PREX1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2672538755007185,0.717082386152954,0.8476394849785408,0.9536317879346743,1.0,4/23,13.72%,PSMB1;TRAF5;EDA;PSMB2
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3100450089140244,-0.7168552586716206,0.856140350877193,1.0,1.0,9/15,26.00%,POLR2K;POLR2A;CCNK;ELP4;CCNH;ELOB;SSRP1;EAF2;TCEA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.2753514712394556,-0.7167107847398154,0.8455882352941176,1.0,1.0,8/23,23.52%,DPP10;STAC;PRKCH;CHP1;PLS1;WNK3;EGFR;STX3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2905675361437799,0.7164698827582296,0.8429752066115702,0.9515309103722931,1.0,6/15,26.62%,PSMB1;PSMB2;ITGAV;PSMA1;PSME4;PSMA5
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2905675361437799,0.7164698827582296,0.8429752066115702,0.9515309103722931,1.0,6/15,26.62%,PSMB1;PSMB2;ITGAV;PSMA1;PSME4;PSMA5
prerank,MSigDB_Hallmark_2020__Apoptosis,0.23821953569124754,0.716246713798559,0.9291666666666667,0.9504163539098184,1.0,5/36,9.32%,ANXA1;BCAP31;GSN;PPT1;GSR
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.24345401572879438,0.7162372114551633,0.9149888143176734,0.9490626333634374,1.0,16/38,27.68%,ATP5MG;NDUFB2;ATP5F1E;NDUFC1;NDUFC2;ATP5PF;NDUFB11;NDUFAB1;ATP5PO;NDUFB8;ATP5F1C;COX5A;ATP5MC2;ATP5MC3;ATP5MF;UQCR11
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.2750401639110939,-0.7145804316154897,0.8565965583173997,1.0,1.0,10/23,30.98%,PTPRM;CDH13;TGFBR1;NRP2;SEMA5A;SULF1;SCG2;CAV1;VEGFD;PROX1
prerank,KEGG_2021_Human__p53 signaling pathway,-0.300547088152759,-0.71356420211406,0.8407407407407408,1.0,1.0,3/16,10.26%,ZMAT3;RCHY1;CYCS
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2795800466893041,0.7113752033752915,0.8839285714285714,0.9527869901658979,1.0,6/18,17.24%,SH3RF2;PARK7;SDCBP;GIPC1;GNA12;NUB1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.2957845191760328,-0.7104985832395626,0.8515901060070671,1.0,1.0,1/16,1.14%,COL24A1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.271839939847394,-0.7097218617422912,0.8874538745387454,1.0,1.0,10/25,23.04%,EIF2S1;TUBB2A;EIF2AK3;SDAD1;SPCS1;DNAJA4;ATP6V0D1;ALDH18A1;XPOT;HERPUD1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.2810019142220087,-0.7096064957639914,0.8703703703703703,1.0,1.0,5/19,13.20%,RAB11A;CHMP4B;SMC1A;SMC3;TOGARAM1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.2941323850556168,-0.7083989325376924,0.8736462093862816,1.0,1.0,2/17,6.12%,GSTO1;SLC2A3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.28032498923900867,0.7047409313162318,0.8891170431211499,0.9584102442280439,1.0,7/18,26.62%,PSMB1;ANAPC1;PSMB2;PSMA1;UBE2D1;PSME4;PSMA5
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.23579564857254168,-0.7035506109688174,0.9430604982206405,1.0,1.0,12/48,18.94%,CHRNA7;ERBB4;FGFR2;ROR2;OPRM1;ABCA7;HTR2C;SPRY3;ROR1;ROS1;PDGFD;TGFBR3
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.2310516995453623,0.703212509698774,0.9314420803782506,0.9586550887422015,1.0,5/41,8.68%,KCNH1;KCNH4;ANO6;KCNN2;TRPM3
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.2597986898106826,0.7023677735173535,0.9059080962800875,0.9581881655070343,1.0,6/23,13.40%,CRY1;SH3RF2;PARK7;HDAC3;NXN;FANCI
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.2982839076492379,-0.6987079822635655,0.8914185639229422,1.0,1.0,9/16,26.00%,POLR2K;POLR2A;CCNK;ELP4;CCNH;ELOB;SSRP1;EAF2;TCEA1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,-0.268565020913102,-0.6959352656684631,0.888045540796964,1.0,1.0,10/24,23.54%,KCNH8;KCNN3;GNG2;GNG7;KCNK1;KCNG2;KCNAB3;KCNN1;KCNK13;KCNQ1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.29621875184139135,-0.6958854999105183,0.8675623800383877,1.0,1.0,3/16,13.98%,ARV1;DHCR24;HMGCR
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.2780649995363338,0.6957699853804549,0.8840262582056893,0.9632137081991115,1.0,5/18,17.66%,MAPK3;PPP3CC;MAML3;NOTCH2;NFATC3
prerank,KEGG_2021_Human__Peroxisome,0.27261244598869616,0.6952964264413578,0.8802660753880266,0.9623181806628972,1.0,4/19,11.36%,ABCD2;PEX1;ABCD3;CAT
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.2853869832884317,-0.6947432326275657,0.8786764705882353,1.0,1.0,5/17,17.50%,RCHY1;HSPA1A;ELOB;RACK1;TRIB2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.25014077771498,-0.6947313094252857,0.8985507246376812,1.0,1.0,3/35,6.38%,PID1;PSMA4;GSDME
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.28484312470338136,0.694683103122999,0.8842794759825328,0.9616199036801218,1.0,6/16,21.66%,RBBP8;TFDP1;PCGF6;CCP110;RNF2;RBBP4
prerank,KEGG_2021_Human__Yersinia infection,0.263609873125051,0.6945645598593371,0.9045643153526971,0.9603697476406946,1.0,8/22,20.14%,MAPK3;RHOA;WASF2;VAV3;CRKL;LIMK1;NFATC3;TRAF6
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.23468343309479722,-0.6926385439131161,0.9537892791127541,1.0,1.0,12/47,21.46%,FGFR2;ROR2;GSDME;ABCA7;SPRY3;ROR1;GRM4;BCAR3;ROS1;TGFBR3;TRIM5;EGFR
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.2981576425541097,-0.6924562876714537,0.8717472118959108,1.0,1.0,3/15,15.70%,HSP90AA1;CCNH;TPD52L1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.27436719362330825,0.6917107170381528,0.9019189765458422,0.9617119712446068,1.0,3/18,10.94%,NRP1;SIRT1;PRKD1
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.24832669616881373,0.690790775197658,0.925601750547046,0.9612446878640358,1.0,7/29,17.06%,GNA13;MAPK3;RHOA;KITLG;KRAS;GNA12;PLCB4
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.19925777927274896,-0.6886546844435735,0.9900332225913622,1.0,1.0,18/111,17.06%,PRKG1;TRIM36;ITPR2;RCHY1;KIF3A;PSMA4;SH3RF1;NCK1;UBE3B;TRIM4;FBXW8;DCAF1;PRKCQ;RLIM;ELOB;REL;KLHL13;FBXO7
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.2693362933954982,-0.6860815188704473,0.879182156133829,1.0,1.0,11/22,30.08%,UQCRQ;TPM1;ATP1A1;COX7B;UQCR10;CACNG5;UQCRC1;TNNT2;COX7A2;ATP1A2;SLC8A3
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.23799861978701847,0.6859344689896549,0.9379014989293362,0.9643400940671586,1.0,4/32,7.56%,KCNH1;KCNH4;SLC24A4;KCNN2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2857824961675487,0.6856712212482776,0.8854625550660793,0.9632200886515632,1.0,4/15,15.86%,BCAP31;RTKN2;FIS1;BID
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.21079404274576513,-0.6854879493842317,0.9792027729636048,1.0,1.0,11/83,12.56%,IL2RA;HSP90AA1;GSTO1;KCNH8;PSMA4;NKIRAS1;SNRPA1;HNRNPA2B1;HAVCR2;OPRM1;TWIST1
prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.25618618772124446,0.685320055537939,0.9063829787234042,0.9621324827735787,1.0,7/24,21.58%,TRAF5;STAT3;SIN3A;BID;IFNAR1;TRAF6;HDAC2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.2877936709892059,-0.6851621234429027,0.8861480075901328,1.0,1.0,10/17,39.08%,HOMER1;CALM3;TNNT2;CAV1;PPP2CB;MT3;TTN;CALM2;SLC11A2;NDRG1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.25907650014140976,0.6832650696577914,0.91875,0.9626020287623239,1.0,5/21,18.62%,NFKBIZ;PTN;CX3CL1;MGST2;IL15
prerank,KEGG_2021_Human__Small cell lung cancer,0.2759831613398204,0.6819808309572811,0.9092827004219409,0.9622748495878285,1.0,5/17,14.18%,RARB;TRAF5;LAMA4;CKS2;COL4A2
prerank,KEGG_2021_Human__MAPK signaling pathway,0.20919955744659036,0.681545079828224,0.9705215419501134,0.9613154780993244,1.0,6/63,6.04%,CACNA1G;CACNB4;MAPKAPK5;MAPK3;PPP3CC;RASGRF2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.26781385944676517,-0.6799200708391543,0.8895238095238095,1.0,1.0,5/21,16.20%,FOXRED1;NDUFB1;COX18;TIMMDC1;NDUFB10
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.23433156549305942,0.6791021403411518,0.9326315789473684,0.9619820099740375,1.0,6/31,13.48%,NRP1;MAPK3;SPTB;SDCBP;SCN1B;AP2S1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.28143395560834533,0.6784260406938,0.8842794759825328,0.9611690336296521,1.0,7/15,27.78%,PSMB1;PSMB2;FBXL7;PSMA1;PSME4;PSMA5;AVEN
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2322910209077042,-0.6779013758226159,0.937037037037037,1.0,1.0,13/41,19.46%,KIF3A;FNBP1L;MNS1;RAB23;KIF27;RAB11A;CFAP54;PDE6D;ATP6V0D1;WDR35;CFAP43;CNGB1;RAB3IP
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.24605238132438909,0.6766995710807007,0.9170305676855895,0.9612653364872951,1.0,2/25,3.22%,NRP1;EPHA7
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.2682523308819901,-0.6760914302326178,0.9080675422138836,1.0,1.0,10/21,33.14%,HSP90AA1;NCK1;TBK1;GATAD2A;ATP1A2;ITGA4;RBBP7;CYSLTR1;IL6R;ITGB1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.24205567393249688,-0.6749539483733229,0.9275092936802974,1.0,1.0,13/36,23.54%,SLC9A9;KCNH8;KCNN3;KCNK1;KCNT2;ATP1A1;KCNG2;KCNAB3;SLC9C1;KCNN1;KCNK13;SLC24A3;KCNQ1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.27436930762870154,0.6731698385156479,0.913232104121475,0.9613433545734968,1.0,6/18,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFB11;NDUFAB1;NDUFB8
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.27436930762870154,0.6731698385156479,0.913232104121475,0.9613433545734968,1.0,6/18,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFB11;NDUFAB1;NDUFB8
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.2889793147713997,-0.6730806202222026,0.8856088560885609,1.0,1.0,6/15,30.08%,SLC9A9;ATP1A1;SLC9C1;ATP1A2;TRPM4;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2828711862320171,-0.6721899826815492,0.8996212121212122,1.0,1.0,1/15,1.44%,BMPR1B
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.2500105970730501,-0.669030586093976,0.933579335793358,1.0,1.0,6/26,19.44%,PTPRM;RIN2;NRP2;GLUL;DNAJA4;GPLD1
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2741567525069265,-0.6677870957921317,0.9148073022312373,1.0,1.0,1/16,0.72%,CAMK2D
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.26344662318703904,0.6637616586449899,0.9213973799126638,0.9672147478556119,1.0,5/18,20.58%,ANO6;ANO2;LRRC8A;SLC6A1;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.26441901073782204,-0.6630537720868279,0.9186046511627907,1.0,1.0,4/19,12.72%,RYR3;EGR1;RRAGD;HRH1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.2169139255692512,-0.6591616640272354,0.9731663685152058,1.0,1.0,13/54,20.68%,SAT1;TUBB2A;SLC2A3;EGR1;ETS2;CFLAR;REL;PDLIM5;PNRC1;JUN;DRAM1;NR4A2;FOSL2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.27843526412652264,-0.6577863356247811,0.9161904761904762,1.0,1.0,2/16,5.72%,RUNX1;PSMA4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.25206801418976466,0.6544502726974966,0.9251559251559252,0.9723582859226628,1.0,9/19,27.78%,PSMB1;PRMT2;PSMB2;RGCC;FBXL7;PSMA1;PSME4;PSMA5;AVEN
prerank,KEGG_2021_Human__Autophagy,-0.25300292811411224,-0.6534311575753639,0.9259962049335864,1.0,1.0,6/25,16.26%,EIF2S1;EIF2AK3;RRAGD;RUBCN;PRKCQ;CFLAR
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.22492776808301712,0.6530493386971405,0.9678111587982833,0.9719717508581267,1.0,2/33,3.02%,RPS27A;RAB5A
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.27464030684367685,-0.6504767462469067,0.9001848428835489,1.0,1.0,5/17,12.40%,NUP93;HNRNPA2B1;ALKBH5;SRSF7;NUP42
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.27464030684367685,-0.6504767462469067,0.9001848428835489,1.0,1.0,5/17,12.40%,NUP93;HNRNPA2B1;ALKBH5;SRSF7;NUP42
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.24640598100569122,0.6497969606629485,0.9212765957446809,0.9728252508928732,1.0,3/21,7.90%,NUP210;SLC24A4;NUP107
prerank,KEGG_2021_Human__Cell cycle,0.2480362881654202,0.6475004378112992,0.9657534246575342,0.9730175467691753,1.0,3/21,9.00%,YWHAH;ANAPC1;SMAD3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.26593548113608956,-0.6461166038834988,0.9420289855072463,1.0,1.0,5/18,21.46%,CDH13;HIP1;CNOT9;BCAR3;EGFR
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.26335005122151256,-0.6440972128076495,0.9207547169811321,1.0,1.0,2/19,3.94%,GSTO1;PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.24875570999962424,-0.6410668887007783,0.9466911764705882,1.0,1.0,6/22,17.24%,DOCK10;ASAP3;BCAR3;RACK1;DOCK11;CALM3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.25787043561716655,-0.6377570772695622,0.9383429672447013,1.0,1.0,6/20,23.62%,RAB11A;RIN2;NRP2;TGFB2;GPLD1;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.21728237575902618,-0.6362264397616498,0.9744525547445255,1.0,1.0,9/47,16.90%,PID1;NCK1;LRPAP1;GRB14;SFRP4;ACVR1;SPRY3;PRKCQ;RACK1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.21805923916505293,-0.6352104505900764,0.9592592592592593,1.0,1.0,9/41,18.56%,EIF2S1;UQCRQ;EIF2AK3;CYCS;NDUFB1;COX7B;NDUFB10;SDHB;JUN
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.23235648282178026,-0.6314319585850424,0.9530956848030019,1.0,1.0,18/31,39.42%,HSP90AA1;EGR1;LRP8;TGFB2;CALM3;RELN;EZH2;CCN1;NOX4;IL34;IL6R;NEDD9;CALM2;SYAP1;ADCYAP1;DLG3;AXIN1;STRADB
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.27068237521742633,-0.6275015253422407,0.9127272727272727,1.0,1.0,4/15,19.44%,MET;RUBCN;MTMR8;GPLD1
prerank,KEGG_2021_Human__Prostate cancer,0.23334520652722618,0.6249533081587472,0.9575371549893843,0.9844249317416705,1.0,4/22,11.56%,FOXO1;MAPK3;HSP90B1;KRAS
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.23713296837902292,-0.6241738902853874,0.961038961038961,1.0,1.0,4/27,12.28%,RUNX1;FGFR2;ESR1;SFRP4
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.22497087804119495,-0.622321283382443,0.9623931623931624,1.0,1.0,11/31,29.12%,ELMOD2;CYLD;LRP8;CAMKMT;CNGB1;TRIM5;PPEF1;TMSB4X;STK24;SPAAR;CAV1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.25240237814088656,-0.6165186158484947,0.9534450651769087,1.0,1.0,5/20,12.40%,NUP93;HNRNPA2B1;ALKBH5;SRSF7;NUP42
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.25074776077773697,-0.6146835614813863,0.9602169981916817,1.0,1.0,5/18,18.06%,ADCY8;MCU;HOMER1;NUDT21;UGDH
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.2432361305013888,-0.6107706578116547,0.9528985507246377,0.999592742106236,1.0,8/22,22.50%,GLDC;TDO2;GLUL;GOT2;NOS1;DLD;KMO;DBT
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.23258889847798814,0.610143239463204,0.9664429530201343,0.9900308495842762,1.0,8/23,22.08%,NUP210;NUP107;HDAC3;H2BC5;NUP155;RBBP4;NUP85;NDC1
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.2342090258849091,-0.6082569966196282,0.9660714285714286,0.9985165956825782,1.0,13/24,37.80%,GRB14;TNFRSF10B;MERTK;SLC7A5;CAV1;ITGA4;SLC16A1;PROS1;PECAM1;ITGB1;ITGA6;INPP5D;SDC2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.21566654374865113,0.608170915066293,0.9782135076252724,0.9895044369701206,1.0,1/29,1.18%,CHGA
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2504286917603069,-0.60772840020187,0.9509090909090909,0.9964010762178974,1.0,4/18,17.24%,SVIL;RAB11A;KLHL13;CALM3
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.2477258474350131,-0.6073825910646048,0.9561068702290076,0.9941862825785688,1.0,2/18,8.82%,EIF2S1;EIF2AK3
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.22091888179004676,0.6072068004453944,0.9664570230607966,0.9885280424054206,1.0,9/26,22.08%,NUP210;SEC24A;NUP107;NUP155;SAR1B;IFNAR1;TRAF6;NUP85;NDC1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.2397898718486705,0.6030865188887502,0.9454926624737946,0.9887393576475163,1.0,4/17,18.62%,NFKBIZ;CX3CL1;MGST2;IL15
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.21934865158997371,0.6027237924349368,0.9745762711864406,0.9875387362550047,1.0,8/27,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFA4;NDUFB11;NDUFAB1;COX10;NDUFB8
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.2196158574401016,0.602021275411277,0.9708333333333333,0.9864646966965898,1.0,8/26,22.20%,NDUFB2;NDUFC1;NDUFC2;NDUFA4;NDUFB11;NDUFAB1;COX10;NDUFB8
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.23005485797604452,-0.6016082365079669,0.9684601113172542,0.9944573533595754,1.0,5/24,17.26%,HSP90AA1;BRK1;HRK;RACK1;MTLN
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.2206878728858874,0.5992871963038964,0.9760348583877996,0.9861854290749579,1.0,1/26,0.74%,RPS27A
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.22055170590103473,-0.5985769378007949,0.9752380952380952,0.9935380134041937,1.0,7/30,21.52%,THEMIS;PSMA4;NCK1;TXK;PRKCQ;PSMD2;PSMC6
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.24549427478967734,-0.5931011105166766,0.9610136452241715,0.993461264228319,1.0,4/17,21.62%,HSP90AA1;IL17D;JUN;TBK1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.20264055915207949,0.590278347239841,0.9918200408997955,0.9880313874796669,1.0,7/32,16.56%,TOR1AIP2;PRKD1;SURF4;COG2;NUP155;REEP3;SERP1
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.19392080521705815,-0.5885807284300976,0.9895470383275261,0.9928544448477471,1.0,14/49,23.76%,PDHA1;UQCRQ;CYCS;NDUFB1;COX18;COX7B;TIMMDC1;NDUFB10;SDHB;LDHA;IDH2;UQCR10;SUCLG2;UQCRC1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.22269650772427957,0.5883632949479477,0.9593147751605996,0.9873048963767854,1.0,3/25,8.52%,PARK7;SIRT1;DEPTOR
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.23756617698241145,0.5829850327338424,0.9694323144104804,0.9877180208610057,1.0,3/16,11.46%,PARK7;DEPTOR;PTPRQ
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.233796543455816,0.5800718103345386,0.9637526652452025,0.9873688575520615,1.0,6/17,22.08%,NUP210;NUP107;H2BC5;NUP155;NUP85;NDC1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.19761162778647542,0.5658668341170795,0.9955947136563876,0.9899294750903214,1.0,10/32,25.76%,CLEC2D;CXCL13;APPL1;IL15;CD276;CD81;PIANP;KLRD1;CD99;SPINK5
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.23360841547854605,-0.5616560319892098,0.9553903345724907,0.9992617738333305,1.0,5/16,29.12%,LRPAP1;RACK1;JUN;CARD18;CAV1
prerank,KEGG_2021_Human__Bile secretion,-0.23394435127092889,-0.5556892125361754,0.9758364312267658,0.9985680874116477,1.0,3/16,13.98%,ADCY8;ATP1A1;HMGCR
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.19917643951334546,-0.5540388499495484,0.9981684981684982,0.9966692325938448,1.0,5/34,19.42%,MET;SLC1A2;HRH1;ROS1;AHR
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.22094613344248656,-0.548054947215262,0.9811676082862524,0.9958223107527227,1.0,7/20,27.98%,GLDC;STARD4;HMGCR;PNRC1;SC5D;ALCAM;ANXA5
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.1988287453524904,-0.5469025789145144,0.988527724665392,0.9937859993469833,1.0,7/32,21.52%,THEMIS;PSMA4;NCK1;TXK;PRKCQ;PSMD2;PSMC6
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2202115708763423,0.5447750151941023,0.9726315789473684,0.9931408046227695,1.0,6/16,26.62%,PSMB1;PSMB2;TRAF6;PSMA1;PSME4;PSMA5
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.20795701217732077,-0.5446749790954725,0.9835466179159049,0.9919539213952143,1.0,13/27,33.14%,KCNH8;NUP93;CHMP4B;NUP42;NUP50;EGFR;CEBPD;EZH2;USH2A;RBBP7;TSG101;RNF103-CHMP3;ITGB1
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.21903144419380122,-0.5275816070985864,0.9770114942528736,0.9930606704588647,1.0,8/17,31.86%,RAB11A;RIN2;RAB3IP;RAB18;RAB21;DENND2B;RAB8B;RAB31
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.2069492010012568,-0.5146691996685896,0.9942418426103646,0.9927646235743822,1.0,9/19,35.84%,ATP8B2;FBXW8;BLZF1;MYO18A;PI4K2B;FAM174B;COG3;USP6NL;SPTBN5
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.20621167403567997,0.49004425027573667,0.9897330595482546,0.999096189187419,1.0,1/15,3.02%,RAB5A
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.19279698076645568,0.48697136856344764,0.9956803455723542,0.9979577586589746,1.0,1/19,4.96%,SORCS1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.155995876704845,0.3868143522851837,1.0,0.9998727461566532,1.0,6/16,29.52%,MTHFD2L;MTRR;ORMDL1;MCCC2;ACOT11;PANK2
